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1.Riassunto della tesi 
L’obesità è una condizione caratterizzata da un eccessivo accumulo di grasso corporeo, 
soprattutto a livello viscerale, che determina gravi danni alla salute. L’obesità è causata, nella 
maggior parte dei casi, da stili di vita scorretti (da una parte, un’alimentazione ipercalorica, e 
dall’altra, ridotta o nulla attività fisica). Dal punto di vista eziologico l’obesità è una patologia 
multifattoriale associata a diverse condizioni patologiche quali insulino-resistenza, diabete 
mellito di tipo 2, ipertensione, aterosclerosi e steatosi epatica da cause non alcolica (NAFLD). 
L’obesità è, attualmente, uno dei più importanti problemi di salute pubblica nel mondo, 
giacché la sua prevalenza è in costante aumento. L’obesità rappresenta, pertanto, una delle 
principali sfide nel campo della ricerca che, da un lato, studia i meccanismi cellulari/tissutali 
coinvolti nello sviluppo e nella progressione della patologia a livello dei diversi organi, 
dall’altro, cerca di identificare composti naturali e sintetici per il trattamento di questa 
condizione, da associare alla dieta e ad una adeguata attività fisica. 
La presente Tesi di Dottorato si inserisce in tale contesto, proponendosi di studiare, dapprima 
i meccanismi molecolari associati ad un eccessivo accumulo di grasso in diversi tipi cellulari 
rappresentativi dei tessuti coinvolti nell’obesità, successivamente di identificare e studiare 
composti naturali (di origine vegetale o comunque endogeni) che possano esercitare effetti 
benefici sui modelli cellulari messi a punto. A tale scopo si sono sviluppati e utilizzati i seguenti 
modelli cellulari di NAFLD, ipertrofia del tessuto adiposo (obesità) e disfunzione endoteliale 
(aterosclerosi): 
• Un modello in vitro di NAFLD che consiste di cellule di epatoma di ratto trattate con 
diversi agenti steatogeni in modo da mimare in vitro gli step che accompagnano la 
progressione della NAFLD in vivo da semplice steatosi a steatoepatite. 
• Un modello in vitro di aterosclerosi che consiste di cellule endoteliali vascolari umane 
esposte ad una miscela di acidi grassi. 
• Un modello in vitro di ipertrofia adipocitaria, rappresentato da pre-adipociti di topo 
trattati con una miscela di sostanza adipogeniche e, successivamente con acidi grassi 
a catena lunga per indurre un quadro di ipertrofia in vitro. 
Partendo dai diversi modelli cellulari sopra citati, l’attività di ricerca si è concentrata sullo studio 
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dei possibili effetti benefici di diversi composti: 
• La silibina, molecola di origine naturale che rappresenta il principale componente della 
silimarina, un estratto del cardo mariano (Silybum marianum). Partendo da precedenti 
studi, sia clinici che su animali, che suggerivano un potenziale effetto benefico della 
silibina a livello epatico, questa tesi ha indagato gli effetti ed i meccanismi molecolari 
del trattamento con silibina nel modello in vitro di NAFLD. 
• La S-Adenosilmetionina (SAMe), una molecola endogena che agisce come principale 
donatore di gruppi metile a livello cellulare. Precedenti studi avevano osservato che 
bassi livelli epatici di SAMe sono correlati a condizioni patologiche a carico del fegato. 
In questa tesi si è andati a valutare se e con quali meccanismi molecolari il SAMe 
potesse migliorare una condizione di steatosi epatica e di disfunzione endoteliale 
utilizzando i due modelli in vitro. 
I risultati hanno dimostrato: (i) che i tre sistemi cellulari in vitro messi a punto 
rappresentano un buon modello delle diverse condizioni fisio-patologiche di interesse, 
ovvero steatosi epatica (NAFLD), disfunzione endoteliale (aterosclerosi) ed ipertrofia 
adipocitaria (obesità); (ii) che sia la silibina che il SAMe hanno significative proprietà 
benefiche. In particolare entrambi i composti hanno dimostrato un effetto anti-steatosico 
ed antiossidante nel modello in vitro di steatosi epatica. Il SAMe ha mostrato anche una 
significativa attività antiossidante e citoprotettiva su cellule endoteliali disfunzionali. 
In conclusione, possiamo affermare che i tre modelli messi a punto ed utilizzati in questa 
tesi rappresentano un buon modello sperimentale in vitro per lo studio dei meccanismi 
molecolari e biochimici coinvolti in condizioni patologiche complesse e che possono essere 




2.Summary of the thesis 
Obesity is a condition characterized by an excessive accumulation of body fat, especially at the 
visceral level, which causes serious damage to health. Obesity is caused, in most cases, by 
unhealthy lifestyles (on the one hand, a high-calorie diet, and on the other, reduced or no 
physical activity). From an etiological point of view obesity is a multifactorial disease associated 
with various pathological conditions such as insulin resistance, type 2 diabetes mellitus, 
hypertension, atherosclerosis and non-alcoholic liver steatosis (NAFLD).  
Obesity is currently one of the most important public health problems in the world, as its 
prevalence is constantly increasing. Obesity therefore represents one of the main challenges in 
the field of research which, on one side, studies the cellular/tissutal mechanisms involved in the 
development and progression of the disease at the level of the different organs and, on the other 
side, tries to identify natural and synthetic compounds for the treatment of this condition, to be 
associated with diet and adequate physical activity. 
This PhD thesis is part of this context, with the aim of studying, first, the molecular mechanisms 
associated with excessive fat accumulation in different cell types representative of the tissues 
involved in obesity, then to identify and study natural compounds (of plant origin or otherwise 
endogenous) that may have beneficial effects on the cellular models developed. 
For this purpose, the following cellular models of NAFLD, adipose tissue hypertrophy (obesity) 
and endothelial dysfunction (atherosclerosis) have been developed and used:  
• An in vitro model of NAFLD consisting of rat hepatoma cells treated with different 
steatogenic agents in order to mimic in vitro the steps of the progression of NAFLD in vivo 
from simple steatosis to steatohepatitis. 
• An in vitro model of atherosclerosis, consisting of human umbilical vein endothelial 
cells exposed to a mixture of fatty acids. 
• An in vitro model of adipocytic hypertrophy, represented by mouse pre-adipocytes 
treated with a mixture of adipogenic substances and then with long chain fatty acids 
to induce a picture of hypertrophy in vitro. 
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Starting from the different cellular models mentioned above, the research activity has been 
focused on the study of the possible beneficial effects of different compounds: 
• Silybin, a natural molecule, that represents the main component of silymarin, an 
extract from Silybum marianum. Starting from previous studies, both clinical and 
animal, which suggested a potential beneficial effect of silybin on the liver, this thesis 
investigated the effects and molecular mechanisms of this molecule treatment in the 
in vitro model of NAFLD. 
• S-Adenosylmethionine (SAMe), an endogenous molecule that acts as the main donor 
of methyl groups at the cellular level. Previous studies had observed that low levels 
of SAMe in the liver are related to pathological organ conditions. In this thesis it was 
evaluated whether and by what molecular mechanisms SAMe could improve a 
condition of liver steatosis and endothelial dysfunction using the two in vitro models. 
The results have shown that: (i) the three in vitro cellular systems developed duing this thesis 
work represent a good model of the different physio-pathological conditions of interest, liver 
steatosis (NAFLD), endothelial dysfunction (atherosclerosis) and adipocytic hypertrophy 
(obesity); (ii) both silybin and SAMe have significant beneficial properties. In particular, both 
compounds have demonstrated an anti-steatotic and antioxidant effect in the in vitro model of 
liver steatosis. SAMe also showed significant antioxidant and cytoprotective activity on 
dysfunctional endothelial cells.  
In conclusion, we can say that the three models developed and used in this thesis represent a 
good in vitro experimental model for the study of molecular and biochemical mechanisms 
involved in complex pathological conditions and that they can be effectively used for the study 
of possible natural compounds to be used as nutraceuticals. 
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3.Aim of the study 
Nowadays, obesity represents one of the main global health problems and the prevalence of this 
condition is continuously increasing in industrialized societies and also in developing countries. 
The present thesis is aimed at studying the molecular mechanisms associated with an excessive 
accumulation of fat in different cell types representative of the main tissues involved in obesity, 
and then to identify and study natural compounds (of plant origin or otherwise endogenous) 
that may have beneficial effects on the cellular models developed and that could be employed 
as nutraceuticals. 
Our interest has been focused, in particular, on liver, vascular endothelium and adipose tissue, 
as these tissues/organs cooperate in onset and progression of obesity and obesity-related 
disorders. For this aim, I developed and employed different cellular models mimicking in vitro 
hepatosteatosis (NAFLD), endothelial dysfunction (atherosclerosis) and adipocyte hypertrophy 
(obesity). The in vitro model of NAFLD consists of rat hepatoma cells treated with different 
steatogenic agents to mimic in vitro the progression of NAFLD from simple steatosis to 
steatohepatitis. A human umbilical vein endothelial cell line exposed to a mixture of fatty acids 
has been used to mimic in vitro atherosclerosis. A mouse pre-adipocyte cell line treated with an 
adipogenic mixture and with long chain fatty acids represent the model of hypertrophy in vitro. 
Starting from these well consolidated cell models, the second part of my activity investigated 
the possible beneficial effects of two natural compounds that might find application as 
nutraceuticals: silybin, the main component of Silybum marianum, and SAMe, an endogenous 




The epidemic of overweight and obesity –“globesity”– in the developed world is continuously 
increasing and represents a major challenge in term of chronic disease prevention and health 
across the life. Obesity is one of today’s main public health problems, paradoxically coexisting 
with undernutrition. Fueled by economic growth, industrialization, sedentary lifestyle and a 
nutritional transition to processed foods and high calorie diets over the last 30 years, in many 
countries the prevalence of obesity is double, and even quadruple. However, the obesity 
epidemic is not restricted to industrialized societies: in developing countries over 115 million 
people suffer from obesity-related problems. According to the World Health Organization 
(WHO), the worldwide prevalence of obesity nearly tripled between 1975 and 2016 and, 
overall, about the 13% of the world’s adult population (11% of men and 15% of women) were 
obese in 2016. 
Obesity is a complex multifactorial disease which is generally defined as a medical condition 
in which excess body fat has accumulated to an extent that it may have a negative effect on 
health. Obesity is commonly caused by a combination of excessive food intake, lack of physical 





Figure 1. Metabolic syndrome and obesity: scheme of the metabolic syndrome and related disorders 
 
Obesity, abdominal obesity especially, is one of the first features of the metabolic syndrome, 
which refers to the co-occurrence of several known pathological conditions, including insulin 
resistance, obesity, non-alcoholic fatty liver disease (NAFLD), atherogenic dyslipidemia and 
hypertension. These conditions are interrelated and share underlying mediators, mechanisms 
and pathways. 
As the prevalence of obesity increases, so does the burden of its associated co-morbidities: 
obesity greatly increases risk of chronic disease morbidity, such as type 2 diabetes, 
cardiovascular disease, certain cancers. 
4.1 Non-alcoholic fatty liver disease 
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic 
syndrome. It is defined by excess fat accumulation in the form of triglycerides (TG) in the 
hepatocytes, due to causes other than significant alcohol consumption or other medical 
conditions. NAFLD encompasses the simple steatosis (NAFL, non-alcoholic fatty liver) to larger 
steatosis with associated inflammation (NASH, non-alcoholic steatohepatitis), fibrosis, 
cirrhosis, and in some cases hepatocellular carcinoma (HCC). Despite its high prevalence, only 
a small minority of patients with steatosis develops inflammation and subsequent fibrosis and 
chronic liver disease. 
Steatosis is histologically defined by the visible accumulation of macro- and/or micro- vesicular 
lipid droplets (LDs) in cytosol of more than 5% of hepatocytes; when the capacity of 
hepatocytes to safely store excess TG in LDs is exceeded, hepatic injury may occur (Vergani, 
2019). 
At the molecular level, hepatic steatosis develops when uptake and/or de novo synthesis of 
free fatty acids (FA) in the liver exceed oxidation and/or secretion. Therefore, the excess FA 
triggering steatosis may derive from different sources: (i) the plasma FA delivered by adipose 
tissue (pathway 1); (ii) de novo hepatic lipogenesis (DNL) (pathway 2); (iii) dietary FA 
transported as intestinally-derived chylomicron (pathway 3) (Rinella, 2015; Bradbury and 
Berk, 2004). 
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The etiopathogenesis of NAFLD is rather complex and multifactorial. In the past, the two-hit 
model of NAFLD development was widely accepted, with the first hit consisting in hepatic lipid 
accumulation depending on different causes, followed by a second hit activating pro- 
inflammatory events (Day and James, 1998). As it has evidently emerged that (i) accumulation 
of triglycerides in hepatocytes may be a protective mechanism from liver damage, and (ii) 
hepatic inflammation can precede the simple hepatic steatosis and can also be a cause of 
steatosis, it has been suggested that many “hit” factors may act simultaneously leading to the 
development of NAFLD (Tilg and Moschen, 2010). The multiple-hit hypothesis proposes that 
many hit factors can interact with each other, forming a vicious circle. Among them there are 
dietary habits, environmental and genetic factors that can lead to development of insulin 
resistance, obesity with adipocyte proliferation and hypertrophy, and changes in gut 
microbiome. Insulin resistance is one of the key factors in the development of NAFLD and 
results in increased hepatic de novo lipogenesis and impaired inhibition of adipose tissue 
lipolysis, with consequent increased flux of fatty acids to the liver. At the liver level, fatty acids 
overflow may result in endoplasmic reticulum stress and mitochondrial dysfunction and 
consequent activation of inflammatory responses. Furthermore, genetic factors might explain 
certain more progressive disease courses in NAFLD. 
4.2 In vitro models of NAFLD progression 
NAFLD represents the hepatic manifestation of metabolic syndrome associated to obesity and 
it is the most common chronic liver disease in Western countries (Loomba and Sanyal, 2013). 
NAFLD is a growing challenge in term of prevention and treatment. In the light of that, the full 
understanding of the mechanisms underlying the onset and progression of NAFLD is of 
extreme importance: despite the new findings in this field, knowledge on the pathogenesis of 
NAFLD is still incomplete. 
In the last decades, cellular models have been developed to elucidate the molecular 
mechanisms involved in the progression of NAFLD. Hepatocytes exposed to high 
concentrations of FA in vitro result in lipid overload which is similar to the steatosis observed 
in both patients and animal models with NAFLD. In the present study, we aimed to develop an 
in vitro model of NAFLD progression to study the molecular mechanisms sustaining 
pathogenesis and development of liver steatosis/steatohepatitis. 
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For this purpose, we employed the rat hepatoma cell line FaO (European Collection of Cell 
Cultures, Sigma-Aldrich Corp., Milan, Italy). FaO cells maintain many hepatocytes specific 
markers and were exposed to different steatogenic agents to mimic what happens in vivo 
during NAFLD. Cells were exposed to: 
- Oleate and palmitate mixture for 3 hours (2:1 molar ratio, final concentration of 0.75 
mM). High levels of circulating FA provide the main source for the hepatic TG synthesis: 
in patients with NAFLD approximately 60% of hepatic TG is synthesized from FA 
deriving from adipose tissue, 26% from DNL, and 15% from the diet (Donnelly et al., 
2005). A critical point for in vitro NAFLD model is the choice of exogenous FA to be 
used, since FA have different steatotic and toxic activity. In normal and in NAFLD 
subjects, the most abundant FA are oleic acid (18:1) and palmitic acid (16:0). The 
treatment with a mixture of these two FA in FaO cells well mimic an in vitro mild 
steatosis. 
- Fructose for 24 hours (final concentration 5.5 mM). The fructose is a monosaccharide 
and in the past, was considered a beneficial dietary component since it does not 
stimulate insulin secretion. Sucrose and high fructose corn syrup are increasingly 
present in our food as alimentary additive. However, the harmful effects of fructose 
have recently gained mainstream attention. Recent studies have reported that high 
fructose intake stimulates de novo lipogenesis (Hudging et al, 2011), and mice fed with 
a diet of fats and high-fructose corn syrup developed equally severe NAFLD (Tetri et 
al., 2008): high fructose in the diet induces: leptin resistance, insulin resistance, and 
increases the blood level of triglycerides. 
- Tumor necrosis factor (TNFα) for 24 hours (final concentration 10 ng/ml). Oxidative 
stress and release of pro-inflammatory cytokines are major consequences of hepatic 
lipid overload. TNFα is a pro-inflammatory cytokine which is associated with insulin 
resistance and systemic inflammatory responses and has a main role in NAFLD 
progression. Therefore, high serum levels of TNFα have been found in patients with 
NASH compared with healthy subjects (Crespo et al., 2001). TNFα plasma levels 
correlate positively with the grade of liver fibrosis in patients with advanced stages of 
NAFLD. For this reason, we choose TNFα as a hit to mimic in vitro NAFLD progression. 
4.3 Atherosclerosis and endothelial dysfunction 
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Visceral obesity and insulin resistance are associated to chronic inflammation and it depends 
mainly on the overproduction of many adipokines such as TNF𝛼, interleukin 1 (IL1), IL6, leptin, 
and adiponectin. These pro-inflammatory molecules act on different systems and tissue types, 
including endothelial cells where can induce a chronic, subclinical vascular inflammation 
which may result in atherosclerosis. 
Endothelium is a semi-permeable barrier between the blood and the tissues and acts as a 
metabolically active organ regulating vascular homeostasis. Endothelial 
dysfunction/activation is the early step in the atherosclerosis, a progressive disease 
characterized by the accumulation of lipids and fibrous elements in arteries (Marchesini et al., 
1999; Cortez-Pinto et al., 1999; Villanova et al., 2005). Hepatic steatosis and insulin resistance 
trigger vascular endothelial dysfunction leading to a decrease in synthesis/release of NO (Liao, 
2013). 
Both ROS generation and nitric oxide (NO) release are involved in the endothelial dysfunction 
in atherosclerosis. NO plays cardio-protective effects acting as vasodilator and inhibitor of 
platelets aggregation; some reports described NO-induced abnormal vasodilation in patients 
with IR (Williams et al., 1996), other ones showed a reduced vasodilation in hypertensive 
patients with liver steatosis (Sciacqua et al., 2011). In endothelial plasma membrane, ICAM-1, 
an immunoglobulin that mediates cell-cell adhesion (Heiska et al., 1998; Kevil et al., 2003), is 
over-expressed as a response to ROS and pro- inflammatory cytokines. ICAM-1 seems to be 
involved in endothelial cell migration, and in endothelial NO synthase (eNOS) activation. In 
atherosclerotic patients, ICAM-1 over- expression in endothelial cells of coronary plaques has 
been reported (Boyle et al., 2000). In mouse, endothelial dysfunction is associated to impaired 
endothelial autophagy which protects cells from oxidative stress resulting in liver fibrosis 
(Ruart et al., 2019). 
During my thesis work, I aimed to develop an in vitro model of atherosclerosis to study the 
molecular effects of synthetic compounds that can improve the condition of oxidative stress 
and counteract the atherogenic factors. For this purpose, we employed the human endothelial 
cell line (HECV) isolated from umbilical vein (Cell Bank and Culture, GMP-IST, Genoa, Italy). As 
for FaO cells, HECV cells were exposed to an oleate and palmitate mixture for 3 hours (2:1 
molar ratio, final concentration of 0.75 mM). The treatment with a mixture of these two FA in 
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HECV cells mimic an in vitro atherosclerosis, by increasing intracellular lipid content and 
oxidative stress. 
4.4 Adipocyte hypertrophy 
The metabolic syndrome is a complex network which correlates with NAFLD, endothelial 
dysfunction and adipocyte hypertrophy. During adipogenesis, fibroblast-like pre-adipocytes 
differentiate into mature adipocytes through a rearrangement of the molecular machinery 
where lipogenic processes are promoted and fatty acid uptake and triglyceride accumulation 
are increased. Mature adipocytes strictly regulate the balance between lipogenesis and 
lipolysis, and produce a panel of adipokines such as leptin, resistin, adiponectin, tumor 
necrosis factor-a (TNF-α), interleukin-1b (IL-1b) that modulate metabolism of the other tissues 
(Rajala and Scherer, 2003). 
Enlarged adipocytes are associated with insulin resistance and are an independent predictor 
of type 2 diabetes. To understand the molecular link between adipocyte hypertrophy and 
metabolic diseases we developed a procedure for inducing hypertrophy. To do this we used 
an in vitro model in which mature 3T3-L1 adipocytes were loaded with oleate/palmitate 
mixture, resulting in artificially hypertrophied mature adipocytes. 
During my thesis work, I aimed to develop an in vitro model of adipocyte hypertrophy to assess 
differences between mature and hypertrophic adipocytes. For this purpose, we employed the 
mouse fibroblast cell line 3T3L1 from the American Type Culture Collection (Manassas, VA, 
USA). In order to induce adipocyte differentiation, cells were at 2-day post confluence, cells 
were treated with the differentiation mixture containing 1μM insulin, 1μM dexamethasone 
(DEX), and 500μM 3-isobuthyl-1-methylxanthine (IBMX) to the culture medium for 2 days. 
Then, cells were incubated with 100nM insulin for 7 days, changing the medium every 2–3 
days. In all experiments, more than 90% of the cells were mature adipocytes after 10 days of 
incubation. Adipogenic differentiation was monitored at different days by lipid staining. To 
induce cellular hypertrophy, mature adipocytes were exposed to oleate and palmitate mixture 
(1 mM) for 2 days. 
4.5 Effects of natural and synthetic compounds on lipid 
accumulation and inflammation in hepatocytes and 
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endotheliocytes 
Definitive treatments for NAFLD and obesity are lacking so far and there are no medications 
approved by the U.S. Food and Drug Administration (FDA) or European Medicine Agency. 
Dietary intervention, regular exercise, and weight loss could improve some of the metabolic 
factors and potentially offset the development of NAFLD. 
In the light of that, in recent years, the increase in cases of NAFLD and NASH has stimulated the 
scientific community to identify compounds that can improve the condition of oxidative stress 
and counteract the atherogenic factors. These molecules could be useful in the treatment of 
these pathological conditions and prevent or slow down the progression in fibrosis and/or 
cirrhosis: this represents one of the most important challenges for the scientific community in 
the coming years. 
4.6 Silybin (from Silybum marianum) 
As an important category of phytochemicals, natural polyphenols have attracted increasing 
attention as potential agents for the prevention and treatment of liver diseases. Polyphenols 
are phenolic compounds containing benzene rings attached with one or more hydroxyl 
groups. Based on their chemical structure, polyphenols are classified into two major groups: 
flavonoids and non-flavonoids. Flavonoids are composed of two aromatic rings connected by 
a three-carbon bridge; they include subgroups of flavonols, flavones, flavan-3-ols, flavanones, 
isoflavones, and anthocyanidins. In nature, the majority of flavonoids are present as glycosides 
so that they have increased structural stability. Non-flavonoids encompass the rest of 
polyphenols, such as stilbenes (resveratrol), lignans, and phenolic acids. 
Silymarin is an extract of the milk thistle seeds (Silybum marianum L. Gaertner, Compositae) 
containing a mixture of flavonolignans (silybin, isosilybin, silycristin, silydianin and others). 
Silybin, which is the major active constituent of silymarin and represents the 70% of the total 
composition of the mixture, has been demonstrated to exert antioxidant, anti-inflammatory 
and antifibrotic properties (Gazak et al., 2007; Loguercio et al., 2012). 
These compounds exhibit a number of pharmacological effects, particularly in the liver: many 
studies demonstrated that silybin ameliorate liver damage and diabetes in animal models of 
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NASH and in patients with diabetes (Serviddio et al., 2010; Di Sario et al., 2005). Recent studies 
from our group demonstrate that silybin exerts an antisteatotic and antioxidant effect also in 
in vitro models of NAFLD and NASH (Vecchione et al., 2016). 
Research conducted so far explained only partially the mechanisms through which the silybin 
exerts its effects. The aim of this project was to clarify the mechanism of action of the silybin 
by using the in vitro model of steatosis explained before. 
4.7 S-adenosylmethionine (SAMe) 
S-adenosylmethionine (SAMe) is an endogenous and pleiotropic common substrate involved 
in many crucial biochemical pathways, including biosynthesis of hormones and 
neurotransmitters (Cantoni, 1985; Bottiglieri, 2001). Although these anabolic reactions occur 
throughout the body, most SAM-e is synthesized and consumed in the liver or distributed 
throughout the body. SAMe is the main methyl donor in mammalian cells, where it transfers 
a methyl group to an acceptor molecule such as DNA, proteins and phospholipids, modifying 
their structure and function. Indeed, DNA methylation switch on/off the gene transcription, 
protein methylation regulates the enzyme activity, phospholipid methylation modulates 
membrane fluidity. Moreover, SAMe is precursor for cysteine, one of the amino acids of 
glutathione, the major physiological defence against reactive oxygen species (ROS), thus it acts 
also as protection against oxidative stress. 
SAMe has been reported to be involved in many liver diseases (Lu and Mato, 2012; Mato, 
2013). Reduced hepatic SAMe levels were described in patients with alcoholic hepatitis 
resulting in decreased hepatic GSH levels (Lee et al., 2004), and SAMe administration has been 
shown to normalize the GSH levels (Vendemiale et al., 1989). Many studies done mostly in 
alcoholic liver disease, cholestasis of pregnancy, and primary biliary cirrhosis have shown 
significant improvement in liver test abnormalities during therapy with SAMe (Anstee and 
Day, 2012). 
Part of the present project was to investigate if SAMe might improve fatty liver disease in rat 
hepatoma cells representing a reliable in vitro model for hepatic steatosis. As FAs seem to play 
also direct effects on oxidative stress of vascular endothelium (Zhou et al., 2009), we used also 
human endothelial HECV cells exposed to FA mimicking the in vivo atherosclerosis, as 
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endothelial damage is typically observed in metabolic syndrome. 
4.8 Cellular models 
Three different cell lines have been employed: 
• FaO cells, a rat hepatoma cell line, to mimic NAFLD onset and progression. The FaO 
rat hepatoma cells were supplied by European Collection of Cell Cultures, (ECCC-
Sigma-Aldrich Corp.). They express a broad array of liver-specific mRNAs and maintain 
the ability to assemble and secrete VLDL as well as to respond to stimuli that activate 
transcription factors such as PPARs (Grasselli et al., 2017; Clayton et al., 1985; Lauris 
et al., 1986). Therefore, this cell line is a good and widely employed cellular system 
maintaining the main features of rat hepatocytes. 
In our experiment, FaO cells at 70-80% confluence were incubated in starvation 
medium (F12 Coon’s modified medium supplemented with 0.25% BSA) with different 
steatogenic agents. It is noteworthy that basal lipid content of FaO cells is much lower 
than that of primary hepatocytes, thus, steatogenic treatments resulted in a more 
rapid and pronounced triglyceride accumulation with respect to primary cultured 
hepatocytes. The exposure to different steatogenic agents alone or in combination, 
led to a marked increase in number and size of cytosolic lipid droplets. These 
observations candidate lipid-loaded FaO cells as a reliable and convenient in vitro 
model of NAFLD (Grasselli et al., 2011). 
• HECV cells, a human endothelial vascular cell line, to mimic human endothelium 
dysfunction. The human endothelial cell line (HECV) was supplied by Cell Bank and 
Culture (GMP-IST- Genoa, Italy). These cells were isolated from human umbilical vein 
and maintain a good number of endothelium function; indeed, they are widely 
employed for in vitro studies. Cells were grown in Dulbecco’s modified Eagle’s 
medium high glucose (D-MEM) supplemented with L-glutamine and 10% FCS. For 
treatments, cells were grown until 80% confluence and, to mimic in vitro the effect 
of high fat diet, were treated with a mixture of long-chain fatty acids (Vergani et al., 
2018). The exposure to oleate and palmitate led to a marked fat accumulation into 
cells, thus suggesting lipid loaded HECV cells represents a reliable in vitro model of 
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endothelial disfunction. 
• 3T3L1 cells, a mouse pre-adipocyte cell line. 3T3-L1 mouse fibroblasts were 
purchased from the American Type Culture Collection (Manassas, VA, USA). The 3T3-
L1 cells are well-established murine preadipocytes displaying a fibroblast-like 
morphology that, under appropriate conditions, progress towards an adipocyte-like 
phenotype (Green and Meuth, 1974). A large body of articles have employed 3T3-L1 
cells to investigate adipogenesis and obesity-related characteristics. One of the main 
advantages of this cell line is that provides a homogenous and reproducible system 
(Poulos et al., 2010). Cells were maintained in Dulbecco’s modified Eagle medium (D-
MEM) containing 25 mmol/l glucose and 10% Foetal Bovine Serum (FBS, Euroclone, 
Milan, Italy). Adipogenesis was induced by adding the differentiation mixture (1μM 
insulin, 12μM dexamethasone and 500μM 3-isobuthyl-1-methylxanthine) to the 
culture medium for 2 days. Then, cells were incubated with 1μM insulin for 7 days. 
More than 90% of the cells were mature adipocytes after 10 days of incubation. To 
induce cellular hypertrophy, mature adipocytes were exposed to oleate/palmitate 
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ABSTRACT 
AIM: To investigate in vitro the therapeutic effect and mechanisms of silybin in a cellular 
model of hepatic steatosis. 
METHODS: Rat hepatoma FaO cells were loaded with lipids by exposure to 0.75 mmol/L 
oleate/palmitate for 3 h to mimic liver steatosis. Then, the steatotic cells were incubated for 
24 h with different concentrations (25 to 100 μmol/L) of silybin as phytosome complex with 
vitamin E. The effects of silybin on lipid accumulation and metabolism, and on indices of 
oxidative stress were evaluated by absorption and fluorescence microscopy, quantitative real-
time PCR, Western blot, spectrophotometric and fluorimetric assays. 
RESULTS: Lipid-loading resulted in intracellular triglyceride (TG) accumulation inside lipid 
droplets, whose number and size increased. TG accumulation was mediated by increased 
levels of peroxisome proliferator-activated receptors (PPARs) and sterol regulatory element- 
binding protein-1c (SREBP-1c). The lipid imbalance was associated with higher production of 
reactive oxygen species (ROS) resulting in increased lipid peroxidation, stimulation of catalase 
activity and activation of nuclear factor kappa-B (NF-κB). Incubation of steatotic cells with 
silybin 50 μmol/L significantly reduced TG accumulation likely by promoting lipid catabolism 
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and by inhibiting lipogenic pathways, as suggested by the changes in carnitine 
palmitoyltransferase 1 (CPT-1), PPAR and SREBP-1c levels. The reduction in fat accumulation 
exerted by silybin in the steatotic cells was associated with the improvement of the oxidative 
imbalance caused by lipid excess as demonstrated by the reduction in ROS content, lipid 
peroxidation, catalase activity and NF-κB activation. 
CONCLUSION: We demonstrated the direct anti- steatotic and anti-oxidant effects of silybin 
in steatotic cells, thus elucidating at a cellular level the encouraging results demonstrated in 
clinical and animal studies. 
Key words: Non-alcoholic fatty liver disease; Steatotic hepatocytes; Silybin; Lipid metabolism; 
Oxidative stress; Lipid droplets; Mitochondrial β-oxidation 
 
INTRODUCTION 
Non-alcoholic fatty liver disease (NAFLD) is characterized by excess fat accumulation, mainly in 
the form of triglycerides (TGs), in hepatocytes of subjects who do not consume excess alcohol. 
NAFLD definition encompasses a large spectrum of liver abnormalities which range from the 
simple steatosis, to nonalcoholic steatohepatitis (NASH), till to cirrhosis and hepatocellular 
carcinoma (Brunt et al., 2015; Rinella, 2015). NAFLD is the most common cause of abnormal 
liver function tests in Western countries, and evidences substantiate a strong association 
between NAFLD and metabolic abnormalities such as obesity, insulin resistance, and metabolic 
syndrome (Portincasa et al., 2004). 
In the hepatocyte, TGs (Alkhouri et al., 2009) are synthesized from fatty acids (FAs) deriving 
from three major sources: plasmatic non-esterified fatty acids (NEFAs) from adipose tissue, de 
novo lipogenesis, and dietary FAs (Donnelly et al., 2005). Uptake of FAs by hepatocytes is 
related to their serum concentrations and is mediated by different classes of fatty acid 
transport proteins (Nakamura et al., 2014). In the liver, FAs follow three different destinations: 
(1) oxidation, mainly in mitochondria, but also in extra-mitochondrial organelles such as 
peroxisomes; (2) assembly and export as very low-density lipoproteins (VLDL); and (3) storing 
as TGs within lipid droplets (LDs). 
Storing of excess TGs in LDs is a protective mechanism against FA-induced toxicity that is mainly 
related to FA oxidation. Most FAs are metabolized through β-oxidation in mitochondria which 
is primarily regulated by carnitine palmitoyltransferase 1 (CPT-1) required for transport of long-
chain fatty acids into mitochondria (Ramsay et al., 2001). Over-active FA oxidation leads to 
over- production of reactive oxygen species (ROS) with consequent oxidative stress (Fromenty 
and Pessayre, 1995; Seifert et al., 2010). Excess ROS as well as pro-inflammatory cytokines can 
activate inflammatory signaling such as that sustained by the transcription factor nuclear 
kappa-B (NF-κB) which is implicated in the response to oxidative stress (Cnop et al., 2012). 
In light of these considerations, a reduction in liver steatosis through a stimulation of lipolytic 
pathways may potentially expose hepatocytes to the damaging effect of excess free FAs 
(Yamaguchi et al., 2007) and this point has to be considered when anti-steatotic molecules are 
tested for therapeutic applications. 
 
Medicinal plants have become popular as the source of dietary supplements (Chang, 2000). 
Flavonoids, a large class of polyphenolic products, are well-known antioxidants and free radical 
scavengers (Kandaswami and Middleton, 1994). Silymarin, the standardized extract from milk 
thistle (Sylibum marianum), and its major active compound silybin, have been used for a long 
time as a hepatoprotective agents for the treatment of acute and chronic liver diseases (Saller 
et al., 2001). Previous clinical findings evidenced the efficacy of silybin on insulin resistance and 
liver injury in patients with NAFLD (Federico et al., 2006). Moreover, in a recent study on sixty 
four patients with NASH, silymarin helped to lower the hepatic enzymes, particularly ALT (Solhi 
et al., 2014). The improvement of liver histology after silybin treatment was recently reported 
in a multicenter randomized controlled trial (Loguercio et al., 2012). However, the molecular 
mechanisms associated with the hepatoprotective activity of silybin remain to be elucidated. 
The hepatic lipid metabolism is governed by two main families of transcription factors, the 
peroxisome proliferator-activated receptors (PPARs) that regulate both lipogenic and lipolytic 
pathways (Huang et al., 2012), and the sterol regulatory element-binding proteins (SREBPs) 
that stimulate sterol and fatty acid biosynthesis (Ferrè and Foufelle, 2010;  Shimano, 2001). FAs 
are endogenous ligands of all PPAR isoforms (Nakamura et al., 2014); uptake of FAs into 
hepatocytes and their oxidation is regulated mainly by PPARα, while their esterification and 
conversion to TGs by PPARγ and SREBP-1, whose expression typically increases in NAFLD 
(Eberlè et al., 2004). Moreover, macroautophagy, a process that leads to the degradation of 
cellular constituents through lysosomes (Mizsushima et al., 2002), participates in lipid 
metabolism through the breakdown of LDs (lipophagy). A decreased autophagic function may 
promote the development of hepatic steatosis and the progression of steatosis to NASH 
(Komatsu et al., 2005). The autophagy-related protein 7 (Atg7) is considered essential for this 
process in mammalian cells (Komatsu et al., 2005). 
This study aimed to clarify whether silybin as phytosome complex with vitamin E may favorably 
affect lipid and radical homeostasis using an in vitro model of NAFLD induced by the exposure 
of hepatoma FaO cells to exogenous FAs. Changes in expression of PPARs and SREBP-1c, the 
main regulators of lipid metabolism, as well as of CPT1, the master controller of mitochondrial 
FA oxidation, and Atg7, a key autophagy-promoting gene, have been assessed to investigate 
the pathways possibly activated by silybin. In parallel, the stimulation of defense systems 
against oxidative stress, such as catalase and NF-κB, were evaluated to assess the potential 
 
protective effects of silybin. 
  
 
MATERIALS AND METHODS 
Chemicals 
All chemicals, unless otherwise indicated, were of analytical grade and were supplied by 
Sigma-Aldrich Corp. (Milan, Italy). 
Cell treatments 
Rat hepatoma FaO cells (European Collection of Cell Cultures, Sigma-Aldrich Corp., Milan, 
Italy) are a liver cell line maintaining hepatocyte specific markers (Clayton et al., 1985). Cells 
were grown in Coon’s modified Ham’s F12 with 10% fetal bovine serum (FBS). For treatments, 
cells were grown until 80% confluence, then incubated overnight in high-glucose medium with 
0.25% bovine serum albumin (BSA). Steatosis was induced by exposing cells for 3 h to an 
oleate/palmitate mixture (2:1 molar ratio, final concentration 0.75 mmol/L). Thereafter, 
steatotic cells were incubated for 24 h with 0 to 100 μmol/L (final concentration) of silybin (S) 
as phytosome complex with vitamin E (Realsil®, Istituto Biochimico Italiano, Lorenzini S.p.a, 
Italy). Silybin stock (10 mmol/L) was prepared in dimethyl sulfoxide (DMSO) and then diluted 
with the culture medium to a final concentration 0.3 mmol/L. 
The viability of FaO cells upon exposure to FAs or silybin, both as single agents or combined, 
was determined by the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] 
and measured spectrophotometrically (Grasselli et al., 2013). 
Quantification of triglycerides 
For determination of intracellular TG content, at the end of each treatment cells were scraped 
and centrifuged at 14000 × g for 3 min. After cell lysis, obtained by passing cell suspension 
through 25 gauge needle, lipids were extracted using the chloroform/methanol (2:1) method 
(Grasselli et al., 2010) and TG content was measured by spectrophotometric analysis 
(“Triglycerides liquid” kit, Sentinel, Milan, Italy). Values were normalized to protein content as 
determined by the bicinchoninic acid (BCA) method using BSA as a standard (Wiechelman et 
al., 1988). In parallel, TG content was determined in the culture medium. Data are expressed 
as percent TG content relative to controls. 
Lipid droplet analysis 
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Cells were grown on collagen-coated glass slides (Falcon, BD, Milan, Italy); neutral lipids were 
visualized using the selective Oil-RedO (ORO) dye. Briefly, after fixing in 4% paraformaldehyde, 
cells were washed with PBS, stained with ORO 1% in triethyl phosphate 60% for 20 min and 
washed (Trunkey, 1990). Slides were examined by Leica DMRB light microscope equipped with 
a Leica CCD camera DFC420C (Leica, Wetzlar, Germany). In parallel, the LD abundance inside 
the cells was assessed fluorimetrically using Nile Red (NR), a vital lipophilic dye. At the end of 
each treatment, cells were incubated with 0.3 μmol/L NR solution (from a stock solution of 
100 μg/mL in PBS) for 30 min at 37 °C. After washing with PBS the NR fluorescence was 
measured by LS-50B spectrofluorimeter (Perkin Elmer, United States) at λex = 580 nm and 
λem = 630 nm and slit width set to 5.0 (Greenspan et al., 1985). All measurements were 
performed at 25 °C using a water-thermostated cuvette holder. 
ROS production and lipid peroxidation measurement 
The oxidation of the cell-permeant 2’-7’ dichlorofluorescin diacetate (DCF-DA, Fluka, 
Germany) to 2’-7’ dichlorofluorescein (DCF) is extensively used for quantifying in situ the 
production of H2O2 and other ROS (Halliwell and Whiteman, 2004). Stock solution of DCF- DA 
(10 mmol/L in DMSO) was prepared and stored at -20 °C in the dark. At the end of each 
treatment, cells were scraped and gently spun down (600 × g for 10 min at 4 °C). After washing, 
cells were loaded with 10 μmol/L DCF-DA in PBS for 30 min at 37 °C in the dark, centrifuged 
and suspended in PBS. The DCF fluorescence was measured fluorometrically at λex = 495 nm 
and λem = 525 nm using. All measurements were performed at 25 °C using a water-
thermostated cuvette holder. 
In parallel, H2O2 production was assessed directly on cells grown on collagen-coated glass 
slides. After treatment, cells were incubated with 100 μmol/L DCF-DA for 1 h (Okuda et al., 
1996). Slides were examined by Leica DMRB light microscope equipped with a Leica CCD 
camera DFC420C. Lipid peroxidation was determined spectrophotometrically through the 
thiobarbituric acid reactive substances (TBARS) assay which is based on the reaction of 
malondialdehyde (MDA; 1,1,3,3-tetramethoxypropane) with thiobarbituric acid (TBA) (Iguchi 
et al., 1993). Briefly, 1 vol. of cell suspension was incubated for 45 min at 95 °C with 2 vol. of 
TBA solution (0.375% TBA, 15% trichloroacetic acid, 0.25 mol/L HCl. Then, 1 vol. of N-butanol 
was added and the organic phase was read using a Varian Cary50 spectrophotometer at 532 
nm. Results were expressed as pmol MDA/mL per milligram protein. 
 
Determination of catalase activity 
Catalase (CAT, EC 1.11.16) activity was evaluated in both 12000 × g supernatant and pellet of 
cell lysates following the consumption of H2O2 at 25 °C according to (Aebi, 1984). Enzyme 
activity (as the sum of both pellet and supernatant) was expressed as μmoles of decomposed 
H2O2 per min/mg protein. Protein content was determined by BCA method. All 
measurements were performed at 25 °C using a water-thermostated cuvette holder. 
RNA extraction and quantitative real-time PCR 
RNA was isolated using the Trizol reagent, cDNA was synthesized and quantitative real-time 
PCR (qPCR) was performed in quadruplicate using 1 × IQTM SybrGreen SuperMix and 
Chromo4TM System apparatus (Biorad, Milan, Italy) (Grasselli et al., 2014). The relative 
quantity of target mRNA was calculated by the comparative Cq method using glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) as housekeeping gene, and expressed as fold induction 
with respect to controls (Pfaffl, 2001). Primer pairs were designed ad hoc starting from the 
coding sequences of Rattus norvegicus available on the GenBank database 
(http://www.ncbi.nlm.nih.gov/Genbank/GenbankSearch.html) and synthesized by TibMolBiol 





Both cellular and nuclear homogenates were processed by Western blot analysis to assess the 
protein levels of SREBP1-c and NF-κB/p65, respectively. In fact, activation of the NF-κB 
transcription factor is associated with its phosphorylation and nuclear translocation of the p65 
component of the complex. Cells were lysed on ice in lysis buffer (NaCl 150 mmol/L, Tris HCl 
pH 7.4, 50 mmol/L, SDS 0.33%) as described elsewhere[34]. For nuclear extraction, the cellular 
pellet was suspended in 400 μL ice-cold Buffer A (20 mmol/L Tris HCl pH 7.8, 50 mmol/L KCl, 
10 μg/mL Leupeptin, 0.1 mmol/L Dithiothreitol-DTT, 1 mmol/L phenylmethanesulfonyl 
fluoride-PMSF); then 400 μL Buffer B (Buffer A plus 1.2% Nonindet P40) was added. The 
suspension was vortex-mixed for 10 sec; after centrifugation (14000× g for 30 s, 4 °C) the 
supernatant was discarded and the nuclear pellet was washed with 400 μL Buffer A and 
centrifuged. Next, the nuclear pellet was suspended in 100 μL Buffer B, mixed thoroughly in 
ice for 15 min and finally centrifuged (14000 × g for 20 min, 4 °C). The supernatant containing 
the nuclear extracts was collected and the protein content was measured by BCA method. 
About 30-50 μg proteins were electrophoresed on sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) (Laemmli, 1970). Membrane was blocked for 1 h in 5% fat-free 
milk/PBS (pH 7.4) and probed using mouse anti–human SREBP-1 (SC-13551) or rabbit anti-
human NF-κB p65 (SC-109) antibodies supplied by Santa Cruz Biotechnology (DBA, Milan, 
Italy). Membranes were incubated overnight at 4 °C with primary antibody in PBST buffer (PBS 
with 0.1% Tween 20) (Towbin et al., 1979), washed and incubated with horseradish peroxidase 
(HRP)-conjugated rabbit anti-mouse IgG (Sigma- Aldrich), as a secondary antibody in PBST for 
1 h at room temperature. Immune complexes were visualized using an enhanced 
chemiluminescence Western blotting analysis system (Bio-Rad ChemiDoc XRS System). Films 
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were digitized and band optical densities were quantified against the actin band using a 
computerized imaging system and expressed as Relative Optical Density (ROD, arbitrary units). 
ROD of each band was expressed as percentage respect to control. 
Statistical analysis 
RNA and protein data are expressed as mean ± SD of at least four independent experiments 
in triplicate. Statistical analysis was performed using ANOVA with Tukey’s post-test (GraphPad 




Effects of silybin on lipid accumulation 
Lipid accumulation was visualized in situ by optical microscopy of ORO-stained cells in control 
(C) and steatotic hepatocytes incubated for 24 h in the absence (SC) or in the presence (SC + 
S) of increasing concentrations of silybin (25, 50, and 100 μmol/L). The number and size of LDs 
increased markedly in steatotic cells, and decreased dose- dependently with silybin incubation 
(Fig. 1A). Also TG content was significantly higher in teatotic than in control cells (+113%; P ≤ 
0.001) (Fig. 1B). Incubation with silybin 50 μmol/L and 100 μmol/L decreased significantly the 
TG content by  -33% and by -38%, respectively,  (P ≤ 0.001 for both doses vs untreated steatotic 




Figure 2. Lipid-lowering effects of silybin in steatotic FaO cells 
(A) Neutral lipids were visualized in situ by ORO-staining in control (C) and steatotic FaO cells incubated in the absence (SC) 
or in the presence (SC + S) of the silybin at different doses (silybin 25; 50; 100 μmol/L) (magnification × 40; Bar: 10 μm). Silybin 
structure is also shown; (B) On the same samples TG content was quantified by spectrophotometric assay; data are expressed 
as percent TG content relative to control and normalized for total proteins; (C) LD accumulation was evaluated by NR-staining 
in control and steatotic FaO cells incubated in the absence or in the presence of 50 μmol/L silybin; data are expressed as 
percent mean fluorescence intensity (MFI) relative to control and normalized for total proteins. Values are mean ± SD from a 
least three independent experiments. ANOVA followed by Tukey’s test was used to assess the statistical significance between 
groups. Significant differences are denoted by symbols: aP ≤0.001, cP ≤0.01 C vs OP and bP ≤ 0.001, dP ≤ 0.01 OP vs silybin. 
 
Following these pilot experiments, silybin at a concentration of 50 μmol/L was used for all 
further experiments. Using NR fluorescence we measured LD accumulation as a function of the 
treatments. The average content of LDs increased significantly by +43% (P ≤ 0.01) in steatotic 
cells compared to control, and decreased by -33% (P ≤ 0.01) with silybin 50 μmol/L compared 
to steatotic cells (Fig 1 C). Cell viability was not significantly affected by FA and/or silybin 
treatments as single agents or combined (data not shown). 
Effects of silybin on lipid metabolism pathways 
Lipid metabolism pathways are controlled by PPARS, a family of FA-regulated transcription 
factors. In rat hepatocytes, we have previously showed the following abundance of the three 
PPAR transcripts: PPARα > PPARδ > PPARγ [38]. The present results show that expression of 
PPARα mRNA was 1.7 fold higher in steatotic cells compared to control (P ≤ 0.05), and 
increased further upon incubation with silybin 50 μmol/L (+54% with respect to steatotic cells; 
P ≤ 0.01) (Fig. 2A). A significant increase was also observed in PPARγ mRNA expression upon 
lipid-loading (2.8 fold induction with respect to control; P ≤ 0.01), but, in in this case, silybin 
50 μmol/L reduced the up-regulation (-34% with respect to steatotic cells, P ≤ 0.05) (Fig. 2A). 
By contrast, mRNA expression of PPARδ decreased upon lipid-loading (about 0.55 fold 
induction with respect to control; P ≤ 0.05) and silybin 50 μmol/L restored PPARδ expression 




 Figure 3. Effects of silybin on transcription factors regulating lipid metabolism 
In control (C) and steatotic FaO cells incubated in the absence (SC) or in the presence (SC + S) of silybin 50 μmol/L we assessed. 
(A) mRNA expression of PPARa, PPARd and PPARγ by qPCR; GAPDH was used as the internal control for quantifying gene 
expression; data expressed as fold induction with respect to controls; (B) Densitometric analysis of SREBP- 1c by Western 
blotting; b-actin was the protein loading control used as housekeeping gene for normalization; data are expressed as 
percentage values with respect to controls. Values are mean ± SD from at least three independent experiments. ANOVA 
followed by Tukey’s test was used to assess the statistical significance between groups Significant differences are denoted by 
symbols: cP ≤ 0.01, eP ≤ 0.05 C vs OP and dP ≤ 0.01, fP ≤ 0.05 OP vs Silybin. 
SREBP-1c is a PPARα-target gene which regulates expression of lipogenic enzymes. Activation 
of SREBP-1c increased in steatotic hepatocytes (+116%; P ≤ 0.05) with respect to control and 
further increased upon exposure to silybin 50 μmol/L (+48% compared to steatotic cells; P ≤ 
0.05) (Fig. 2B). 
A reduced TG accumulation in hepatocytes might be sustained by both stimulation of oxidative 
and/or secretory pathways. CPT-1, the main regulator of mitochondrial β-oxidation of FAs, is 
significantly up-regulated in steatotic cells upon incubation with silybin 50 μmol/L (+217% with 
respect to steatotic cells; P ≤ 0.001) (Fig. 3A). At the same time, the mRNA expression of Atg7, 
an autophagy-promoting gene in hepatocytes, was significantly increased in steatotic cells 
(1.45 fold induction with respect to control; P ≤ 0.05), but it did not change upon treatment 
with silybin 50 μmol/L (Fig. 3B). On the other hand, steatotic cells showed an increased TG 
secretion into the culture medium compared to control cells (+57%; P ≤ 0.001), but incubation 





Figure 4. Effects of silybin on lipid catabolism pathways 
In control (C) and steatotic FaO cells incubated in the absence (SC) or in the presence (SC + S) of silybin 50 μmol/L we assessed: 
mRNA expression of CPT-1 (A) and of Atg7 (B) by qPCR; GAPDH was used as the internal control for quantifying gene 
expression and data expressed as fold induction with respect to controls; extracellular TG content quantified in the medium 
by spectrophotometric assay (C); data are expressed as percent TG content relative to control and normalized for total 
proteins; Values are mean ± SD from at least three independent experiments. ANOVA followed by Tukey’s test was used to 
assess the statistical significance between groups Significant differences are denoted by symbols: aP ≤ 0.001, eP ≤ C vs OP 
and bP ≤ 0.001, dP ≤ 0.01 OP vs Silybin. 
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Effects of silybin on oxidative stress 
The intracellular production of ROS, mainly hydrogen peroxide (H2O2), was visualized in situ 
by fluorescence microscopy of DCF-stained cells (Fig.4). Higher and diffuse DCF fluorescence 
was observed in steatotic cells (Fig. 4C, D) and it was lower in cells treated with silybin 50 
μmol/L (Fig. 4E, F). DCF fluorescence was almost null in control cells (Fig. 4A). These changes 
were quantified by spectrofluorometer readings (Fig. 4B) that showed a significant DCF 
decrease (-45%; P ≤ 0.001) in silybin-treated cells with respect to steatotic cells used as 
control. 
   
Figure 5. Effects of silybin on reactive oxygen species production 
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The intracellular level of reactive oxygen species (ROS), mainly hydrogen peroxide, was visualized in situ by optical microscopy 
in control (A and inset) and steatotic FaO cells incubated in the absence (C-D) or in the presence (E-F) of silybin 50 μmol/L. 
The ROS level were also quantified by spectrofluorimeter assay of DCF-stained cells (B) and data are expressed as percent 
mean fluorescence intensity (MFI) relative to steatotic cells and normalized for total proteins. DCF: 2’-7’ dichlorofluorescein. 
bP < 0.001 SC vs SC + S. 
 
Also MDA level was greater in steatotic than in control cells (+100%; P ≤ 0.001) and decreased 
with silybin 50 μmol/L (-57% with respect to steatotic cells; P ≤ 0.001) (Fig. 5A). The analyses 
of antioxidant defence mechanisms showed increased catalase activity in steatotic cells with 
respect to control (+45% vs control, P ≤ 0.01) that decreased with silybin 50 μmol/L (-38% with 
respect to steatotic cells, P ≤ 0.01) (Fig. 5B). Also NF-κB activation showed a trend to an 
increase in steatotic cells and a significant reduction upon exposure to silybin 50 μmol/L (-29% 




Figure 6. Effects of silybin on oxidative stress markers 
In control and steatotic FaO cells incubated in the absence or in the presence of silybin 50 μmol/L we assessed. (A) The 
intracellular level of MDA (pmol MDA/mL x mg of sample protein) quantified by TBARS assay data are expressed as percentage 
values with respect to controls and normalized for total proteins; (B) Catalase specific activity (micromoles of decomposed 
H2O2 per min/mg of sample protein) evaluated by spectrophotometric assay, data are expressed as percentage values with 
respect to controls and normalized for total proteins. (C) Densitometric analysis of nuclear NF- κB/p65 evaluated by Western 
blotting; b-actin was the protein loading control used as housekeeping gene for normalization; data are expressed as 
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percentage values with respect to controls. Values are mean ± SD from at least three independent experiments. ANOVA 
followed by Tukey’s test was used to assess the statistical significance between groups Significant differences are denoted by 
symbols: aP ≤ 0.001, cP ≤ 0.01 C vs OP and bP ≤ 0.001; dP ≤ 0.01; fP ≤ 0.05 OP vs silybin. 
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DISCUSSION 
The burden of nonalcoholic liver steatosis is rapidly increasing worldwide and is exposing the 
populations to the risk of liver-related complications (Brunt et al., 2015). Ultimate therapeutic 
approaches are lacking so far, besides diet and physical exercise. The nutraceutic silybin has 
shown preliminary encouraging results either in clinical and animal studies (Reina and 
Martinez, 2015; Rosso et al., 2015) The present study provides a deeper characterization of 
some pathophysiologically relevant mechanisms of action of silybin administered as 
phytosome complex with vitamin E directly to fatty hepatocytes mimicking a steatosis 
condition in vitro. In this study, silybin disclosed direct anti-steatotic and anti-oxidant 
properties in steatotic cells, thus extending previous observations carried out by our group in 
studies with patients suffering with liver steatosis (Loguercio et al., 2012), and in animal models 
fed a steatogenic diet (Grattagliano et al., 2013). 
Accumulation of LDs within hepatocytes is the first step in the development of NAFLD (Vanni 
et al., 2010), while oxidative stress causing membrane lipid peroxidation and necro- 
inflammatory changes represents the second step leading to NASH (Aragno et al., 2009; Day, 
2002). The exposure of hepatoma cells to exogenous FAs mimicked the first “hit” of NAFLD and 
led to TG accumulation within large cytosolic LDs that we observed by microscopic, fluorimetric 
and spectrophotometric analyses. 
At the molecular level, TG accumulation in LDs seems to be sustained by the up-regulation of 
PPARα that promotes FA transportation inside the cells, and by a larger up-regulation of 
PPARγ, the lipogenic isoform that promotes TG synthesis from FAs. It has to be underlined 
that, although PPARα is mostly known for its ability to induce FA oxidation, growing evidence 
points to its role in regulation of lipogenesis. In fact, PPARα regulates many aspects of hepatic 
lipid metabolism including FA uptake through membranes, intracellular FA trafficking and 
oxidation, TG storage and lipolysis. In the present study, the changes in PPARα mRNA 
expression are paralleled by those in the protein levels of SREBP-1c, that in fact is a PPARα 
target gene (Fernández-Alvarez et al., 2011). Moreover, PPARα up-regulation can explain both 
the increase in lipophagy, TG secretion and in CPT-1 expression observed in steatotic cells. In 
fact, PPARα typically promotes lipid mobilization from the cytosolic stores by stimulating both 
LD autophagy, lipid secretion and FA oxidation in mitochondria. 
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The activation of all these pathways represents an attempt of the cell to reduce excess fat 
accumulation, but are usually accompanied by increased ROS production. Indeed, the present 
data show that excess fat accumulation is accompanied by increased oxidative stress. To 
assess cellular oxidative stress, we measured: (1) content of ROS and hydrogen peroxide and 
activity of catalase, the main scavenger of H2O2; (2) lipid peroxidation, one of the most 
common indicators of free radical formation and a key indicator of oxidative stress; and (3) 
activation of NF-κB, the master transcription factor in the control of molecular pathways 
related to oxidative stress. All these indices were increased in steatotic cells. 
Incubation of steatotic cells with silybin 50 μmol/L significantly reduces TG accumulation likely 
by promoting lipid catabolism pathways, as suggested by the up-regulation of PPARα and 
PPARδ, and by inhibiting lipogenic pathways, as suggested by the down-regulation of PPARγ. 
In fact, PPARα and PPARδ stimulation is known to promote hepatic fatty acid oxidation, and 
one of the strategies for improving lipid metabolism in metabolic diseases is to use a molecule 
which can simultaneously activate these two PPARs (Arment et al., 2016), action that seems 
to be played by silybin. The stimulation of mitochondrial catabolism of FAs by silybin is also 
indicated by the marked up-regulation of CPT-1, which is the first component and rate-limiting 
step of mitochondrial β-oxidation as it allows long chain fatty acids (LCFA) to enter the 
mitochondria. Many studies indeed indicate that the activity of CPT1 determines the rate of 
LCFA oxidation and that over-expression of CPT1a in cultured cells increases fatty acid 
oxidation (Eaton, 2002; Rubí et al., 2002). On the other hand, silybin- dependent TG reduction 
occurred without a significant stimulation of lipophagic pathways and of TG release into the 
culture medium, as indicated by the unaltered levels of Atg7 transcripts and extracellular TG 
content. It is noteworthy that this fact could be important for possible therapeutic 
applications. 
In general, when TG storage inside LDs is inhibited, the extent of liver steatosis decreases, but 
liver damage might even increase due to excess of reactive free FAs produced by fat oxidation 
reactions. In fact, Teissier et al. (2004) found that PPAR agonists induce ROS production by 
stimulating NADPH oxidase activity. By contrast, in our study, the reduction in fat 
accumulation exerted by silybin in the steatotic hepatocytes is associated with the 
improvement of the oxidative unbalance caused by lipid excess as demonstrated by the 
reduction in lipid peroxidation (MDA levels, namely), catalase activity and NF-κB activation. 
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Taken together, our results suggest that the antioxidant capacity of silybin effectively 
counteracts the possible damaging effects of a high rate of fat catabolism which is stimulated 
in the attempt to reduce excess FA accumulation. This step occurs by neutralizing the free 
radicals produced by fat oxidation reactions, thus rendering unnecessary the TG synthesis as 
a protection against toxic and proapoptotic effects of excess FAs (Ricchi et al., 2009). 
In conclusion, the present study points to the cellular modulatory and protective effect of 
silybin with respect to lipid accumulation, expression of lipid metabolism genes, TG secretion, 
and FA-driven oxidative stress. This study fits with prior studies investigating the beneficial 
effects of silybin on liver steatosis in animal models (Grattagliano et al., 2013), on 
inflammation and fibrosis in human hepatic stellate cells (Trappoliere et al., 2009) and in 
patients with NAFLD and metabolic disorders (Loguercio et al., 2012). Therefore silybin could 
represent a promising molecule for therapy of NAFLD and maybe of NASH. The prosecution of 
our work will be focused on testing the possible efficacy of silybin in NASH. 
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ABSTRACT 
Non-alcoholic fatty liver disease (NAFLD) is a major cause of liver-related morbidity and 
mortality. Oxidative stress and release of pro-inflammatory cytokines, such as tumor necrosis 
factor α (TNFα), are major consequences of hepatic lipid overload, which can contribute to 
progression of NAFLD to non-alcoholic steatohepatitis (NASH). Also, mitochondria are involved 
in the NAFLD pathogenesis for their role in hepatic lipid metabolism. Definitive treatments for 
NAFLD/NASH are lacking so far. Silybin, the extract of the milk thistle seeds, has previously 
shown beneficial effects in NAFLD. Sequential exposure of hepatocytes to high concentrations 
of fatty acids (FAs) and TNFα resulted in fat overload and oxidative stress, which mimic in vitro 
the progression of NAFLD from simple steatosis (SS) to steatohepatitis (SH). The exposure to 50 
µM silybin for 24 h reduced fat accumulation in the model of NAFLD progression. The in vitro 
progression of NAFLD from SS to SH resulted in reduced hepatocyte viability, increased 
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apoptosis and oxidative stress, reduction in lipid droplet size, and up- regulation of IκB kinase 
β-interacting protein and adipose triglyceride lipase expressions. The direct action of silybin on 
SS or SH cells and the underlying mechanisms were assessed. Beneficial action of silybin was 
sustained by changes in expression/activity of peroxisome proliferator-activated receptors and 
enzymes for FA oxidation. Moreover, silybin counteracted the FA-induced mitochondrial 
damage by acting on complementary pathways: (i) increased the mitochondrial size and 
improved the mitochondrial cristae organization; (ii) stimulated mitochondrial FA oxidation; (iii) 
reduced basal and maximal respiration and ATP production in SH cells; (iv) stimulated ATP 
production in SS cells; and (v) rescued the FA- induced apoptotic signals and oxidative stress in 
SH cells. We provide new insights about the direct protective effects of the nutraceutic silybin 
on hepatocytes mimicking in vitro NAFLD progression. 
Keywords: non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, FaO hepatoma 
cells, lipid metabolism, oxidative stress, silybin 
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INTRODUCTION 
Hepatic steatosis is defined as the accumulation of triglycerides (TGs) exceeding 5% of liver 
weight. Without excess alcohol consumption, the simple steatosis (SS) is named non- 
alcoholic fatty liver, which may progress to more severe conditions, such as non-alcoholic 
fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH) with hepatocyte injury and 
lobular and portal inflammation, and non-alcoholic liver cirrhosis with massive fibrosis and 
vascular remodeling (Brunt et al., 2015), up to hepatocellular carcinoma (Nagaya et al., 2008; 
Baffy et al., 2012). Patients with NAFLD exhibit peculiar metabolic abnormalities, which 
include insulin resistance (IR), overweight, and obesity (Yki-Järvinen, 2014). Following the 
epidemics of obesity, NAFLD has become the leading cause of liver disease in developed 
countries. 
Excess TG deposition in the liver occurs when hepatic availability of fatty acids (FAs) from 
plasma and/or de novo synthesis exceeds hepatic FA disposal by oxidation and TG export as 
very low-density lipoprotein (Vergani, 2014). TG synthesis is an adaptive, beneficial response 
in hepatocytes exposed to potentially toxic concentrations of FAs or their metabolites. FAs 
and cholesterol, especially when accumulated in the mitochondria, are “aggressive” lipids 
leading to tumor necrosis factor α (TNFα) and reactive oxygen species (ROS) production and 
acting as early “inflammatory” hits (Berlanga et al., 2014), which contribute to promote NASH 
(Tilg and Moschen, 2010). 
Excess TGs are stored in lipid droplets (LDs), a protective mechanism against FA lipotoxicity. 
LDs consist of a core of neutral lipids covered by phospholipids and proteins. Adipose 
differentiation-related protein (ADRP) is the major LD-associated protein, which promotes 
FA uptake and LD formation (Gao and Serrero, 1999). In fact, the absence of ADRP reduces 
LD formation and protects against the development of steatosis (Paul et al., 2008). LDs also 
regulate lipid metabolism and trafficking through a network of molecules localized at the LD 
surface including the adipose triglyceride lipase (ATGL), which catalyzes the first reaction of 
TG hydrolysis (Zimmermann et al., 2009). The master regulators of hepatic lipid metabolism 
are the peroxisome proliferator-activated receptors (PPARs), a family of transcription factors 
controlling both lipogenic and lipolytic pathways (Huang et al., 2013). FAs are endogenous 
ligands of all PPAR isofoms (Nakamura et al., 2014); uptake and oxidation of FAs are regulated 
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mainly by PPARα, while their esterification and conversion to TGs by PPARγ whose expression 
typically increases in NAFLD (Eberlé et al., 2004). 
Mitochondria are the main site for β-oxidation of FAs, which is primarily regulated by 
carnitine palmitoyltransferase 1 (CPT-1), an enzyme required for transport of long-chain FAs 
inside mitochondria (Serviddio et al., 2011). Mitochondria play an important role in the 
pathogenesis and progression of NAFLD, which has been proposed as a mitochondrial disease 
(Pessayre and Fromenty, 2005). Mitochondrial defects may underlie NAFLD process by 
altering energetic homeostasis and stimulating ROS production with consequent oxidative 
stress and impairment of fat oxidation processes (Begriche et al., 2011). In addition to 
mitochondria, FAs are oxidized in peroxisomes by acyl-CoA oxidase (AOX) and in endoplasmic 
reticulum (ER) by CYP2E1; both processes lead to the overproduction of ROS and consequent 
oxidative stress, which triggers progression of steatosis toward NASH (Fromenty and 
Pessayre, 1995; Seifert et al., 2010). 
Moreover, excess lipid accumulation disturbs the ER function, thereby generating ER stress. 
In the ER, we find the IκB kinase β (IKBKB)-interacting protein (IkBip), a serine kinase that 
plays a role in the nuclear factor kappa-B (NF-κB) signaling, which is activated by multiple 
stimuli such as inflammatory cytokines, DNA damages, and other cellular stresses (Choi et 
al., 2016). NF-kB activation was observed in the livers of obese mice where it causes liver 
inflammation and apoptosis and increases local and circulating levels of interleukins (Cnop 
et al., 2012). In contrast, IkBip is associated with the progression of SS to steatohepatitis (SH) 
as it links steatosis with the activation of apoptotic pathways (Hennig et al., 2014). 
While the knowledge of the complex pathophysiological mechanisms involved in the onset 
and progression of livers steatosis has increased exponentially, a definitive therapy is still 
missing in NAFLD/NASH patients. Medicinal plants are largely employed as the source of 
dietary supplements (Baselga-Escudero et al., 2017). Silymarin, the extract from milk thistle 
(Silybum marianum), and its major active compound silybin are hepatoprotective agents for 
the treatment of liver diseases (Saller et al., 2001). Previous clinical findings evidenced the 
efficacy of silybin on improving IR and liver injury in patients with NAFLD (Federico et al., 
2006) and in lowering some hepatic enzymes in patients with NASH (Solhi et al., 2014). 
Moreover, silybin improved liver histology in a multicenter randomized controlled trial 
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(Loguercio et al., 2012). However, the direct hepatoprotective activity of silybin in both non- 
alcoholic steatosis and SH remains to be elucidated and the possible mechanisms involving a 
potential anti-inflammatory effect require deeper investigations. 
The present study aimed to clarify whether silybin may favorably affect lipid and radical 
homeostasis in in vitro model of NAFLD progression induced by sequential exposure of 
hepatoma FaO cells to high concentrations of FAs and TNFα. The experimental protocol 
mimics what occurs in vivo where chronically elevated levels of FAs induce IR in many organs 
and fat accumulation in the liver. In the adipose tissue, IR enhances lipolysis and increases 
the delivery of adipose-derived FAs to the liver. In contrast, in adipocytes FA excess increases 
TNFα production, which act on the liver by promoting inflammation and oxidative stress 
(Berlanga et al., 2014). Therefore, TNFα is the first inflammatory molecule linked with IR 
(Lang et al., 1992) and high serum levels of TNFα have been found in patients with NASH 
compared with healthy subjects (Crespo et al., 2001). TNFα plasma levels correlate positively 
with the grade of liver fibrosis assessed by ultrasound-guided liver biopsy in patients with 
advanced stages of NAFLD (Lesmana et al., 2009). For this reason, we choose TNFα as the 
second hit to model in vitro NAFLD progression. 
Our results show that silybin reduced excess TG accumulation in the in vitro models of both 
steatosis and SH. Changes in the expression of transcription factors such as PPARs and of 
enzymes for mitochondrial, peroxisomial, and ER oxidations of FAs have been evidenced. In 
particular, silybin rescued the FA-induced mitochondrial dysfunction as well as apoptotic 
signals and oxidative stress characteristic of SH condition. 
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MATERIALS AND METHODS 
Cell Treatments 
Rat hepatoma FaO cells (European Collection of Cell Cultures, Sigma-Aldrich Corp.) (Clayton 
et al., 1985) were grown in Coon’s modified Ham’s F12 with 10% fetal bovine serum. Cells 
were grown until 80% confluence, incubated in high-glucose medium with 0.25% bovine 
serum albumin (BSA) to increase stability and solubility of FFA (Joshi-Barve et al., 2007). A 
condition mimicking human steatosis (SS) was induced by incubating FaO cells for 3 h with 
oleate/palmitate mixture (2:1 M ratio, final concentration 0.75 mM). A SH condition was 
mimicked by incubating SS cells for 24 h with 10 ng/mL TNFα (Zhang et al., 2010). After replacing 
the medium, both SS and SH cells were treated for 24 h with 50 µM silybin (S) [Istituto 
Biochimico Italiano (IBI), Lorenzini, Italy]. Silybin stock (10 mM) was prepared in dimethyl 
sulfoxide. 
Cell Viability and Apoptosis 
For both resazurin and sulforhodamine B (SRB) assays 1.5 × 104 cells/well were seeded in 96- 
well plates. For resazurin assay, after treatment, the medium was removed and cells were 
incubated for 30 min with medium supplemented with 10 µg/mL resazurin. The reduction of 
resazurin to resorufin,  indicative  of  metabolic  activity,  was  measured  fluorimetrically  (λexc 
570 nm; λem 600 nm) in Biotek-Cytation 3 reader (Biotek Instruments, Winooski, VT, USA) 
(Voytik-Harbin et al., 1998). For SRB assay, cells were fixed with ice-cold methanol containing 
1% acetic acid for 30 min and then incubated with 0.5% SRB in 1% acetic acid for 1 h at 37°C. 
The unbound dye was removed with 1% acetic acid solution. The dye bound to proteins was 
extracted with 10 mM Tris-base solution pH 10, and absorbance was measured at 540 nm 
(Vichai et al., 2006). 
For apoptosis assessment, cells were collected and the pellet resuspended in 20 mM 
HEPES/NaOH pH 7.5, 250 mM sucrose, 10 mM KCl, 2 mM MgCl2, 1 mM EDTA, 2 mM 
dithiothreitol (DTT), and 100 µM phenylmethylsulfonyl fluoride (PMSF), a protease-inhibitor 
cocktail (1 µg/mL of leupeptin, antipain, chymostatin, and pepstatin A). Caspase 3-like 
activity was measured in cell extracts containing 25 µg protein determined by the 
bicinchoninic acid method using BSA as a standard (Wiechelman et al., 1988). For calibration, 
known concentrations of p-nitroanilide (pNA) were measured. Cell extracts were incubated 
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for 1 h at 37°C in 25 mM Hepes pH 7.5, 10% sucrose, 10 mM DTT, 0.1% CHAPS, and 100 µM 
caspase substrate Ac-DEVD-pNA; the pNA released after cleavage from the substrate was 
measured. The results are expressed as amount of nanomoles of pNA released per 
microgram of protein (Moreira et al., 2014). 
TG Content 
Cells were scraped and lysed. Lipids were extracted using the chloroform/methanol (2:1) 
method (Grasselli et al., 2010). TG content was quantified spectrophotometrically by using 
“Triglycerides liquid” kit (Sentinel, Milan, Italy) in a Varian Cary-50Bio spectrophotometer 
(Agilent, Milan, Italy). Values were normalized to protein content. Data are expressed as 
percent TG content relative to controls. 
LD Imaging 
Cells grown on coverslips were rinsed with phosphate-buffered saline (PBS) pH 7.4 and fixed 
with 4% paraformaldehyde for 20 min at room temperature.  Slides were incubated with 1 
µg/mL BODIPY 493/503 (Molecular Probes, Life technologies, Monza, Italy) in PBS for 30 min 
(Grandl and Schmitz, 2010). After washing and mounting with 4′,6-diamidino-2- phenylindole 
(DAPI) (ProLong Gold medium with DAPI; Invitrogen) slides were examined by Nikon Eclipse 
E80i light microscope (Nikon, Tokyo, Japan) equipped with the standard epifluorescence 
filter set up. Images were captured under oil with a 100× plan apochromat objective. 
Analyses were performed on two independent experiments measuring at least 40 cells for 
each treatment using the ImageJ software. 
Mitochondria Imaging 
Cells grown on μ-slides eight-well ibiTreat (Ibidi, Germany) were incubated with 50 nM 
tetramethylrhodamine ethyl ester (TMRE) and 1 µg/µL Hoechst for 30 min at 37°C in the dark. 
A lower concentration of TMRM+ was maintained in the medium to avoid leakage from 
mitochondria. Cells were observed under a Nikon Eclipse Ti-S microscope. Images were 
obtained through LSM Image Browser (Scaduto and Grotyohann, 1999). 
Electron Microscopy 
Cells grown on glass chamber slides (Lab-Tek, Nunc, 177380) were washed in 0.1 M 
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cacodylate buffer and fixed in 0.1 M cacodylate buffer containing 2.5% glutaraldehyde for 1 
h at room temperature. Cells were post-fixed in osmium tetroxide for 2 h and 1% uranyl 
acetate for 1 h. Samples were dehydrated through a graded ethanol series and flat 
embedded in resin (Poly-Bed; Polysciences, Inc., Warrington, PA, USA) for 24 h at 60°C. 
Ultrathin sections (50 nm) were cut parallel to the substrate until reaching the apical surface, 
stained with 5% uranyl acetate in 50% ethanol, and observed with CM10 electron microscope 
(Philips, Eindhoven, the Netherlands), images were taken with a Megaview 3 camera. 
Mitochondrial number and size were assessed in 12 randomly taken images at 25k 
magnification for each treatment. The mitochondrial length (major axis) and width (minor 
axis) were measured with iTEM software package (Olympus-SYS). Statistical analysis for 
mitochondrial diameter was performed using the Mann–Whitney test. The total number of 
mitochondria and mitochondrial cristae was manually scored. Statistical analysis was 
performed with Student’s t-test. 
Catalase Activity 
Catalase activity was evaluated spectrophotometrically in both 12,000 × g of supernatant 
and pellet of hepatocyte lysates (Aebi, 1984). Catalase specific activity was expressed as 
micromoles of decomposed H2O2 per minute per milligram of sample protein. Data are 
expressed as percent relative to controls. 
Lipid Peroxidation 
Lipid peroxidation was determined through the thiobarbituric acid reactive substances assay 
based on the reaction of malondialdehyde (MDA; 1,1,3,3-tetramethoxypropane) with 
thiobarbituric acid (TBA) (Iguchi et al., 1993). Briefly, 1 vol of cell suspension was incubated 
for 45 min at 95°C with 2 vol of TBA solution (0.375% TBA, 15% trichloroacetic acid, 0.25 N 
HCl) and, then, 1 vol of N-butanol was added and the absorbance of the organic phase was 
measured spectrophotometrically. Results were expressed as picomoles MDA per 
milliliter/milligram protein. Data are expressed as percent relative to controls. 
8-Hydroxy-2-Deoxy Guanosine (8-OHdG) Release 
The 8-OHdG excreted into the medium after DNA repair/turnover was quantified using 
DNA/RNA Oxidative Damage ELISA kit (Cayman Chemical Company, MI, USA). Samples were 
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analyzed in duplicate. Standard 8-OHdG was assayed over a concentration range of 10.3– 
3,000 pg/mL (Chen et al., 1996). Results were expressed as picogram 8-OHdG per milliliter 
RNA Extraction and Real-time Quantitative PCR (qPCR) 
RNA was isolated using Trizol reagent, cDNA was synthesized, and real-time qPCR performed 
in quadruplicate using 1× IQ™SybrGreen SuperMix and Chromo4™ System apparatus (Bio- 
Rad, Milan, Italy) (Grasselli et al., 2014). The relative quantity of target mRNA was calculated 
by the comparative Cq method using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
as housekeeping gene and expressed as fold induction with respect to controls (Pfaffl, 2001). 
Primer pairs designed ad hoc starting from the coding sequences of Rattus norvegicus and 
synthesized by TibMolBiol (Genova, Italy) are listed in Table 1. 
 
 
mtDNA Copy Number 
DNA extracted using Genomic-tip 20/G kit (Qiagen, Valencia, CA, USA) was quantified using 
the PicoGreen dsDNA reagent (Invitrogen, Milan, Italy). Relative mtDNA copy numbers were 
measured by qPCR using iQ5 System Apparatus (Bio-Rad) and corrected by simultaneous 
measurement of nuclear DNA. Amplification of mitochondrial cytochrome c oxidase subunit 
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II (COII, mitochondrial-encoded gene) and β-actin (nuclear-encoded gene) was performed 
using the primers listed in Table 1. The mtDNA content was calculated using ΔCt = average 
Ctnuclear DNA − average CtmtDNA and, then, was obtained using the formula mtDNA 
content = 2(2ΔCt). 
Western Blotting 
In nuclear homogenates, NF-kB/p65 was detected by Western blot. Cellular pellet was 
suspended in 400 µL ice-cold Buffer A (20 mM Tris-HCl pH 7.8, 50 mM KCl, 10 µg/mL 
Leupeptin, 0.1 mM DTT, 1 mM PMSF) and 400 µL Buffer B (Buffer A plus 1.2% Non-indet P40). 
After vortex and centrifugation (14,000 × g for 30 s, 4°C) the nuclear pellet was washed with 
400 µL Buffer A, resuspended in 100 µL Buffer B, mixed in ice for 15 min, and centrifuged 
(14,000 × g for 20 min, 4°C). The supernatant containing nuclei was collected, and 30–50 µg 
proteins were electrophoresed on SDS polyacrylamide gel electrophoresis (Laemmli, 1970). 
Membrane was blocked for 1 h in 5% fat-free milk/PBS (pH 7.4), probed overnight using 
rabbit anti-human NF-kB p65 (SC-109; Santa Cruz Biotechnology, DBA, Milan, Italy) in PBST 
buffer (PBS 0.1% Tween 20) at 4°C (Towbin et al., 1979), and then washed and incubated  
with horseradish peroxidase-conjugated rabbit anti-mouse IgG (Sigma-Aldrich) in PBST for 1 
h at room temperature. Immune complexes were visualized using chemiluminescence 
western blotting analysis system (Bio-Rad ChemiDoc XRS System). Films were digitized and 
band optical densities were quantified against the actin band and expressed as Relative 
Optical Density (ROD, arbitrary units). ROD of each band was expressed as percentage 
respect to control. 
Oxygen Consumption 
Oxygen consumption was measured at 37°C using Seahorse XFe96 Extracellular Flux Analyzer 
(Seahorse Bioscience, Germany). About 2 × 104 cells/well were seeded in 96-well plates. In 
parallel, an XFe96 sensor cartridge for each cell plate was placed in a 96-well calibration plate 
containing 200 µL/well calibration buffer and left to hydrate overnight at 37°C. Medium was 
replaced with 200 µL/well of low-buffered serum-free medium pH 7.4 left at 37°C for 1 h 
without CO2 to allow de-gassing the plate. A final concentration of 3 µM oligomycin, 1 µM 
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), and a mixture of 1 µM 
rotenone and 1 µM antimycin were added sequentially to cells from prot A, B, and C, 
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respectively. A total of 25 µM of each compound was pre-loaded into the ports of each well 
in the XFe96 sensor cartridge. The sensor cartridge and the calibration plate were loaded into 
the XFe96 Extracellular Flux Analyzer for calibration, and then, the calibration plate was 
replaced with the study plate. Three baseline rate measurements of oxygen consumption 
rate (OCR) were made using a 3 min mix and 3 min measure cycle. The compounds were 
injected pneumatically by the XFe96-Analyzer into each well, mixed, OCR measurements 
made using the 3 min mix and 3 min measure cycle (Deus et al., 2015). 
Statistical Analysis 
Data are expressed as mean ± SD of at least three independent experiments in triplicate. 
Statistical analysis was performed using ANOVA with Tukey’s post-test (GraphPad Software, 




Effects of Silybin on Intracellular Fat Overload 
Intracellular TG content increased significantly and to a similar extent in steatotic (SS) 
(+109%; p ≤ 0.001) and in SH (+90%; p ≤ 0.001) cells compared to control (Fig. 1A). Exposure 
to silybin 50 µM did not affect the TG content of control cells (data not shown) but 
significantly decreased to a similar extent the TG content in both SS and SH cells (−38 and 




Figure 7. Effect of silybin on lipid accumulation 
Lipid accumulation parameters were measured in FaO cells incubated in the absence (Ctrl) or in the presence of fatty acids 
[simple steatosis (SS)] or fatty acids and tumor necrosis factor α (TNFα) [steatohepatitis (SH)] and subsequently treated with 
50 µM silybin (SS + Sil or SH + Sil, respectively). (A) Intracellular triglyceride (TG) content quantified by spectrophotometric 
assay. Data are expressed as percent TG content relative to control and normalized for total proteins determined with 
bicinchoninic acid (BCA). Values are mean ± SD from at least three independent experiments. (B) Lipid droplets (LDs) 
visualized by fluorescence microscopy using BODIPY 493/503 (green fluorescence) and nuclei visualized by 4′,6-diamidino-
2- phenylindole (DAPI) (blue fluorescence) (magnification 100×; scale bar: 10 µm). Representative images and the average 
LD number for all the experimental conditions were also shown. (C) Average LD size measured on two independent 
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experiments (40 cells per treatment for each experiment) by using Huygens professional suite software. The results were 
plotted as box-and-whisker plot, showing the interquartile range, the median as horizontal bar and the whiskers are the 
minimum and maximum values. (D) The mRNA expression of adipose differentiation-related protein (ADRP) and IκB kinase 
β-interacting protein (IkBip) evaluated by quantitative PCR (qPCR); glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
was used as the internal control and data expressed as fold induction with respect to controls. ANOVA followed by Tukey’s 
test was used to assess the statistical significance between groups. Significant differences are denoted by symbols: Ctrl vs 
all treatments ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05; simple steatosis (SS) vs all treatments ###p ≤ 0.001, ##p ≤ 0.01, #p ≤ 0.05; 
steatohepatitis (SH) vs all treatments $$$p ≤ 0.001. 
 
Lipid accumulation was associated to increased number and size of LDs, as visualized by 
BODIPY staining. At fluorescence microscopy, control cells showed few (about 72 LDs/cell) 
and small (0.9 µm average diameter) LDs, which were dispersed in the cytosol (Fig. 1B, C). In 
SS, we observed an increase in both number (294 LDs/cell) and size (1.5 µm) of LDs, with 
average diameter increasing of about +67% (p ≤ 0.001) compared to controls, and sylibin 
reduced the LD diameter to a value similar to controls (1.1 µm; p ≤ 0.001) (Fig. 1B, C). In 
contrast, SH cells displayed a LD number similar to that of SS cells but a LD size slightly lower 
(1.3 µm) (Fig. 1B, C); silybin did not affect LD size. 
The mRNA levels of ADRP and IkBip, two markers of LDs and NAFLD progression, respectively, 
were analyzed by qPCR (Fig. 1D). Excess lipid accumulation in SS cells resulted in up- 
regulation of ADRP expression (2.4-fold induction vs control; p ≤ 0.05) that was further 
stimulated by silybin (4.2-fold induction compared to control; +77% vs SS; p ≤ 0.01). In SH 
cells, ADRP expression was at a level similar to control and it was unaffected by silybin. In 
regard to IkBip expression, we observed only a small, non-significant up-regulation in SS cells, 
while it was dramatically up-regulate in SH cells (4.6-fold induction compared to control; p ≤ 
0.001). Exposure to silybin greatly and comparably reduced IkBip expression in both SS 
(−59% with respect to SS; p ≤ 0.05) and SH (−57% with respect to SH; p ≤ 0.001) cells. Sylibin 
did not affect ADRP and IkBip expression in control cells (data not shown). 
Effects of Silybin on Lipid Metabolism 
Lipid metabolism is regulated by PPARs, the main transcription factors for lipolytic and 
lipogenic genes (48). The mRNA level of PPARs was assessed by qPCR (Figure (Figure2A).2A). 
As compared to control cells, SS cells showed a significant increase in expression of PPARα 
and PPARγ (1.29-fold induction, p ≤ 0.05; 2.8-fold induction, p ≤ 0.001, respectively), and a 
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down-regulation of PPARδ (about 0.55-fold induction; p ≤ 0.05). The lipid-lowering action of 
silybin was sustained by increased expression of PPARα (2.6-fold induction compared to 
controls; +99% compared to SS, p ≤ 0.01), decreased expression of PPARγ (1.6-fold induction 
compared to controls, −42% compared to SS; p ≤ 0.05), and increased expression of PPARδ 
(1.6-fold induction compared to controls; +193% compared to SS, p ≤ 0.001). In SH 
hepatocytes, the profile of PPARα and PPARγ expression was similar to SS, whereas PPARδ 
expression showed values similar to controls. Exposure of SH cells to silybin reduced 
transcription of both PPARα (1.1-fold induction compared to controls; −39% compared to SH, 
p ≤ 0.05) and PPARγ (1.5-fold induction compared to controls; −48% compared to SH, p ≤ 
0.01), without affecting PPARδ expression. 
 
59  
Figure 8. Effect of Silybin on lipid metabolism 
In FaO cells treated as described above the following parameters were evaluated: (A) The mRNA expression of peroxisome 
proliferator-activated receptor (PPAR) α, PPARγ, and PPARδ by quantitative PCR (qPCR). (B) The extracellular triglyceride 
(TG) content by spectrophotometric analysis. (C) The mRNA expression of carnitine palmitoyltransferase 1 (CPT-1) and 
CYP2E1 by qPCR. (D) The enzymatic activity of peroxisomial acyl CoA oxidase (AOX) (nmol H2O2/min/mg protein) by using 
spectrophotometric assay. Data are expressed as percentage values with respect to controls and normalized for total 
proteins. (E) The mRNA expression of adipose triglyceride lipase (ATGL) by quantitative PCR (qPCR). For qPCR experiments, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the internal control and data were expressed as fold 
induction with respect to controls. Values are mean ± SD from at least three independent experiments. ANOVA followed by 
Tukey’s test was used to assess the statistical significance between groups. Significant differences are denoted by symbols: 
Ctrl vs all treatments ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05; simple steatosis (SS)  vs all treatments  ###p ≤ 0.001,  ##p ≤ 0.01, 
#p ≤ 0.05; steatohepatitis (SH) vs all treatments $$$p ≤ 0.001, $$p ≤ 0.01, and $p ≤ 0.05. 
 
The lipid-lowering action of silybin could be sustained by increased TG secretion, since SS 
cells released more TGs into culture medium than controls (+157%; p ≤ 0.001). The addition 
of silybin 50 µM did not modify this picture. In SH cells, a significant reduction in TG secretion 
was observed compared to SS (−28%; p ≤ 0.001). The addition of silybin counteracted this 
condition as TG secretion was stimulated (+103% with respect to SH; p ≤ 0.001) (Fig. 2B). 
In contrast, TG accumulation might be also reduced by stimulation of oxidative pathways 
taking place in mitochondria, peroxisomes, and ER (Grasselli et al., 2014). Thus, 
mitochondrial CPT-1 and peroxisomal AOX for β-oxidation and microsomal cytochrome P450 
(CYP) 2E1 for ω-oxidation were assessed. The mRNA levels of CPT-1 were significantly up- 
regulated in both SS and SH cells (2.44- and 2.91-fold inductions, respectively; p ≤ 0.05) and 
further increased upon incubation with silybin (+199% and +164 with respect to SS and SH 
cells, respectively; p ≤ 0.001) (Fig. 2C). CYP2E1 expression was up-regulated in SS cells (2.20- 
fold induction; p ≤ 0.001) and was further increased upon incubation with silybin (+63% with 
respect to SS; p ≤ 0.001), whereas in SH hepatocytes, CYP2E1 expression was at basal level 
and it was markedly increased by silybin (+518 with respect to SH cells; p ≤ 0.01) (Fig. 2C). In 
peroxisomes, AOX activity was stimulated in SS cells (+53%, p < 0.001 compared to controls), 
while silybin did not change it. We observed a decrease in AOX activity in SH cells compared 
to SS (−56% with respect to SS; p < 0.001) and an increase upon silybin treatment (+90% with 
respect to SH cells; p < 0.001) (Fig. 2D). 
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Up-stream of FA oxidation there is ATGL, a lipase controlling lipid mobilization from LDs. A 
significant increase in ATGL transcripts was observed in SS cells (2.29-fold induction with 
respect to control; p ≤ 0.05) and a larger increase in SH cells (11.7-fold induction with respect 
to controls; p ≤ 0.001) (Fig. 2E). ATGL mRNA expression was reduced after incubation of SH 
cells with silybin (−85% compared to SH; p ≤ 0.001). 
Hepatoprotective Effects of Silybin 
We observed no significant changes in cell viability in SS cells, whereas a reduced viability 
was observed in SH cells (−24% compared to control; p ≤ 0.001) and silybin did not counteract 
this effect (Fig. 3A). Similar results were supplied by cell density analysis: no significant 
decrease in cell density occurred in SS cells, while cell density was reduced in SH cells (−26%, 
compared to control; p ≤ 0.001) and silybin did not counteract this effect (Fig. 3A). In regard 
to apoptosis, we observed an increase in the caspase 3-like activity in SS cells (+126% 
compared to control; p ≤ 0.001) and a larger increase in SH cells (+219% compared to control; 
p ≤ 0.001). Of note, incubation of both SS and SH cells with silybin significantly reduced 
caspase 3-like activity (−68 and 158%, respectively, in SS + sil and SH + sil; p ≤ 0.01 and p ≤ 
0.001) (Fig. 3B). 
 
 
Figure 9. Effect of silybin on cell proliferation and apoptosis 
Under the conditions of Figure 1, the following parameters were measured: (A) The metabolic activity and the cell mass by 
resazurin and sulforhodamine B (SRB) assay, respectively. Data are expressed as percentage values with respect to controls. 
(B) The activity of effector caspase 3, measured as p-nitroanilide (pNA) released after cleavage from the substrate (nmoles 
of pNA released/μg protein). Calibration was done using known concentrations of pNA. Values are mean ± SD from at least 
three independent experiments. ANOVA followed by Tukey’s test was used to assess the statistical significance between 
groups. Significant differences are denoted by symbols: Ctrl vs all treatments ***p ≤ 0.001; simple steatosis (SS) vs all 
treatments ###p ≤ 0.001, ##p ≤ 0.01, #p ≤ 0.05; steatohepatitis (SH) vs all treatments $$$p ≤ 0.001. 
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Effects of Silybin on Mitochondrial Activity and Damage 
Mitochondrial respiration was analyzed by using the Seahorse Extracellular Flux Analyzer 
(Fig. 4). Basal respiration remained unchanged across control, SS, and SH cells; silybin did not 
affect basal respiration of SS cells, but significantly reduced that of SH cells (−47% with 
respect to control; p ≤ 0.001) (Fig. 4A). The proton leak was significantly reduced in both SS 
and SH cells with respect to controls (−42% and −31%, respectively; p ≤ 0.001 and p ≤ 0.05), 
and silybin did not influence this picture (Fig. 4B). Maximal respiration remained unchanged 
between control, SS cells, and SS cells exposed to sylibin, but it was significantly increased in 
SH cells (+12% respect to control, p ≤ 0.05) and silybin dramatically reduced it (−70%, 
compared to SH; p ≤ 0.001) (Fig. 4C). Also, the oxygen consumption associated with ATP 
production did not change in SS cells, while it increased in SH cells (+20% respect to control; 
p ≤ 0.05). Silybin exerted an opposite effect by increasing ATP production in SS cells (+20%  
respect to SS; p ≤ 0.05)  and  decreasing  it  in  SH   cells   (−56%   respect   to   SH cells; p ≤ 




Figure 10. Effect of silybin on mitochondrial oxygen consumption rates (OCRs) 
Under the conditions of Figure 1, we measured the cellular OCR by using Seahorse XFe96 Extracellular Flux Analyzer. The 
following respiratory parameters were evaluated: (A) Cell basal respiration (OCR pmol/min/SRB labeling). (B) Proton leak 
(OCR pmol/min/SRB labeling). (C) Cell maximal respiration (OCR pmol/min/SRB labeling); (D) ATP production (OCR 
pmol/min/SRB labeling). Data are expressed as mean ± SD of 14 separate experiments. ANOVA followed by Tukey’s test was 
used to assess the statistical significance between groups. Significant differences are denoted by symbols: Ctrl vs all 
treatments ***p ≤ 0.001, *p ≤ 0.05; SS vs all treatments, #p ≤ 0.05; SH vs all treatments $$$p ≤ 0.001. 
 
To assess possible mitochondria damage, we evaluated the mtDNA copy number and 
expression of the two main genes involved in mtDNA repair by qPCR (Fig. 5). The mtDNA  
copy number did not change in SS cells, but it was reduced in SH cells (−43% respect 
to control; p ≤ 0.05), and silybin was not able to rescue this damage (Fig. 5A). With regard to 
the enzymes for DNA repair, SH cells exhibited an increase in mRNA expression of both APE1 
(1.50-fold induction compared to control; +68% with respect to SS, p ≤ 0.001) and POLG 
(1.45-fold induction compared to control; +75% with respect to control, p ≤ 0.001), and 





Figure 11. Effect of silybin on mitochondrial DNA (mtDNA) copy number and membrane polarization 
Under the conditions of Figure 1, the following parameters were measured: (A) mtDNA copy number by quantitative PCR 
(qPCR) using primer for COII. The nuclear gene β-actin was used as the internal control; data were expressed as fold 
induction with respect to controls. (B) The mRNA expression of APE1 and POLG genes related to mtDNA repair; β-actin was 
used as the internal control and data were expressed as fold induction with respect to controls. (C) The mitochondrial 
polarization through cell vital staining with TMRE (mitochondria, red fluorescence) and Hoechst33342 (nuclei, blue 
fluorescence). Representative images for all the experimental conditions are reported separately for each staining 
(black/white) and then merged in colors. Images were acquired using 40× objective (scale bar 35 µm). Values are mean ± 
SD from at least three independent experiments. ANOVA followed by Tukey’s test was used to assess the statistical 
significance between groups. Significant differences are denoted by symbols: Ctrl vs all treatments ***p ≤ 0.001, *p ≤ 0.05; 
simple steatosis (SS) vs all treatments ###p ≤ 0.001, #p ≤ 0.05; steatohepatitis (SH) vs all treatments $$$p ≤ 0.001. 
In contrast, fluorescence microscopy of TMRE-stained mitochondria was performed to assess 
the potential of mitochondrial inner membrane (Fig. 5C). We observed a higher fluorescent 
signal in SS cells than in control cells, and fluorescence was reduced and less organized in SH 
cells where it appeared rather diffuse and irregular. Treatment of both SS and SH cells with 
silybin increased TMRE signal with cells appearing more brilliant compared to untreated 
counterparts. 
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Ultrastructural morphology of mitochondria was assessed by EM analysis to measure 
mitochondrial number, major and minor axe diameters, number, and organization of cristae 
(Fig. 6A-C). Our results showed that both mitochondrial morphometry and cristae number 
did not change in SS cells. Upon treatment of SS cells with silybin mitochondria showed a 
significant increase in size (both major and minor axes, p ≤ 0.001) and the mitochondrial 
cristae increased in number and were better organized and parallel to each other’s (Fig. 6A- 
C). In SH cells, mitochondrial size did not change (Fig. 6A, B) and the mitochondrial cristae 
were largely disorganized and significantly reduced in number compared to SS cells (p ≤ 0.05) 
(Fig. 6C). Interestingly, in SH cells, treatment with silybin rescued both the number (p ≤ 0.001) 
and the parallel organization of mitochondrial cristae compared to SS cells (Fig. 6C). 
 
Figure 12. Effect of silybin on mitochondrial shape 
Under the conditions of Figure 1, cells were analyzed by electron microscopy and the following parameters were assessed: (A) 
mitochondrial length (major axis) and mitochondrial size (minor axis) (B) were measured. The results were plotted as box-and-
whisker plot, showing the interquartile range, the median as horizontal bar and the whiskers are the minimum and maximum 
values. (C) Cristae number was also evaluated. Values are mean ± SD from all mitochondria scored in 20 images for each 
experimental condition. Representative electron micrographs of randomly selected mitochondria from each experimental 
condition are also shown. (magnification 25k; scale bar: 0.5 µm). Significant differences are denoted by symbols: Ctrl vs all 
treatments, *p ≤ 0.05; simple steatosis (SS) vs all treatments ###p ≤ 0.001 and #p ≤ 0.05; steatohepatitis (SH) vs all treatments 
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$$$p ≤ 0.001. 
 
Effects of Silybin on Oxidative Stress 
Increased fat oxidation produces excess of ROS, which react with cellular structures leading 
to lipid peroxidation and DNA oxidative damage, which are classical markers for cellular 
oxidative stress (Seifert et al., 2010). By measuring lipid peroxidation, we found increased 
MDA levels in both SS and SH cells with respect to controls (+195 and +255%, respectively; p 
≤ 0.001), which decreased upon incubation with silybin (−49 and −52% with respect to SS and 
SH cells, respectively; p ≤ 0.001) (Fig. 7A). When extracellular levels of 8- OHdG were 
measured as a marker for oxidative DNA damage, a slight but no significant increase was 
observed in both SH and SS cells, and silybin reduced 8-OHdG levels in both conditions (−49% 
in SS and −50% in SH cells with respect to their counterparts; p ≤ 0.05) (Fig. 7B). 
The ability of silybin in protecting cells from fat-induced oxidative stress was confirmed by 
measuring the activity of the antioxidant enzyme catalase and expression of the transcription 
factor NF-κB, which is activated by oxidative stress. Catalase activity increased in both SS and 
SH cells with respect to control (+145% and +140%, respectively; p ≤ 0.01) and decreased 
upon incubation with silybin (−38% and −65% with respect to SS and SH cells, respectively; p 
≤ 0.01 and p ≤ 0.001) (Fig. 7C). NF-κB activation did not change significantly in SS and SH cells 
with respect to controls, but a significant reduction was observed upon exposure to silybin 




Figure13. Effect of silybin on oxidative stress end-points 
Oxidative stress end-points were determined in FaO cells treated under the conditions described in Figure 1: (A) the 
intracellular level of MDA (pmol MDA/mL/mg of proteins) by spectrophotometric thiobarbituric acid reactive substances 
(TBARS) assay. Data are expressed as percentage values with respect to controls and normalized for total proteins. (B) Levels 
of 8-hydroxy-2-deoxy guanosine (8-OHdG) (pg/mL) released into the culture medium measured by competitive ELISA. (C) 
Catalase enzymatic activity (μmoles of decomposed H2O2/min/mg of proteins) by spectrophotometric assay. Data are 
expressed as percentage values with respect to controls and normalized for total proteins. (D) Densitometric analysis of 
nuclear nuclear factor kappa-B (NF-κB)/p65 evaluated by Western blotting. Data are expressed as percentage values with 
respect to controls and normalized for β-actin. Immune complexes were visualized using an enhanced chemiluminescence, 
quantified using a computerized imaging system (Biorad Quantity One 1-D Analysis Software) and expressed as relative 
optical density (ROD, arbitrary units). Inset: representative image of NF-κB/p65 immunoreactive bands: control (lane 1), 
simple steatosis (SS) (lane 2), SS + Sil (lane 3), steatohepatitis (SH) (lane 4), and SH + Sil (lane 5).Values are mean ± SD from 
at least three independent experiments. ANOVA followed by Tukey’s test was used to assess the statistical significance 
between groups. Significant differences are denoted by symbols: Ctrl vs all treatments ***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05; 




By using a novel cellular model mimicking initiation and progression of NAFLD in vivo, we 
demonstrated that silybin provides important protective and anti-steatotic effects involving 
crucial pathways, especially at mitochondrial level. Our model paves the way to simultaneous 
assessment of morphological and functional characteristics of hepatocytes exposed to the 
steatogenic and pro-inflammatory hits, thus resulting an optimal and reliable system to test 
the beneficial and direct effects of silybin, a bioactive compound known for its vague 
“hepatoprotective” features. 
Chronic caloric overload initiates an inflammatory response originating from the adipose 
tissue with production of cytokines, such as TNFα, that impairs lipid metabolism in remote 
tissues such as the liver thus promoting the progression of SS to SH (Hotamisligil et al., 1995). 
Therefore, in our model, we induced a condition mimicking NAFLD progression by exposing 
SS cell to TNFα for 24 h. NAFLD progression was ascertained by assessing: (i) cell viability, 
which was not altered in SS cells but was significantly reduced in SH cells; (ii) IkBip  expression, 
a classical liver damage marker, which increased in SS cells and further increased in SH cells; 
and (iii) caspase activity, a marker of apoptosis, which was stimulated in SS cells and further 
stimulated in SH cells. 
A first result of our study is that TG accumulation did not increase when our SS cells 
progressed to SH cells, thus suggesting that this experimental system might mimic the so- 
called burned-out NASH, a NASH sub-type in, which hepatic TG accumulation does not 
increase with the progression of disease (Nagaya et al., 2010). Interestingly, the progression 
of SS cells to SH cells was associated to a slightly reduction in LD size and these changes of 
LD morphometry were paralleled by alterations of ADRP, the main LD-associated protein, 
which promotes FA uptake and LD enlargement. In fact, ADRP expression increased in SS 
cells, but it was reduced in SH hepatocytes. Therefore, we can suggest that the worsening of 
hepatocyte condition in our in vitro model of NAFLD progression may depend on a 
fragmentation of LDs rather than on an increased fat content per se. Increased LD surface 
may facilitate the traffic of FAs across LDs and the intracellular environment. In line with this 
result, ATGL expression showed a very large increase in SH cells; this indicates a high rate of 
lipid mobilization in SH cells with harmful potentials. According to expectations, we observed 
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a stimulation of TG secretion in SS cells, a likely attempt to protect cells from excess TG 
accumulation, while TG secretion was reduced in SH cells, and this impair in lipid release 
might worsen the damage in lipid homeostasis. 
To limit excess fat accumulation, in both SS and SH cells, the systems involved in the 
mitochondrial oxidation of FAs were stimulated (CPT-1 expression), whereas microsomal 
(CYP2E1 expression) and peroxisomial (AOX activity) oxidation of FAs were stimulated only 
in SS cells. Over-active FA oxidation increases production of ROS with consequent oxidative 
stress, one of the key mechanisms responsible for NAFLD progression (Fromenty and 
Pessayre, 1995; Seifert et al.,2010). Indeed, in both SS and SH cells, we found a condition of 
oxidative stress as indicated by the increase in (i) the cellular level of MDA, marker of lipid 
peroxidation; (ii) the extracellular level of 8-OHdG, marker of oxidative damage, which is 
increased in patients with NASH with respect to SS and it was related to grade of 
inflammation; and (iii) the specific activity of catalase, the main antioxidant enzyme. 
Impaired mitochondrial structure and function are reported to be a crucial event during 
progression of NAFLD. Ultrastructural analysis by EM showed that mitochondrial size was not 
significantly altered in both SS and SH cells compared to control cells. However, the 
mitochondrial cristae were largely disorganized and reduced in number in SH cells, and 
analysis of TMRE-stained mitochondria showed a reduced inner membrane polarization in 
SH cells, a further sign of damage (Aharoni-Simon et al., 2011). We observed a loss of 
mitochondria during progression from SS to SH, which was indicated by the marked reduction 
in the mtDNA copy number in SH cells. Also, the expression of APE1 and POLG, two main 
genes for mtDNA repair, was stimulated in SH cells. All these facts clearly indicate that 
mitochondria structure and number are largely damaged in our in vitro model of NAFLD 
progression. 
Mitochondrial respiration parameters were assessed by using the Seahorse XF Analyzer. We 
did not observe significant differences in basal respiration in both SS and SH cells with respect 
to control, but the proton leak was significantly reduced in both SS and SH cells with respect 
to controls. This observation could indicate a decrease in mitochondrial uncoupling, possibly 
resulting from mitochondrial membrane alterations, which made it more impermeable to 
protons. In contrast, maximal respiration and ATP production did not change in SS cells, but 
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they increased in SH cells, which is an expected finding since mitochondrial function would 
be expected to be damaged in NASH (García-Ruiz et al., 2015). Finally, in response to 
protonophore addiction (FCCP), SH cells showed increased respiration, indirectly suggesting 
higher activity of the respiratory chain. We wish to emphasize that progression from 
increased to deteriorated mitochondrial function has been also observed in the context of 
fatty liver disease (Koliaki et al., 2015). Our present biological model may recapitulate the up-
regulation of mitochondrial function observed in the initial stages of the disease. This 
probably indicates that SH cells were more damaged than SS cells. Taken together, our data 
parallel previous studies conducted in patients with simple liver steatosis and biopsy-proven 
SH undergoing functional breath tests with stable isotope to assess mitochondrial function 
in vivo and showing that indeed SH is the worst functional scenario (Portincasa et al., 2006). 
The nutraceutic silybin has shown preliminary encouraging results for NAFLD either in clinical 
and animal studies (Reina and Martínez, 2015). The present study aimed to verify and better 
understand the molecular mechanisms sustaining the beneficial action of silybin on the 
hepatocyte. A key finding is that silybin exerts hepatoprotective effects on both SS and SH 
cells, at different levels depending on the NAFLD grade. First of all, silybin was able to reduce 
the apoptosis observed in SS and SH cells, although it did not improve the viability 
compromised in SH cells. More specifically, in our cellular models of NAFLD progression we 
observed a significant anti-steatotic action of silybin. In particular, silybin treatment led to (i) 
marked reduction of excess TGs accumulated in both SS and SH cells and (ii) down-regulation 
of IkBip expression that resulted increased passing from control to SS till to SH cells. The lipid- 
lowering action of silybin in SS cells was associated to a decrease in LD size but not in LD 
number. 
The lipid-lowering effect of silybin was sustained by a transcripitonal modulation of PPARs, 
the master regulators of lipogenic and lipolytic pathways (Varga et al., 2011). In both SS and 
SH cells, silybin reduced expression of PPARγ, the lipogenic isoform promoting esterification 
of FAs. PPARγ expression typically increases in NAFLD; indeed, it was up-regulated in both SS 
and SH cells. Regarding PPARα, an activator of mitochondrial and peroxisomal β-oxidation of 
FAs, it was only slightly up-regulated in SS and SH cells and silybin played different effects 
depending on the extension of cell damage. In SS cells, silybin increased PPARα expression, 
whereas in SH cells, it reduced it. Further studies need to clarify if such results imply distinct 
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effects of silybin at different levels of steatogenic damage and play a role also in vivo. 
The lipid-lowering effect of silybin was not supported by increased TG secretion, but by 
stimulation of FA oxidation. Expression of both mitochondrial CPT-1 and microsomal CYP2E1 
was significantly up-regulated by silybin in both SS and SH cells. By contrast, the peroxisomial 
oxidation played by AOX was stimulated by silybin only in SH cells. The action of silybin 
appeared to be mainly dependent on its effects at the mitochondrial level, with different 
mechanisms depending on the NAFLD grade. In fact, at mitochondrial level, although silybin 
did not rescue the loss of mitochondria observed in SH cells, in both SS and SH cells, it led to 
a significant increase in mitochondria size (both major and minor axes), improved the 
organization of mitochondrial cristae, which became more evident and parallel to each 
other’s, and increased the polarization of the inner membrane of mitochondria as indicated 
by the increased and better defined TMRE signal. Moreover, silybin increased expression of 
the DNA repair enzymes APE1 and POLG and reduced both basal and maximal respiration 
only in SH cells, where their rates were increased, and this may stem from different factors 
including modulation of mitochondrial substrate import or decreased ATP production. 
Interestingly, silybin stimulated ATP production in SS cells but decreased it in SH cells, where 
the ATP production rate was already higher, and these changes paralleled those observed for 
PPARα expression. In contrast, silybin did not counteract the reduction of proton leak 
observed in both SS and SH cells. Although more work needs to be performed, silybin appears 
to act as an inhibitor of mitochondrial function under diseased conditions (especially in SH 
cells), which may have beneficial effects as observed previously with other agents (Jenkins et 
al., 2013). The apparent increased oxidative metabolism in SH cells may be justified by 
increasing anabolic pathways, as previously described (Satapati et al., 2015). 
Oxidative stress was observed in both SS and SH cells. Interestingly, the increased ROS 
generation following intracellular FA accumulation was almost completed blunted by co- 
treating the cells with silybin. In fact silybin was able to counteract the FA-dependent 
increase in (i) the lipid peroxidation measured as production of MDA; (ii) the oxidative DNA 
damage measured as extracellular levels of 8-OHdG; and (iii) the catalase activity. Excess ROS 
as well as pro-inflammatory cytokines can activate inflammatory signaling such as that 
sustained by the transcription factor NF-κB, which is widely implicated in the response to 
oxidative stress (Cnop et al., 2012). The ability of silybin in protecting cells from fat-induced 
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oxidative stress was confirmed by analyzing NF-κB activation, which was reduced upon 
exposure to silybin. 
In conclusion, the present study provides new insights about the protective effects of silybin 
administered directly to hepatocytes mimicking in vitro the NAFLD progression. Further 
studies are on the way to translate such promising results into long-term beneficial effects, 
in the hope that onset, progression and worsening of NAFLD/NASH will be 
prevented/delayed in human being by using more natural nutraceutic approaches. 
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ABSTRACT 
Hepatic steatosis is the hallmark of non-alcoholic fatty liver disease (NAFLD), the hepatic 
manifestation of the metabolic syndrome and insulin resistance with potential evolution towards 
non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma. Key roles of 
autophagy and oxidative stress in hepatic lipid accumulation and NAFLD progression are 
recognized. Here, we employed a rat hepatoma cell model of NAFLD progression made of FaO 
cells exposed to oleate/palmitate followed or not by TNFα treatment to investigate the 
molecular mechanisms through which silybin, a lipid-lowering nutraceutical, may improve 
hepatic lipid dyshomeostasis. The beneficial effect of silybin was found to involve amelioration 
of the fatty acids profile of lipid droplets, stimulation of the mitochondrial oxidation and 
upregulation of a microRNA of pivotal relevance in hepatic fat metabolism, miR-122. Silybin was 
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also found to restore the levels of Aquaporin-9 (AQP9) and glycerol permeability while reducing 
the activation of the oxidative stress-dependent transcription factor NF-κB, and autophagy 
turnover. In conclusion, silybin was shown to have molecular effects on signaling pathways that 
were previously unknown and potentially protect the hepatocyte. These actions intersect TG 
metabolism, fat-induced autophagy and AQP9- mediated glycerol transport in hepatocytes. 
Key words: Steatosis, steatohepatitis, silybin, aquaglyceroporins, hepatic glycerol, mono- 




Non-alcoholic fatty liver disease (NAFLD) is accompanying the growing epidemics of obesity, 
type 2 diabetes, and metabolic syndrome worldwide (Krawczyk et al., 2010). In this context, 
hepatic steatosis is the response to high levels of fatty acids (FA) from diet and adipose tissue, 
as well as from intrahepatic de novo lipogenesis and defective export as very low-density 
lipoproteins (VLDL) (Vergani, 2019). FA entering the hepatocytes are mainly esterified with 
glycerol to originate triglycerides (TG). The saturated palmitic acid (PA, 16:0) and the 
monounsaturated oleic acid (OA, 9-cis 18:1) are the most abundant FA in both diet and 
serum, and they show different lipotoxicity. In rodent hepatocytes cultured in vitro, excess 
PA induces apoptosis, whereas OA prevents cell death and promotes TG secretion (Ricchi et 
al., 2009). The formation of monounsaturated fatty acids (MUFAs) from saturated fatty acids 
(SFAs) is catalyzed mainly by the stearoyl-CoA desaturase (SCD-1) (Paton & Ntambi, 2009). In 
hepatocytes, TG are either packed as lipid droplets (LD) for storing, or as VLDL for secretion 
(Donnel et al., 2005). 
The proprotein convertase subtilisin/kexin type 9 (PCSK9) is a hepatic protease that degrades 
the low-density lipoprotein receptor (LDLR) thereby elevating plasma LDL cholesterol levels 
(Lagace et al., 2006). Moreover, PCSK9 is involved in TG metabolism by acting on degradation 
of CD36, a major receptor involved in transport of long-chain FA and TG storage (Demers et 
al., 2015). 
Although storing of lipids inside LD is beneficial, excess hepatocyte enlargement may result 
in cell dysfunction (Yamahguchi et al., 2007; Baldini et al., 2019), and benign hepatic steatosis 
can progress to non-alcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma 
(Eckel et al., 2010). Adipokines, interleukins and Tumor Necrosis Factor α (TNFα) are known 
mediators of NAFLD progression (Bekaert et al., 2016). As a defense mechanism, excess TG 
accumulation promotes autophagy of LD (lipophagy) (Wang, 2016). Conventional autophagy 
is driven by a concerted action of a suite of “autophagy-related” molecules (Atg). The 
Atg8/MAP1LC3 (microtubule associated protein 1 light-chain 3, hereafter referred to as LC3) 
acts in elongation and maturation of the autophagosome, while Atg7 mediates the 
conversion of LC3-I to the active form LC3-II (Choi et al., 2013). Autophagy dysfunction has 
been linked to development of NAFLD (Kwanten et al., 2016). 
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The mobilization of lipids from LD results in excess FA entering oxidation pathways (Vergani, 
2019). The long chain FA are oxidized mainly in mitochondria, where the very long-chain acyl- 
CoA dehydrogenase (VLCAD) catalyzes the first step of oxidation (Primassin et al., 2011), the 
cytochrome c oxidase (COX) in the respiratory chain converts molecular oxygen to water 
(Vecchione et al., 2017), and the uncoupling protein 2 (UCP2) in the inner membrane 
dissipates excess energy by separating oxidative phosphorylation from ATP synthesis (Baffy, 
2005). 
Stimulation of fat oxidation induces oxidative stress that promotes increased production of 
TNFα in adipose tissue and in the liver, which, in turn, may induce mitochondrial dysfunction. 
On the other hand, oxidative stress and stimulated autophagy activate the transcription 
factor NF-κB which regulates the expression of a broad range of anti-oxidants genes (Criollo 
et al., 2012), plays anti-apoptotic and pro-inflammatory functions and inhibits autophagy 
(Schlottmann et al., 2008). 
MicroRNAs (miRNAs) are non-protein-coding, small single-stranded RNA, that bind to the 3΄- 
UTR of the nucleotide sequence leading to inhibition of translation or mRNA degradation 
(Ambros, 2004). Dysregulation of miRNA expression has been observed in rodent models of 
NAFLD, often aligning with the changes observed in patients with steatosis and NASH 
(Cheung et al., 2008; Kong et al., 2011). In the liver, miR-122 represents about 70% of total 
miRNA and its down- or up-regulation can modify FA and cholesterol metabolism (Jin et al., 
2014). 
Aquaporin-9 (AQP9) belongs to Aquaglyceroporins, a branch of the Aquaporin family of 
membrane channels allowing permeation of glycerol and, to a lesser extent, water, hydrogen 
peroxide, urea and ammonia (Bernardino et al., 2016; Tesse et al., 2018). In liver, AQP9 
represents the major route through which hepatocytes import glycerol (Jelen et al, 2011; 
Calamita et al., 2012; Calamita et al., 2015; Gena et al., 2017). Reduction in hepatic AQP9 
levels resulting in reduced glycerol permeability decreases substrate availability for the TG 
synthesis in the cell (Portincasa et al., 2008; Calamita et al., 2015). Hepatic AQP9 is regulated 
by insulin and leptin (Rodriguez et al., 2011), and its pathophysiological relevance was shown 
in both cell and animal models of NAFLD, and in liver biopsies of obese patients with NAFLD 
(Gena et al., 2013; Rodriguez et al., 2014; Rodriguez et al., 2015a; Rodriguez et al., 2015b). 
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Male rats fed a high-fat diet (HFD) show reduction in liver steatosis after knock-down of liver 
Aqp9 at disease onset (Cai et al., 2013). Leptin-deficient mice, an animal model of NAFLD, 
have decreased levels of hepatic AQP9 (Gena et al., 2013). Therefore, AQP9 might become 
an additional therapeutic target for treatment of NAFLD/NASH (Calamita & Portincasa, 2007; 
Calamita et al., 2018). The possible correlation between AQP9 and autophagy in hepatic lipid 
metabolism needs to be investigated (Kwanten et al., 2016), as changes in AQP9 may prevent 
or reduce TG accumulation through autophagy (Calamita et al., 2018). 
So far, therapeutic options in NAFLD and NASH are lacking, and currently the best approach 
is limited to changes of lifestyles (i.e. balanced diet, regular physical exercise, and reduction 
of overweight) (Molina-Molina et al., 2018). As oxidative stress seems to have a central role 
in hepatic cell injury in the context of NASH, the influence of several antioxidants such as the 
phytochemical silybin and other compounds are being actively investigated. Silybin is the 
most relevant flavonolignan of silymarin, the extract of milk thistle seed (Silybum marianum). 
Silybin has antioxidant, anti-inflammatory and cytoprotective actions and it has been used in 
patients with NAFLD with some beneficial effects (Loguercio & Festi, 2011; Loguercio et al., 
2012). Here, in addition to a significant amelioration of the lipid profile of LD, we report 
involvement of AQP9 in the lipid-lowering activity of silybin on a hepatocyte model of NAFLD 
through modulation of autophagy. 
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MATERIALS AND METHODS 
Chemicals 
All chemicals, unless otherwise indicated, were supplied by Sigma-Aldrich Corp. (Milan, Italy). 
Cell Treatments 
Rat hepatoma FaO cells [The European Collection of Authenticated Cell Cultures (ECACC)], 
(Clayton et al., 1985) were grown in Coon's modified Ham's F12 with 10% foetal bovine serum 
(FBS). Cells grown until 80% confluence were incubated in high-glucose medium with 0.25% 
bovine serum albumin (BSA) to increase stability and solubility of FA (Vergani et al., 2018). A 
condition mimicking human steatosis (SS) was induced by incubating FaO cells for 3 h with 
an oleate/palmitate mixture (2:1 molar ratio, final concentration 0.75 mM). A steatohepatitis 
(SH) condition was mimicked by incubating SS cells for 24 h with 10 ng/mL TNFα (Zhang et 
al., 2010). After replacing the medium, both SS and SH cells were treated for 24 h with 50 μM 
silybin (Sil) (Istituto Biochimico Italiano, Lorenzini SpA, Italy) (Vecchione et al., 2016). Silybin 
stock (10 mM) was prepared in dimethyl sulfoxide (DMSO). 
Lipid Droplet imaging 
Cells grown on coverslips were rinsed with PBS and neutral lipids were visualized by optical 
microscopy using the selective Oil-Red-O (ORO) dye (Koopman et al., 2001). Briefly, after 
fixing in 4% paraformaldehyde for 20 min at room temperature, cells were washed with PBS, 
stained for 30 min with 0.3% ORO solution in isopropanol 60%. After fixation and washing, 
cells were mounted with 4′,6-diamidino-2-phenylindole (DAPI). Images were obtained using 
a Leica DMRB light microscope equipped with a Leica CCD camera DFC420C (Leica, Wetzlar, 
Germany). A first image was obtained by acquiring the ORO-stained LD with bright field set- 
up, then a second image of the DAPI stained nuclei was acquired with fluorescence set-up. 
Images were captured with 40x objective and merged (Khalil et al., 2019). Both the average 
size and the number of LD/cell were evaluated on acquired images using the open source 
image processing program ImageJ free software (http://imagej.nih.gov/ij/). At least five 
images from random fields in each sample were acquired for each experiment set, and at 
least forty cells for each image were analyzed. Values were expressed as mean ± S.D. from at 
least three independent experiments. 
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Lipid Droplet isolation and composition 
Lipid droplets were isolated from cells following a standard protocol with minor 
modifications (Atshaves et al., 2001). FaO cells were scraped from the dishes. Cell suspension 
(about 40x106 cells/sample) was homogenized with a glass dounce homogenizer on ice, and 
centrifuged at 800xg for 10 min at 4 °C. The supernatant was centrifuged at 5,000xg for 20 
min. Then the supernatant was further centrifuged at 43,000 rpm in SW55 rotor (230,000xg) 
for 2 h at 4 °C. The LD fraction forming a distinct white band on the surface of the preparation 
was collected. Lipids were then extracted from isolated LD using the method of Folch et al. 
(Folch et al., 1957) as previously described (Grasselli et al., 2014). Briefly, the lipid phase was 
saponified with methanolic KOH (3 M) and the non-saponifiable lipids were extracted by 
diethylether, and the aqueous phase was acidified and extracted with n-hexane. The hexane 
phases containing NEFAs were collected, the solvent evaporated, and the residue derivatized 
by acid-catalyzed esterification (Morrison & Smith, 1964). Then, samples resuspended in 
hexane were injected in a HP5890 series II gas chromatograph coupled to a HP5970 mass 
spectrometer equipped with an electron impact ionization source (Agilent). Separation was 
performed on a DB5MS capillary column (Phenomenex, 0.25 mm × 30 m); the helium gas 
flow was 1 mL/min. The oven temperature gradient was as follows: initial temperature of 
100 °C, isothermal at 100 °C for 3 min, 100 to 300 °C (rate, 15 °C/min) and isothermal at 
300 °C for 5 min. The MS analysis was performed in full-scan mode. FAME (fatty acid methyl 
ester) quantification was performed using a calibration curve obtained injecting different 
FAME standards referring to selected ions. The most abundant and specific ions were used 
for the quantification of FAMEs: m/z 74 was used for saturated FAMEs and m/z 55 for 
monosaturated FAMEs. The regression curves were linear in the range of the FAME 
concentrations used for the analysis. 
RNA extraction and real-time qPCR 
RNA was isolated using Trizol reagent, cDNA was synthesized and quantitative real-time PCR 
(qPCR) performed in quadruplicate using 1x IQTMSybrGreen SuperMix and Chromo4TM System 
apparatus (Biorad, Milan, Italy) as previously described (Grasselli et al., 2016). The relative 
quantity of target mRNA was calculated by the comparative Cq method using glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) as housekeeping gene, and expressed as fold 
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induction with respect to controls (Vecchione et al., 2016). Primer pairs designed ad hoc 
starting from the coding sequences of Rattus norvegicus 
(http://www.ncbi.nlm.nih.gov/Genbank/GenbankSearch.html) and synthesized by 
TibMolBiol (Genova, Italy) are listed in Table 1. 
Expression of miRNA 122 (miR-122) was measured as described elsewhere (Baselga-Escudero 
et al., 2015). Briefly, reverse transcription was performed using the High capacity cDNA kit 
(ThermoFisher Scientific, Milan, Italy), following manufacturer’s instructions, and the miRNA- 
specific reverse-transcription primers provided with the TaqMan MicroRNA Assay 
(ThermoFisher Scientific, Milan, Italy). Amplification was performed using the Stepone plus 
Real-Time PCR system (ThermoFisher Scientific) at 50 °C for 2 min and at 95 °C for 10 min 
followed by 40 cycles at 95 °C for 15 s and 60 °C for 1 min. Probe and primers for both miRNA-
122-5p (4427975-002245) and miRNA U6 (4427975-001973) were purchased from 
ThermoFisher Scientific. The relative quantity of miRNA-122-5p was calculated by the 
comparative Cq method using miRNA U6 as housekeeping gene and expressed as fold 
induction with respect to controls. 
Immunofluorescence of LC3 and AQP9 
Cells grown on poly-L-lysine coated coverslips were rinsed with phosphate-buffered saline 
(PBS) at pH 7.4, fixed with 4% paraformaldehyde for 20 min and then permeabilized with 
0.1% Triton X-100 for 15 min at room temperature (RT). After several washings (3 times for 
5 min), slides were blocked with 0.1% gelatin in PBS for 15 min and incubated for 2 h at RT 
with rabbit polyclonal anti-LC3 (14600-1-AP; Proteintech, Manchester, UK) and/or anti-AQP9 
affinity-purified antibodies (AQP9-1A; Alpha Diagnostics International, San Antonio, TX) at a 
concentration of 3 μg/mL and 4 μg/mL, respectively, in blocking solution (PBS added with 
0.1% gelatin). Successively, slides were washed and incubated with fluorescein- 
isothiocyanate (FITC)-conjugated secondary antibody (Alexa Fluor 488; Thermo Fisher 
Scientific, Milano, Italy) diluted 1:1000 in blocking solution for 1h at RT. After staining, slides 
were washed thoroughly with PBS and mounted with an anti-fade medium containing DAPI 
(Vectashield, DBA, Segrate, Italy). Finally, slides were sealed and viewed with a Nikon Eclipse 
600 photomicroscope equipped with a Nikon DMX 1200 camera (Nikon Instruments SpA, 
Calenzano, Italy). 
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Cytochrome C oxidase activity 
Cytochrome C oxidase (COX) is the terminal enzyme complex in the respiratory chain. COX 
activity was assayed according to Moyes and coworkers (Moyes et al., 1997) following the 
decrease in absorbance at 550 nm. Briefly, 50 µM reduced cytochrome c was dissolved in  
0.5% Tween-20 in 20 mM Tris-HCl (pH 8.0). Cytochrome c was reduced with ascorbate and 
dialyzed overnight to remove unreacted ascorbate. Then, the concentration of reduced 
cytochrome c was determined using an ε550=28.5 mM-l. Immediately before the assay, cell 
extracts (about 3–10×104 cells) were added to the assay medium and incubated for 5 min. 
The reaction was started by adding 10 μM reduced cytochrome c and the change in 
absorbance was recorded at 550 nm for 3 min. 
Western blotting 
Immunoblotting analyses to assess the protein level of LC3α/β and of NF-kB were performed 
as previously described (Vecchione et al., 2017). For LC3α/β immunoblotting cells were lysed 
on ice in lysis buffer (NaCl 150 mM, Tris HCl pH 7.4, 50 mM, SDS 0.33%). For of NF-kB, nuclei 
were isolated by suspending the cellular pellet in 400 µL ice-cold Buffer A (20 mM Tris-HCl 
pH 7.8, 50 mM KCl, 10 µg/mL Leupeptin, 0.1 mM Dithiothreitol-DTT, 1 mM 
phenylmethanesulfonyl fluoride-PMSF); and 400 µL Buffer B (Buffer A plus 1.2% Nonindet 
P40). The suspension was vortex-mixed for 10 s, centrifuged, and washed. The nuclear pellet 
was resuspended in 100 µL Buffer B, mixed thoroughly in ice for 15 min and finally 
centrifuged. The supernatant containing the nuclear extracts was collected. About 30-50 μg 
proteins were electrophoresed on 10% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) (Laemmli, 1970). Membrane was blocked in 5% fat-free 
milk/PBST (pH 7.4) and probed overnight at 4 °C using rabbit NF-kB p65 antibody (SC-109; 
Santa Cruz Biotechnology, DBA, Milan, Italy), or mouse anti-MAP LC3α/β p (SC-398822 Santa 
Cruz Biotechnology) in PBST buffer (PBS with 0.1% Tween 20) at 4°C (Towbin et al., 1979). 
Membranes were washed and incubated with horseradish peroxidase (HRP)-conjugated 
secondary antibody in PBST for 1 h at room temperature. Immune complexes were visualized 
using an enhanced chemiluminescence Western blotting analysis system (Bio-Rad ChemiDoc 
XRS System). Films were digitized and band optical densities were quantified against the actin 
band using a computerized imaging system and expressed as Relative Optical Density (ROD, 
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arbitrary units). ROD of each band was expressed as percentage respect to control and about 
30-50 μg proteins of cellular homogenates were electrophoresed on SDS polyacrylamide gel 
electrophoresis (SDS-PAGE). 
Measurement of extracellular glycerol 
Glycerol content was measured in cellular medium after a brief centrifugation (14,000xg for 
3 min at 4°C) after separation in chloroform:methanol (2:1). The water-soluble glycerol was 
determined by using the ‘Triglycerides liquid’ kit (Sentinel, Milan, Italy) (Vecchione et al., 
2016). Varian Cary 50 spectrophotometer (Agilent, Milan, Italy) was used for 
spectrophotometric analysis. Data were expressed as percent glycerol content relative to 
controls. 
Statistical analysis 
Data were expressed as means ± standard deviation (S.D.) of at least three independent 
experiments in triplicate. Statistical analysis was performed using ANOVA with Tukey’s post- 




Effect of silybin on the fatty acid composition of LD 
The cytosolic accumulation of TG in the different steatotic conditions, as visualized by ORO 
staining, was associated with a marked increase in LD number and size compared to control 
cells (Fig. 1A-C). Control FaO cells showed only few (about 72 LD/cell) and small (about 0.9 
µm average diameter) LD, while both number and size of LD resulted significantly increased 
in SS and SH cells. While the number of LD was comparable between SS and SH cells (about 
295 LD/cell), the average size of LD in SH was smaller than in SS cells (1.3 µm vs 1.5 µm, 
respectively). In SS cells silybin reduced the LD diameter to a value similar to that of control 
cells (1.1 μm), without effects on the number of LD. No change in LD diameter was seen in 
the SH cells exposed to silybin. 
 
 
Figure 14. Effect of silybin on fatty acid accumulation 
FaO cells were incubated in the presence of oleate/palmitate (SS), or oleate/palmitate and TNFα (SH), then treated for 24 h 
with 50 μM silybin (Sil). Untreated FaO cells were used as control (Ctrl). (A) Representative micrographs of FaO cells 
stained with DAPI and Oil-Red-O (ORO) (magnification 40x). (B-C) Average size of LDs and number of LDs/cells. Values are 
mean±S.D. from at least three independent experiments. Statistical significance between groups was assessed by ANOVA 
followed by Tukey’s test. Symbols: Ctrl vs. all treatments *p≤0.001; SS vs. all treatments & p≤0.001. 
Gas chromatography analysis of LD purified from steatotic cells (Fig. 2A) revealed an acyl 
composition of the TG in LD consistent with that typically found in mammalian cells in terms 
of both saturated (SFA) and unsaturated (UFA) fatty acids. The most abundant fatty acids 
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stored in LD included SFA such as myristic acid (MA, 14:0), palmitic acid (PA, 16:0), stearic 
acid (SA, 18:0), and UFA such as oleic acid (OA, 18:1) and linoleic acid (LA, 18:2). Analytically, 
the acyl profile in LD from SS cells showed a prevalence of PA (50.1%), followed by SA (27.4%), 
OA (10.8%), MA (7.4%) and LA (4.2%). SH cells exhibited an increase in PA content (65.6%) 
and a decrease in OA (6.4%), MA (1.1%) and LA (0.6%) contents, while SA did not change 
(26.2%). Silybin did not markedly modify the FA pattern in SS cells whereas in SH cells led to 
a reduction in PA (to 46.5%) and SA (to 20.2%) content and to an increase in OA (to 11.5%) 
and MA (to 13.8%) levels. 
Of note, SH cells showed a marked increase in SFA/UFA ratio compared to SS cells (13.7 vs 5.7 in 
SH and SS cells, respectively), and a reduction in the content of short-medium chain FA (<C16) 
(4.3% vs 11.6% in SS and SH cells, respectively) (Fig. 2A, panel). Treatment with silybin rescued 
the altered FA profile since the SFA/UFA ratio decreased when SH cells were treated with silybin 
(from 13.6 to 7.0% in SH and SH+Sil cells). On the other hand, treatment with silybin increased 
the amount of FA <C16 that reached mean values of 15.9% and 18.6% in SS+Sil and SH+Sil 
conditions, respectively. 
As shown in Figure 2B, both SS and SH cells showed a decrease in SCD-1 mRNA expression 
compared to control (0.39- and 0.62-fold induction, respectively; p≤0.01 and p≤0.05, 
respectively), while treatment with silybin increased SCD-1 mRNA level of +249% (p≤0.05) and 
+292% (p≤0.001) with respect to their counterpart SS and SH, respectively. 
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Figure 15. Effect of silybin on fatty acids composition of LDs 
FaO cells were incubated in presence of oleate/palmitate (SS), or oleate/palmitate and TNFα (SH), then treated for 24 h 
with 50 μM silybin (Sil). Untreated FaO cells were used as control (Ctrl). (A) Acyl composition of LDs purified and analyzed 
by gas chromatography. (B) Real-time qPCR analysis of SCD-1 transcriptional expression. Values are mean±S.D. from at least 
three independent experiments. Statistical significance between groups was assessed by ANOVA followed by Tukey‟s test. 
Symbols: Ctrl vs. all treatments *p≤0.05, **p≤0.01, ***p≤0.001; SS vs. all treatments &p≤0.05, &&&p≤0.001; SH vs. all 
treatments # p≤0.05. 
Effect of silybin on hepatocyte AQP9, glycerol uptake and autophagy of LD 
Since liver steatosis in vivo has been reported to lead to AQP9 dysregulation (Gena et al., 
2013; Cai et al., 2013; Rodriguez et al., 2014) and dysfunctional autophagy (Kwanten et al., 
2016) we assessed the possible changes in AQP9 expression, glycerol import and autophagic 
process in FaO cells in the different experimental conditions. 
By real-time qPCR, no differences in AQP9 transcript levels occurred in both steatotic SS and 
SH cells compared to control (Fig. 3A), whereas marked upregulation of AQP9 was observed 
in SS and SH cells exposed to silybin (1.55- and 1.72-fold induction vs control cells, in SS and 
SH cells, respectively; p≤0.001) (Fig. 3A). In terms of protein, SS and SH cells showed a 
significant reduction of plasma membrane AQP9 immunoreactivity compared to control cells 
(Fig. 3B,C,E), and silybin restored the levels of AQP9 protein in SS and SH cells (Fig. 3D,F) 
to extents comparable to those of the control FaO cells. No changes in the transcript and 
protein levels of AQP9 were seen in control cells receiving silybin (data not shown). 
Given the role of AQP9 in glycerol transport within hepatocytes, we measured the glycerol 
concentration in the culture medium in the attempt of correlating the levels of AQP9 with 
those of the glycerol influx. The extracellular level of glycerol for both SS and SH cells was 
similar to that of control cells, while it was significantly reduced by the treatment with silybin 




Figure 16. Effect of silybin on AQP9 expression and glycerol import 
FaO cells were incubated with oleate/palmitate (SS), or oleate/palmitate and TNFα (SH), then treated for 24 h with 50 μM 
silybin (Sil). Untreated FaO cells were used as control (Ctrl). (A) Realtime qPCR analysis of AQP9 transcriptional expression. 
(B-F) Immunofluorescence analysis. AQP9 immunoreactivity (green fluorescence) is seen over the plasma membrane. Nuclei 
are stained by DAPI (blue fluorescence). (G) Glycerol content of culture medium. Values are mean±S.D. from at least three 
independent experiments. Statistical significance between groups was assessed by ANOVA followed by Tukey‟s test. 
Symbols: Ctrl vs. all treatments ***p≤0.001; SS vs. all treatments &&p≤0.01, &&&p≤0.001; SH vs. all treatments ### 
p≤0.001).  
The possible effects of silybin on cell autophagy were investigated by assessing the 
intracellular expression and distribution of LC3-II, and by quantifying the LC3-II/LC3-I ratio 
(Tanida et al., 2004). In control conditions, only few punctuate structures, seen as green dots, 
were observed indicating LC3 recruitment on autophagosomes (Fig. 4A). Both SS and SH 
hepatocytes showed an increase in these cytosolic puncta (Fig. 4B, D), a profile indicating 
increased autophagy turnover accompanying NAFLD progression. The immunofluorescence 
was of wider diffusion when SS and SH were treated with silybin (Fig. 4C,E), resulting in a 
pattern more similar to that of the control cells (Fig. 4A). In line with these results, Western 
blot analysis (Fig. 4F) showed a significant increase in LC3-II/LC3-I ratio in both SS and SH cells 
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(+24% and +17%, respectively, vs control; p≤0.001 and p≤0.05), while silybin counteracted 
this increase in both steatotic conditions (−29% and -31%, respectively, vs their counterparts; 
p≤0.001). No changes in LC3-II/LC3-I ratio were seen in control FaO cells receiving silybin 
(data not shown). 
In both steatotic conditions the Atg7 mRNA was overexpressed, but the increase was larger 
in SH cells compared to SS cells (2.84 vs 1.53-fold induction vs control, respectively; p≤0.01 
and p≤0.001) (Fig. 4G). On the other hand, silybin was able to restore Atg7 expression near 
to control in SH hepatocytes (-60% vs SH; p≤0.001). 
Since autophagy is known to activate NF-κB we assessed by immunoblotting the NF-κB 
activation as a downstream effect of autophagy stimulation (Fig. 4H). A significant decrease 
in NF-κB activation was seen when both SS and SH hepatocytes were treated with silybin 
(about -30% for both SS and SH; p≤0.05). 
 
Figure 17. Effect of silybin on hepatocyte autophagy 
(A-E) Immunofluorescence analysis. LC3-II immunoreactivity (green fluorescence) is seen over the plasma membrane. Nuclei 
are stained by DAPI (blue fluorescence). Control cells (A) show few punctuate structures (green dots) indicating LC3 
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recruitment on autophagosomes. Both SS (B) and SH (D) hepatocytes show an increase in these cytosolic puncta reflecting 
an increase in autophagy turnover. The immunofluorescence becomes more diffuse in SS and SH cells were treated with 
silybin (C, E), resulting in a pattern more similar to that of control cells. F. Western blot analysis of LC3-II/LC3-I ratio. Both 
SS and SH cells show a significant increase in LC3-II/LC3-I ratio, while silybin counteracts this increase in both steatotic 
conditions. (G) Real-time qPCR analysis of Atg7 transcriptional expression. In both steatotic conditions, Atg7 mRNA results 
overexpressed, largely in SH cells compared to SS cells. The treatment with silybin restores the Atg7 expression near to 
control in SH hepatocytes. (H) Western blot analysis of NF-κB. A significant decrease in NF-κB activation is observed when 
both SS and SH hepatocytes are treated with silybin. Values are mean±S.D. from at least three independent experiments. 
Statistical significance between groups was assessed by ANOVA followed by Tukey‟s test. Symbols: Ctrl vs. all treatments 
*p≤0.05, ***p≤0.001; SS vs. all treatments &&&p≤0.001, SH vs. all treatments ###p≤0.001. 
 
Effects of silybin on genes of hepatic lipid metabolism 
Uptake of circulating FA by hepatocytes is also regulated by PCSK9. Analysis by qPCR showed 
that PCSK9 mRNA expression was downregulated in both SS and SH cells, with respect to 
control (0.59- and 0.45-fold induction, respectively; p≤0.001), and silybin partially reversed 
this downregulation as PCSK9 mRNA expression increased significantly in SH cells (+102% vs 
SH; p≤0.01) (Fig. 5A). 
Mitochondria are the final destination of long chain FA for β-oxidation. In mitochondria, 
expression of VLCAD (Fig. 5B), the shuttle for FA, was up-regulated in SS and SH cells with 
respect to control (1.61- and 1.86-fold induction, respectively; p≤0.05), and it was further 
stimulated when cells were treated with silybin (2.21- and 4.47-fold induction vs control, 
respectively; p≤0.01). COX acting in the mitochondrial electron transport chain (Fig. 5D) 
increased significantly its activity only in SH cells (+97% vs control; p≤0.001), but not in SS 
cells, and silybin was able to stimulate COX activity in SS cells (+27% vs control), but not in SH 
cells (Fig. 5C). Expression of the uncoupling protein UCP2 (Fig. 5D) was also up-regulated in 
SS and SH cells with respect to control (1.72- and 2.97-fold induction vs control; p≤0.01 and 
p≤0.0011, respectively), and silybin counteracted this upregulation (-31% with respect to SH 
cells; p≤0.01). Silybin did not play any significant effect on the expression/activity of these 
proteins in control FaO cells (data not shown). 
In hepatocytes miR-122 is recognised to be a major regulator of lipid metabolism (Tsai et al., 
2009). A significant increase in miR-122 level was observed in SS cells upon treatment with 




Figure 18. Effects of silybin on genes of hepatic lipid metabolism 
FaO cells were incubated in the presence of oleate/palmitate (SS), or oleate/palmitate and TNFα (SH), then treated for 24 
h with 50 μM silybin (Sil). Untreated FaO cells were used as control (Ctrl). (A) Real-time qPCR analysis of PCSK9 
transcriptional expression. (B) Real-time qPCR analysis of VLCAD transcriptional expression. (C) Cytochrome C oxidase 
activity measured by enzymatic assay. (D) Real-time qPCR analysis of UCP2 transcriptional expression. (E) Real-time qPCR 
analysis of miR-122 transcriptional expression. The level of miR-122 is increased in SS cells upon treatment with silybin. 
Values are mean±S.D. from at least three independent experiments. Statistical significance between groups was assessed 
by ANOVA followed by Tukey‟s test. Symbols: Ctrl vs. all treatments ** p≤0.01, ***p≤0.001; SS vs. all treatments 




NAFLD is a worrisome health problem worldwide commonly encountered with the metabolic 
syndrome. No established therapy exists for NAFLD, and changes in lifestyles remain the 
most common approaches to treat overweight, obesity, insulin resistance, and liver steatosis. 
The nutraceutical silybin has shown beneficial effects in patients with NAFLD (Loguercio et 
al., 2012), and potential hepatoprotective effects in both animal and cellular models of 
NAFLD (Grasselli et al., 2019; Vecchione et al., 2017; Vecchione et al., 2016; Grattagliano et 
al., 2013). 
In the present study, employing a cellular model of NAFLD progression widely employed in 
previous studies (Baldini et al., 2019), we found that the beneficial effect of silybin on hepatic 
steatosis involves amelioration of the FA profile of LD, stimulation of the mitochondrial 
oxidation and upregulation of miR-122 expression. Interestingly, silybin is also found to 
restore the levels of AQP9 and glycerol permeability while reducing the autophagy triggered 
by the ectopic accumulation of lipids. These results suggest a rather complex and pleiotropic 
role for silybin in the hepatic cells, involving several key molecular intracellular pathways 
active during liver steatosis. 
The accuracy of the cellular model of NAFLD progression was verified by a series of 
morphometric and biochemical parameters. First of all, steatotic FaO cells showed an 
increase in number/size of LD compared to controls. However, the LD diameter was smaller 
in SH cells than in SS cells, suggesting that these conditions mimic microvesicular and 
macrovesicular steatosis, respectively. Of note, differences in type of histological steatosis 
might correlate with distinct phenotypic and prognostic manifestations of liver steatosis. For 
example, in drug-induced liver injury, acute steatosis is severe, and usually microvesicular 
because of disrupted mitochondrial beta-oxidation of lipids and oxidative energy production 
(Cullen, 2005). Also, acute liver failure of pregnancy occurs as microvesicular steatosis (Bacq, 
1998). More chronic forms of liver damage, by contrast, occur with macrovesicular steatosis 
as (Ramachandran and Kakar, 2009). However, treatment with silybin was able to reduce the 
number of LD in both SS and SH cells and the diameter of LD in SS cells, while did not play 
detectable effects on the size of LD in SH cells. Another sign that silybin improves hepatic 
steatosis is the increase in miR-122 level in SS cells upon treatment with silybin according to 
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previous studies showing the involvement of miR-122 in NAFLD (Tsai et al., 2009). Indeed, in 
vitro studies showed downregulation of miR-122 in fatty hepatocytes, and reduced 
expression of major lipogenic genes upon upregulation of miR-122 in HepG2 cells (Cheung et 
al., 2008). 
In terms of acyl composition, the LD of SS cells are rich in the saturated fatty acids PA and SA, 
and of the unsaturated OA. The PA content increases in SH cells (+15% vs SS cells) being 
partially balanced by a reduction in OA content (-4% vs SS cells). SH cells showed also a lower 
content of short-medium chain FA (<C16) compared to SS cells. The changes in SFA/UFA ratio 
might be a sign of more severe steatosis in SH cells compared to SS cells. Of note, the 
beneficial effect of silybin in SH cells was accompanied to a reduction in content of the 
saturated fatty acids PA and SA, and to an increase in content of the unsaturated OA, as well 
as to an increase in the amount of short-medium chain FA. In both SS and SH cells, the 
changes in the FA profile of LDs could be sustained by downregulation of the SCD-1 mRNA 
expression. Interestingly, silybin was able to counteract the SCD-1 mRNA downregulation. 
Uptake of FA by hepatocytes is regulated by PCSK9, and this effect is independent of its action 
on LDLR (Demers et al., 2015). Indeed, PCSK9 binds LDLR resulting in its internalization and 
degradation (Horton et al., 2009), but PCSK9 promotes also degradation of CD36, which is 
involved in FA uptake and TG storage/secretion. Indeed, Pcsk9−/− mice develop hepatic 
steatosis with liver sections showing accumulation of LD and marked increase in TG content 
(Demers et al., 2015). In the present experimental steatogenic setting, PCSK9 mRNA was 
downregulated in both SS and SH cells. This condition would likely promote FA entry in 
hepatocytes, a mechanism potentially counteracting the excess of external FA. Notably, 
silybin significantly reversed PCSK9 downregulation in SH cells, and apparently restored 
cellular function while reducing FA influx in the hepatocyte. The potential “double sword” 
effect of PCSK9 inhibition/activation in the hepatocyte, and the action of silybin, needs to be 
shortly commented, due to potential effects on systemic lipid metabolism. In vivo 
dysfunctional PCSK9 leads to persistently elevated serum LDL-cholesterol and increased risk 
of coronary heart disease (Lagace et al., 2006), nevertheless loss-of-function mutations are 
frequently associated with decreased LDL-cholesterol and low risk of heart disease (Cohen 
et al., 2006, Benn et al., 2010). Of note, statins, acting as hypolipemic drugs, lead to increased 
levels of PCSK9 resulting in a LDL-C-lowering effect in vitro (Dubuc et al., 2004), but clinical 
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studies do not confirm this effect (Huijgen et al., 2012). In this study, it appears that liver 
steatosis leads to dysregulation of PCSK9 (and possibly LDLR), while silybin restores at least 
in part the hepatocyte function. Furthermore, silymarin (and its main constituent silybin) are 
deemed as adjuvants in hyperlipoproteinemia (Skottova and Krecman, 1998) and reduce LDL 
lipid peroxidation. Silybin exerts an inhibitory effect on HMG-CoA reductase in vitro while, in 
vivo, reducing cholesterol synthesis (Cicero et al., 2017). 
Together with the effect on other biomarkers of cardiovascular risk, the net effect of 
silymarin appears to be rather protective on the liver and on serum lipids (Voroneanu et al., 
2016), although further studies need to investigate in vivo the effect of silybin on PCSK9- 
mediated effects during ongoing liver steatosis. 
Mitochondria are the final destination of long chain FA for β-oxidation. In both SS and SH 
cells, UCP2 expression was upregulated in the attempt to avoid the excess synthesis of ATP. 
Moreover, as a response of toxic TG accumulation, SH cells stimulated the COX activity in the 
respiratory chain. The lipid lowering activity of silybin in both SS and SH cells was associated 
to increased long chain FA entering mitochondria through up regulation of VLCAD expression. 
Our results suggest that the anti-steatotic action of silybin implies upregulation of AQP9 and 
increase of glycerol permeability in hepatocytes. This result is an important insight into the 
full understanding of the role played by this aquaglyceroporin in NAFLD/NASH. In humans, 
AQP9 is highly expressed in liver (Lindskog et al, 2016), where in post-prandial conditions it 
sustains the hepatic import of extracellular glycerol for the ex-novo synthesis of TG. Likely, 
silybin might increase the AQP9 levels through an epigenetic mechanism as most bioactive 
plant polyphenols do (Joven et al, 2014). 
Moreover, silybin is found to diminish the fat-stimulated autophagy as demonstrated by the 
downregulation of the LC3-II and Atg7 expression in both SS and SH hepatocytes. Indeed, the 
autophagosome formation is regulated by Atg7 (Komatsu et al., 2005). The parallel reduction 
in NF-κB activation upon treatment with this phytocompound well fits with the role of NF-κB 
activation in promoting autophagic process (Trocoli and Djavaheri-Mergny, 2011). 
The inverse correlation found between AQP9 levels and autophagy is compelling. Low levels 
of hepatocyte AQP9 were associated with the increased autophagy accompanying the TG 
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overaccumulation, whereas the opposite was observed after restoring the levels of AQP9. 
This finding is consistent with hepatocyte AQP9 expression being positively regulated by the 
mammalian target of rapamycin (mTOR) (Rodriguez et al, 2011), a paramount signaling 
pathway in the regulation of autophagy as the initiation of autophagosome formation by 
phosphorylating UNC51-like kinase 1 (ULK1) is inhibited by mTOR (Ravikumar et al., 2009; 
Rubinsztein et al., 2012). Of note, AQP9 might have good potentials as drug target in 
preventing or treating NAFLD/NASH (Calamita et al., 2018), and small compounds selectively 
and potently gating the AQP9 channel are already available (Jelen et al., 2011; Wacker et al., 
2013; Sonntag et al., 2019). The present results lead to the attractive idea that 
pharmacological modulation of AQP9 may prevent or reduce TG over accumulation and 
consequent liver dysfunction through autophagy. 
In summary, the beneficial effect of silybin on the in vitro model of NAFLD and NASH implied 
amelioration of the profile of FA stored in LD with an increase the short/medium chain FA ratio 
and a decrease of the saturated/monounsaturated FA ratio, (ii) stimulation of mitochondrial FA 
oxidation through upregulation of VLCAD and UCP2 and stimulation of COX activity, (iii) increase 
of the master regulator of hepatic lipid metabolism miR-122, (iv) increase of AQP9 expression 
and glycerol permeability, and (iv) diminution of fat-stimulated autophagy. Altogether, these 
results show that silybin has molecular effects on signaling pathways that were previously 
unknown and potentially protect the hepatocyte. These effects intersect TG metabolism, fat-
induced autophagy and AQP9-mediated glycerol transport in hepatocytes. 
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Overconsumption of fats and sugars is a major cause of development of non-alcoholic fatty 
liver disease (NAFLD). The main objectives of the present study were to explore the pathways 
sustaining the interfering metabolic effects of excess fructose and fatty acids in hepatocytes, 
and to clarify the mechanisms through which the nutraceutical silybin rescues the functional 
and metabolic alterations that are associated with the NALFD progression. Cultured 
hepatocytes were exposed to fructose and fatty acids, alone or in combination, to induce 
different grades of steatosis in vitro. Cell viability, apoptosis, free radical production, lipid 
content, lipid peroxidation and activity of lipogenic enzymes were assessed by 
spectrophotometric assays. Oxygen consumption and mitochondrial respiration parameters 
were measured using a Seahorse analyzer. Expression of markers for liver steatosis and 
dysfunction were also evaluated by reverse transcription-quantitative polymerase chain 
reaction. The data revealed that fructose and fatty acid combination in vitro had a positive 
interference on lipogenic pathways, leading to more severe steatosis and liver dysfunction, 
reduced cell viability, increased apoptosis, oxidative stress and mitochondrial respiration. 
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Hepatic cell abnormalities were almost completely alleviated by silybin treatment. These 
findings suggest that silybin may serve as a novel and cost-effective dietary supplement for 




Overnutrition plays a pivotal role in obesity and comorbidities including nonalcoholic fatty 
liver disease (NAFLD), type 2 diabetes mellitus and cardiovascular disease (CVD) (Vecchie et 
al., 2017). NAFLD is characterized by hepatic accumulation of fat, particularly triglycerides 
(TGs), and may range from simple steatosis to nonalcoholic steatohepatitis (NASH), cirrhosis 
and hepatocellular carcinoma (Mendez-Sanchez et al., 2018). In liver cells, excess TGs are 
stored in lipid droplets (LDs), and LD‑ associated proteins, such as the adipose 
differentiation‑related protein (ADRP), regulate lipid packing and traffic (Listenberger et al., 
2007). TG synthesis is a beneficial response against excess of potentially toxic fatty acids 
(FAs), leading to inflammation and reactive oxygen species (ROS) formation, particularly in 
mitochondria (Feldstein et al., 2004), which trigger lipid peroxidation of membranes acting 
in NAFLD progression (Neuschwander-Tetri, 2010). Fructose‑enriched food may contribute 
to the development of NAFLD (Ter Horst and Serlie, 2017). Fructose can enter de novo FA 
synthesis in liver cells through the action of fatty acid synthase (FAS). However, the extent to 
which fructose contributes to the metabolic disorders remains unclear, as only a limited 
number of data reporting its direct effects on hepatocyte during NAFLD progression are 
available (Gnocchi et al., 2014). In liver cells, NAFLD is associated with alterations in lipogenic 
and lipolytic pathways, which are controlled by a number of transcription factors, such as 
peroxisome proliferator‑activated receptor (PPAR) (Grasselli et al., 2017), and by microRNAs 
(miRNAs/miRs), including miR‑122, which is the most abundant hepatic miRNA (Moore et 
al., 2011). Dysregulation of miRNA expression has been reported in rodent models of NAFLD, 
and in certain cases aligned with the changes observed in obese patients with steatosis 
(Dongiovanni et al., 2018). 
A deeper understanding of the mechanisms underlying NAFLD progression would help 
identifying novel cost‑effective therapeutic strategies. It has been reported that plant 
polyphenols are promising molecules for the management of NAFLD (Baselga-Escudero et 
al., 2017). Silybin, the most relevant flavonolignan extract from the seeds of milk thistle 
(Silybum marianum) (Loguercio et al., 2011), exhibited certain beneficial effects in a 
preliminary study on NAFLD patients (Loguercio and Festi, 2011). 
In the present study, an in vitro model of NAFLD progression was established to identify the 
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pathways sustaining the interference between excess fructose and fatty acids on 
dysregulating lipid and radical metabolism in hepatocytes, and to verify the ability of silybin 
to reverse these alterations. The results may have an important translational value for 
possible therapy of hepatic steatosis associated with NAFLD. 
MATERIALS AND METHODS 
Cell treatments. 
Rat hepatoma FaO cells (European Collection of Authenticated Cell Cultures, Salisbury, UK; 
cat. no. 89042701) were supplied as mycoplasma‑free and cultured in Coon's modified 
Ham's F12 with 10% fetal bovine serum (South American origin, EU‑approved; Euroclone, 
Milan, Italy). When 80% confluence was reached, the cells were incubated in starvation 
medium containing 0.25% bovine serum albumin (BSA). Subsequently, cells were treated 
with an oleate/palmitate mixture (2:1 molar ratio; final concentration, 0.75 mM) for 3 h 
(referred to as the FA treatment group), with 5.5 mM fructose for 72 h (Fru group), or with 
sequential combination of fructose for 72 h and FAs for 3 h (Fru/FA group). Cells in the Fru/FA 
group were then treated for 24 h with 50 μM silybin (stock solution, 10 mM in dimethyl 
sulfoxide). Silybin treatment was also performed on untreated FaO cells, which served as the 
control group. 
Cell viability and apoptosis 
The sulforhodamine B (SRB) assay, relying on the property of SRB to bind stoichiometrically 
to proteins, is used to determine cell density. Briefly, 1.5x104 cells/well were seeded in 96‑ 
well culture plates and treated. Next, the cells were fixed and incubated with 0.5% SRB in 1% 
acetic acid for 1 h at 37˚C. The dye bound to proteins was extracted with 10 mM Tris‑HCl (pH 
10), and quantified in a Varian Cary‑50 Bio spectrophotometer (Agilent Technologies, Inc., 
Milan, Italy) (Vichai and Kirtikara, 2006). Caspase 3‑like activity is a marker of apoptosis as it 
initiates DNA fragmentation (Wiechelman et al., 1988). Caspase activity was measured in cell 
extracts containing 25 μg proteins determined by the bicinchoninic acid method (Moreira et 
al., 2014). Following resuspension in 20 mM HEPES/NaOH (pH 7.5), 250 mM sucrose, 10 mM 
KCl, 2 mM MgCl2, 1 mM EDTA, 2 mM dithiothreitol (DTT) and 100 μM phenylmethylsulfonyl 
fluoride, the cell extracts were incubated for 1 h at 37˚C in 25 mM HEPES (pH 7.5), 10% 
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sucrose, 10 mM DTT, 0.1% CHAPS and 100 μM caspase substrate Ac‑D EVD‑ pNA. The 
released pNA was measured spectrophotometrically, and the results are expressed as nmol 
of pNA released per μg of protein (Grasselli et al., 2011). 
Lipid quantification and imaging 
TGs were extracted from the different cell groups and spectrophotometrically quantified as 
previously described (Grasselli et al., 2010). Data are expressed as the percent TG content 
relative to the control group. For LD visualization, cells growing on coverslips were treated 
as aforementioned, rinsed with PBS, fixed with 4% paraformaldehyde, stained by Oil Red O 
(Goodridge, 1972) and then examined with a Leica DMRB light microscope equipped with a 
Leica CCD camera DFC420C (Leica, Wetzlar, Germany). 
FAS activity 
FAS activity in the different cell groups was measured according to Goodridge (Vecchione et 
al., 2016). Briefly, cell lysate was obtained by mixing cells with 0.1 M KPi (pH 7.0), 3 mM EDTA 
and 1 mM DTT via a syringe needle. Then 20 μg of lysate were mixed to 0.1 M KPi (pH 7.0), 
0.025 mM acetyl coenzyme A (CoA), 0.2 mM NADPH, 3 mM EDTA, 1 mM DTT, 25 mg/ml BSA 
and 0.1 mM malonyl‑CoA. NADPH disappearance was followed by spectrophotometric 
examination. FAS activity (nmol NADPH/min/mg protein) was expressed as the percentage 
relative to the control group. 
ROS production and lipid peroxidation 
ROS production was quantified through the oxidation of 2',7'‑dichlorofluorescin diacetate 
(DCF‑DA; Fluka, Germany) to 2',7'‑dichlorofluorescein (DCF), which was measured using a 
LS50B fluorimeter (PerkinElmer, Inc., Waltham, MA, USA). Briefly, suspended cells were 
loaded with 10 μM DCF‑DA at 37˚C in the dark, centrifuged (800 x g for 10 min at 4˚C) and 
resuspended in PBS (Iguchi et al., 1993). The fluorescent intensity was normalized to the 
protein content. Lipid peroxidation was then evaluated through the thiobarbituric acid 
reactive substance assay, as previously described (Pfaffl, 2001). Cells were incubated for 45 
min at 95˚C with 2 vol thiobarbituric acid (TBA) solution, containing 0.375% TBA, 15% 
trichloroacetic acid and 0.25 N HCl. Subsequently, 1 vol N‑butanol was added, and the 
absorbance of the organic phase was measured. Values [pmol of malondialdehyde (MDA) 
98  
per ml/mg protein] were expressed as the percentage relative to the controls. 
RNA extraction and reverse transcription‑quantitative polymerase chain reaction (RT‑ 
qPCR) 
Total RNA was extracted using TRIzol reagent (Thermo Fisher Scientific, Inc., Milan, Italy) and 
quantified spectrophotometrically. Then, cDNA was synthesized by using RevertAid H Minus 
transcriptase according to manufacturer's instructions (Thermo Fisher Scientific, Inc.); qPCR 
was performed in quadruplicate using 1X IQ™ SYBR® Green SuperMix and a Chromo4™ 
system (Bio‑Rad Laboratories, Inc., Milan, Italy) (Baselga-Escudero et al., 2015). Primer pairs 
for the assessed genes were designed ad hoc starting from the coding sequences of Rattus 
norvegicus (http://www.ncbi.nlm.nih.gov/Genbank/GenbankSearch.html) and listed in 
TableI. The amplification conditions were as follows: 3 min at 95˚C, followed by 40 cycles 
consisting of 5 sec at 95˚C, 30 sec of annealing (temperatures listed in Table I), and 40 sec of 
extension at 72˚C. At the end, a melting curve ranging between 55 and 95˚C was measured. 
The relative quantity of target mRNA was calculated by using the comparative Cq method 
and was normalized for the expression of GAPDH gene (Vecchione et al., 2017). In order to 
measure miR‑122 expression, the High‑Capacity cDNA RT kit and the miRNA‑specific 
primers provided with the TaqMan MicroRNA Assay kit (Thermo Fisher Scientific, Inc.) were 
used. Amplification was performed using the StepOnePlus Real‑Time PCR system (Thermo 
Fisher Scientific, Inc.). Probe and primers for miR‑122‑5p (4427975‑002245) and miRNA U6 
(4427975‑001973) were provided by Thermo Fisher Scientific, Inc. The relative expression of 
miR‑122 and mRNAs was calculated by the comparative Cq method using miRNA U6 and 
GAPDH as housekeeping genes (Vecchione et al., 2017). 
Oxygen consumption 
Oxygen consumption was measured using the Seahorse XFe96 Extracellular Flux analyzer 
(Agilent Technologies, Inc., Santa Clara, CA, USA) as previously described (Deus et al., 2015). 
Briefly, approximately 2x104 cells/well were seeded into 96‑well plates. A final concentration 
of 3 μM oligomycin, 1 μM FCC P, and a mixture of 1 μM rotenone and 1 μM antimycin were 
added sequentially to cells. The sensor cartridge and the calibration plate were used for 
calibration. Three baseline rate measurements of oxygen consumption rate (OCR) were 
made using a 3‑min mixing and 3‑min measure cycle. The compounds were injected 
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pneumatically by the Seahorse XFe96 analyzer into each well and mixed, following which the 
OCR measurements were conducted using the 3‑min mixing and 3‑min measure cycle 
(Hudgins et al., 2011). 
Statistical analysis 
Data are expressed as the mean ± standard deviation of at least three independent biological 
experiments performed as technical triplicates. Statistical analysis was performed using 
analysis of variance with Tukey's post‑test (GraphPad Software, Inc., San Diego, CA, USA). 




Excess FAs and fructose alter lipid metabolism and cell function 
The extent of steatosis was assessed by ORO-staining and TG quantification. The steatosis 
features were assessed as accumulation of cytosolic LDs whose number and size markedly 
increases compared to control cells (Fig.1A). Quantification of intracellular TGs (Fig.1B) 
showed that both fructose and fatty acids alone increased the TG content (+57%, p≤0.01 and 
+87%, p≤0.001 vs control, respectively), and their combination (Fru/FA) led to a larger 
increase (+277% vs control; p≤0.001). As markers for LD accumulation and hepatic cell 
dysfunction we assessed mRNA expression of ADRP and IkBip, respectively (Fig.1C). ADRP 
expression was up-regulated by FAs alone (1.85-fold induction vs control; p≤0.001), and even 
more by Fru/FA combination (2.08-fold induction vs control; p≤0.001). IkBip expression was 
significantly up-regulated only by Fru/FA combination (1.61-fold induction vs control; 
p≤0.001). Fru alone, but not FAs, stimulated FAS activity (+125% vs control; p≤0.05), and 
Fru/FA combination reduced it (-59% vs Fru; p≤0.05). (Fig.1D). On the other hand, expression 
of the miR-122 showed a slight significant increase only in Fru/FA cells (1.52-fold induction 
vs control; p≤0.05) (Fig.1E). 
Lipid peroxidation was assessed as a marker of oxidative stress. The MDA level increased in 
response to both FAs alone and Fru/FA combination (+89% and +67% vs control, respectively; 
p≤0.001) (Fig.1F). This oxidative imbalance was paralleled by changes in caspase 3-like 
activity which increased in cells exposed to both FAs alone and to Fru/FA combination 
(+142% and +145% vs control, respectively; p≤0.001) (Fig.1G). By contrast, cell viability did 
not change in FA cells, but it was s reduced in cells exposed to Fru alone (-13% vs control; 




Figure 19. Steatogenic effects of Fru, FAs and their combination (Fru/Fa) in FaO cells 
(A) Lipid droplet accumulation was visualized by Oil Red O staining (magnification, x40; bar, 100 µm). (B) TG content was 
quantified spectrophotometrically and normalized to total protein level. (C) Expression levels of AdRP and IKBIP mRNA were 
evaluated by RT-qPcR and expressed as the fold induction relative to the control. (D) FAS activity (nmol NAdPH/min/mg 
protein) was quantified spectrophotometrically. (E) miR‑122 expression was evaluated by RT‑qPCR using U6 as the internal 
control and is expressed as the fold induction relative to the control. (F) Malondialdehyde level (pmol MDA/ml/mg protein) 
was quantified by TBARS assay. (G) Activity of caspase 3 (nmol of pNA released/µg protein) was measured 
spectrophotometrically. (H) Metabolic activity was measured by sulforhodamine B assay (percentage relative to the 
controls). All values are expressed as the mean ± standard deviation from at least three independent experiments.  *P≤0.05, 
**P≤0.01 and ***P≤0.001. Fru, fructose; FA, fatty acid; Ctrl, control; TG, triglyceride; ADRP, adipose differentiation‑related 
protein; IKBIP, inhibitor of nuclear factor‑κB kinase subunit β‑interacting protein; RT‑qPCR, reverse 
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transcription‑quantitative polymerase chain reaction; FAS, fatty acid synthase; TBARS, thiobarbituric acid reactive 
substance. 
 
Silybin counteracts the steatogenic effects of fructose and FAs 
Exposure of Fru/FA cells to silybin 50µM for 24 h reduced markedly both the steatosis grade 
(-35% of TG ontent; p≤0.01), and the IkBip up-regulation (-32%; p≤0.001) compared to Fru/FA 
cells, whereas did not change the ADRP mRNA level (Fig.2A-C). Moreover, silybin led to 
changes in the lipogenic transcription factor PPARγ, whose expression was up-regulated in 
Fru/FA cells (1.55-fold induction vs control; p≤0.01) and reduced by silybin (-67% with respect 
to Fru/FA; p≤0.001), whereas both PPARα and PPARδ levels did not change (Fig.2D). Exposure 
to silybin further increased miR-122 expression (1.84-fold induction vs control; p≤0.001) in 
Fru/FA cells in which it was already over-expressed (Fig.2E). Treatment of control cells with 
silybin had no effects on expression of these genes. 
 
 
Figure 20. Silybin counteracts lipid metabolism dysregulation 
Cells incubated with Fru/FA were then treated for 24 h with 50 µM silybin. (A) Microphotographs of Oil Red O‑stained cells 
at a magnification of x40 (bar, 100 µm), and (B) histogram of TG content. (C) mRNA expression levels of ADRP and IKBIP, (D) 
mRNA expression levels of PPARα, γ and δ, and (E) miR-122 expression. All values are expressed as the mean ± standard 
deviation from at least three independent experiments. **P≤0.01 and ***P≤0.001. Fru, fructose; FA, fatty acid; TG, 
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triglyceride; ADRP, adipose differentiation‑related protein; IKBIP, inhibitor of nuclear factor-κB kinase subunit β-interacting 
protein 
Silybin counteracts apoptosis and mitochondrial dysfunction 
Silybin did not rescue the reduction in cell viability caused by Fru/FA, but it played anti- 
apoptotic effects as indicated by the decrease in the caspase 3-like activity (-38% compared 
to Fru/FA cells; p≤0.001) (Fig.3A-B). Silybin was also able to counteract the lipid peroxidation 
(-30% compared to Fru/FA; p≤0.05) and the ROS levels (-50% with respect to Fru/FA; p≤0.001) 
(Fig.3C-D) being associated to excess fat in Fru/FA cells. 
 
 
Figure 21. Silybin counteracts the cell viability and oxidative stress 
Cells incubated with Fru/FA were then treated with silybin. (A) Activity of caspase 3. (B) Metabolic activity measured by 
sulforhodamine B assay, indicating the cell viability. (C) Malondialdehyde level was quantified by TBARS assay. (D) 
Intracellular level of reactive oxygen species was quantified fluorimetrically. All values are expressed as the mean ± standard 
deviation from at least three independent experiments. *P≤0.05, **P≤0.01 and ***P≤0.001. Fru, fructose; FA, fatty acid; 
TBARS, thiobarbituric acid reactive substance. 
 
Steatotic hepatocytes typically stimulate respiration and ATP production in the attempt to 
counteract the excess TG (Vecchione et al., 2016). Silybin reduced basal respiration (-56%, 
p≤0.01), maximal respiration (-62%, p≤0.001) and ATP production (-60%, p≤0.001) in Fru/FA 
cells, without significant effects on proton leak (Fig.4A-D). Moreover, the expression of the 
mitochondrial proteins CPT-1 and UCP2, the main regulatory steps of mitochondrial FA 
oxidation, was increased in Fru/FA cells (2.29- and 1.74-fold induction, respectively, vs 
control; p≤0.001 and p≤0.01) and a further up-regulation was observed upon exposure to 
silybin (+68% and +50%, p≤0.001 for both (Fig.4E). Treatment of control cells with silybin had 
104  




Figure 22. Silybin ameliorates mitochondrial dysfunction 
Cells incubated with Fru/FA were then treated with silybin, and the following respiratory parameters were evaluated using 
the Seahorse XFe96 Extracellular Flux Analyzer: (A) cell basal respiration, (B) cell maximal respiration, (C)  ATP production 
and (D) proton leak (all presented as the OcR pmol/min/SRB labeling). data are expressed as the mean ± standard deviation 
of 14 separate experiments (n=16). (E) mRNA expression levels of UcP2 and cPT1 were evaluated by reverse transcription- 
quantitative polymerase chain reaction. Values are expressed as the mean ± standard deviation from at least three 
independent experiments (n=16 for Seahorse experiments). **P≤0.01 and ***P≤0.001. Fru, fructose; FA, fatty acid; OCR, 
oxygen consumption rate; SRB, sulforhodamine B; CPT1, carnitine palmitoyltransferase 1; UCP2, uncoupling protein 2. 
105  
DISCUSSION 
This study provided insights into the molecular mechanisms through which excess fructose 
impair the lipogenic pathways in hepatocytes. In the past, fructose was considered as a 
beneficial dietary component because it does not stimulate insulin secretion, but the harmful 
effects of fructose have recently gained mainstream attention. Studies reported that high 
fructose intake stimulates de novo lipogenesis (Hudgins et al., 2011), and mice fed fats and a 
high-fructose corn syrup equivalent developed severe NAFLD (Tetri et al., 2008). Our findings 
show that exposure of FaO cells to fructose/fatty acid combination led to larger TG synthesis 
and accumulation compared to the single agents, and that the more severe steatosis was 
associated to worsening of cell dysfunction parameters including cell viability, oxidative 
stress and mitochondrial respiration. 
In our model, the sequential exposure of hepatocytes to high fructose and fatty acids mimics 
the NAFLD progression in vitro. Excess fructose alone stimulates FAS activity resulting in TG 
overproduction, and Fru/FA combination led to more severe cell dysfunction compared to 
single treatments as confirmed by: (i) larger steatosis; (ii) maximal up-regulation of ADRP and 
IkBip expression; (iii) enhanced lipid peroxidation, ROS production, and caspase 3-like 
activity, which are indexes of oxidative stress and apoptosis, respectively. The extensive 
damaging effect of Fru/FA combination was also evident looking at expression of miR-122 
which seems to be involved in the onset/progression of NASH (Dongiovanni et al., 2018). 
Mitochondria are the main site for FA degradation, and steatotic hepatocytes typically 
enhance mitochondrial β-oxidation to limit excess fat accumulation. Accordingly to this 
scenario, the mitochondrial proteins CPT-1 and UCP2 were overexpressed in cells treated 
with Fru/FA combination. Also basal and maximal mitochondrial respiration as well as ATP 
production were stimulated by Fru/FA combination in the attempt to compensate for the 
increased FA oxidation. Of note, the increase in oxidative stress due to the over-active β- 
oxidation may trigger proinflammatory pathways sustaining NAFLD progression. 
The results of this in vitro study fit with those described in patients and animals. While a 
“high fat” diet results in obesity, insulin resistance, and hepatic steatosis with minimal 
inflammation and no fibrosis, the “Western cafeteria” diet being rich in fructose leads to 
steatosis associated to hepatic fibrosis, inflammation, oxidative stress and apoptosis. 
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The nutraceutical silybin is known as a general hepatoprotective, anti-steatotic agent 
(Vecchione et al., 2016; Vecchione et al., 2011), which has provided encouraging results in 
animal and cellular models of NAFLD (Vecchione et al., 2011; Rosso et al., 2015), and in 
clinical studies (Abenavoli et al., 2015; Federico et al., 2017; Wah Kheong et al., 2017). As 
further insight, we showed that silybin counteracted the metabolic dysfunctions caused by 
Fru/FA combination acting directly on hepatocytes. First, silybin reduced the largest TG 
accumulation resulting from Fru/FA combination by down-regulating the expression of 
PPARγ, the main transcription factor for lipogenic genes. The hepatoprotective action of 
silybin was able to counteract in vitro the Fru/FA-dependent increase in: (i) IkBip expression; 
(ii) intracellular ROS production and lipid peroxidation; (iii) apoptosis rate. However, silybin 
was no able to blunt the reduction in cell viability associated to exposure to Fru/FA 
combination. The action of silybin seems to be mainly dependent on its effects on 
mitochondria, with different mechanisms depending on the NAFLD grade (Vecchione et al., 
2017). In our model mimicking a rather severe NAFLD, silybin exerts beneficial activity by 
inhibiting mitochondrial respiration which is stimulated in steatosis progression as a 
consequence of an increased oxidative metabolism due to stimulation of anabolic pathways 
(Satapati et al., 2015). 
In conclusion, our model consisting of lipid-loaded hepatocytes mimicking in vitro the NAFLD 
progression offers new insights about the harmful steatogenic effects of fructose on liver 
cells, and supports the hepatoprotective activity of silybin. Further studies can translate 
these results into long-term beneficial effects, in the hope that onset, progression and 
worsening of NAFLD/NASH will be prevented/delayed in patients by using nutraceutical 
approaches
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ABSTRACT 
Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease often associated with 
overnutrition. Number and morphometry of lipid droplets (LDs) define micro vs 
macrovesicular steatosis, influence the morphology and function of hepatocytes and possibly 
their stiffness. The link between grade and features of steatosis and biomechanical 
properties of single hepatocytes requires deeper investigations. In vitro NAFLD models with 
distinct steatosis conditions were set by exposing FaO hepatoma cells to single or combined 
fructose (Fru), fatty acids (FA), and tumor necrosis factor (TNF)α. Single Cell Force 
Spectroscopy and Quantitative Phase Microscopy quantified the single cell stiffness and a 
series of morphometric parameters; the mRNA expression of genes involved in lipid 
metabolism was quantified by real-time PCR. In our models, LD size and number increased 
with Fru and FA as single agents, and more with combined Fru/FA (macrovesicular steatosis), 
while FA/TNFα combination increased LD number with a reduction in their size 
(microvesicular steatosis). We found that the changes in LD size and number profoundly 
influenced cell stiffness and morphometry as follows: (i) single cell elasticity increased in 
macrovesicular steatosis (maximally with combined Fru/FA); (ii) FA-induced steatosis 
resulted in cells thinner and larger, whereas combined FA/TNFα shrunk the hepatocytes. 
Taken together the data on hepatocyte biomechanics show that, in addition to extent of lipid 
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accumulation, cell stiffness is mainly influenced by LD size, while cell morphometry directly 
relates to LD number. Our findings suggest that a novel mechanobiology perspective might 




The liver is not a primary fat storage depot and the steady state concentration of hepatic 
triglycerides (TGs) is rather low under physiological conditions. Excess TG accumulation in 
hepatocytes results in nonalcoholic fatty liver disease (NAFLD), the metabolic liver disease 
which attracts ever more attention in Western countries for its increasing prevalence as 
consequence of overnutrition (Brunt et al., 2015). NAFLD may encompass a spectrum of liver 
abnormalities ranging from the simple steatosis, to nonalcoholic steatohepatitis (NASH), to 
cirrhosis and hepatocarcinoma (Nagaya et al., 2008). Hepatic steatosis typically results from 
an imbalance in lipid metabolism network leading to excess TGs which derive from either 
excess fatty acid (FA) intake or de novo lipogenesis (Vergani, 2014). TGs are stored as 
cytosolic lipid droplets (LDs) (Sahini and Borlak, 2014; Gluchowski et al., 2017) which consist 
of a hydrophobic lipid core surrounded by a phospholipid monolayer and by LD-associated 
proteins which regulate lipid metabolism and traffic (Xu et al., 2018). Among them, the 
adipose differentiation-related protein (ADRP) is crucial for formation and structural 
maintenance of LDs and is a marker for the extent of lipid accumulation, as its overexpression 
stimulates lipogenesis and inhibits lipolysis (Grasselli et al., 2010). ADRP is mainly regulated 
by the peroxisome proliferator-activated receptors (PPARs), which are ligand-dependent 
transcription factors also involved in NAFLD progression (Wang et al., 2017; Silva et al., 2018). 
In NAFLD patients, steatosis typically appears as macrovescicular steatosis (large LDs), which 
has rather good long-term prognosis with rare progression to fibrosis or cirrhosis. By 
contrast, microvescicular steatosis denotes a separate clinical entity with small LDs 
commonly associated with severe liver damage (i.e. by drugs) and worse prognosis (Tandra 
et al., 2010). 
In hepatocytes, TG synthesis is a beneficial response against potentially dangerous FAs which 
are “aggressive” species leading to tumor necrosis factor (TNF)α and reactive oxygen species 
(ROS) production that act as early “inflammatory” hits and promote NAFLD progression 
(Bessone et al., 2018; Tilg and Moschen, 2010). Intracellular fat excess may damage 
mitochondrial and endothelial reticulum (ER) function (Lebaupin et al., 2018). The fat- 
dependent ER stress is associated with over-expression of the IκB kinase β (IKBKB)-interacting 
protein (IkBip), a marker for the progression of liver damage during NAFLD (Fromenty and 
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Pessayre, 1995). 
Both excess fatty acids or fructose are steatosis-triggering agents. Our previous studies 
showed that sequential exposure of cultured hepatocytes to high concentrations of FAs and 
TNFα resulted in fat overload and oxidative stress which mimic in vitro the NAFLD progression 
(Vecchione et al., 2017). After 1960s, fructose consumption has increased worldwide and 
now represents more than 20% of total daily carbohydrate intake (10% of daily total energy 
intake) with effects on conditions such as insulin resistance and obesity (Gross et al., 
2004). High-intake of fructose acts as a potent steatogenic agent in western- type diet (Tetri 
et al., 2008; Kohli et al., 2010). 
Altered biomechanical properties of cells have been described in several diseases (Yarpuzlu 
et al., 2014). Our hypothesis is that fat accumulation should influence the biomechanics of 
single hepatocytes and trigger mechanosensitive processes. The progression of NAFLD in vivo 
is associated with an altered mechanical liver phenotype, in which the stiffness is strictly 
linked to organ dysfunction and used as a diagnostic marker (Singh et al., 2013). As LDs are 
stiffer than the surrounding cytosol, accumulation of LDs may mechanically distort the 
intracellular environment (Shoham et al., 2014). Nevertheless, a connection between 
changes in biomechanical properties and altered physiological functions of the cell has not 
been yet identified, and requires further investigations. 
We hypothesize that the mechanical properties of single hepatocytes could depend on the 
steatosis grade and LD features. A detailed biophysical single cell study of different steatotic 
models mimicking NAFLD progression in vitro was performed by Single Cell Force 
Spectroscopy (SCFS) (Mescola et al., 2012) and high resolution Quantitative Phase 
Microscopy (QPM) (Barone-Nugent et al., 2002) to verify whether and how the cell elasticity 




MATERIALS AND METHODS 
Chemicals 
All chemicals, unless otherwise indicated, were supplied by Sigma-Aldrich Corp. (Milan, Italy). 
Cell culture and treatments 
Rat hepatoma FaO cells were obtained from European Collection of Authenticated Cell 
Cultures (ECACC- Salisbury, Wiltshire ,UK). The cells were routinely checked for contaminants 
and screened for mycoplasma contamination. Cells were cultured in low glucose (1.8 gr/L) 
Coon's modified Ham's F12 supplemented with 2mM Glutamine and 10% Foetal Bovine 
Serum (FBS) (Euroclone Milan, Italy) at 37°C in a humidified atmosphere containing 5% CO2 
(Grasselli et al., 2011). For treatments, FaO cells were plated in plastic dishes and grown for 
24h in high-glucose (4.5 gr/L) medium with 0.25% bovine serum albumin (BSA), and subjected 
to different treatments: Control (Ctrl) no treatment; Fructose (Fru) incubation with fructose 
5.5 mM for 72 h; Fatty acids (FA) incubation with oleate/palmitate mixture (2:1 molar ratio, 
final concentration 0.75mM) for 3h; Fructose + Fatty acids (Fru/FA) sequential incubation 
with fructose for 72 h, then with FA for 3 h; Fatty acids + TNFα (FA/TNFα) sequential 
incubation with FA for 3 h and then with TNFα for 24 h [15]. 
Cell viability assessment 
Cell viability in the different experimental conditions was assessed by Resazurin assay.  
Briefly, 1.5×104 cells/well were seeded in 96-well plates and treated as above described. At 
the end of treatment, medium was removed and cells were incubated for 30 min with 
10μg/ml resazurin in fresh medium. The reduction of resazurin to resorufin, indicative of 
metabolic activity of the cells, was measured fluorimetrically (λexc 570nm; λem 600nm) in 
Biotek-Cytation 3 reader (Biotek Instruments, Winooski, VT, USA) (Voytik-Harbin et al., 1998). 
Lipid droplet imaging 
Cells grown on coverslips were rinsed with phosphate-buffered saline (PBS) pH 7.4 Neutral 
lipids were visualized by optical microscopy using the selective Oil-RedO (ORO) dye 
(Koopman et al., 2001). Briefly, after fixing in 4% paraformaldehyde for 20 min at room 
temperature, cells were washed with PBS, stained for 20 min with 0.3% ORO solution 
prepared from a stock 0.5% in isopropanol and diluted in water. After washing, slides wer 
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examined by Leica DMRB light microscope equipped with a Leica CCD camera DFC420C 
(Leica, Wetzlar, Germany) as previously described (Vecchione et al., 2017). 
RNA extraction and real-time qPCR 
RNA was isolated using Trizol reagent, cDNA was synthesized and quantitative real-time PCR 
(qPCR) performed in quadruplicate using 1x IQTMSybrGreen SuperMix and Chromo4TM System 
apparatus (Biorad, Milan, Italy). The relative quantity of target mRNA was calculated by the 
comparative Cq method using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as 
housekeeping gene, and expressed as fold induction with respect to controls (Vecchione et 
al., 2017). Primer pairs designed ad hoc starting from the coding sequences of Rttus 
norvegicus (http://www.ncbi.nlm.nih.gov/Genbank/GenbankSearch.html) and synthesized 
by TibMolBiol (Genova, Italy) are reported in previous papers (Vecchione et al., 2017). 
Single cell force spectroscopy (SCFS) 
SCFS allows to measure single cell elasticity using a nano-indentation device (Piuma Chiaro, 
Optics11, Amsterdam, NL) mounted on an inverted microscope. Living cells were measured 
in Petri dishes in the culture medium. The probe was brought in contact with the cell and the 
resulting interaction force was measured as a function of the cell deformation. The probe 
was a µm-sized glass sphere (radius of 9µm and stiffness of 0.2 N/m). After every experiment 
the probe was washed in ethanol 70% for 10 min. The probe was glued to an elastic cantilever 
which bends proportionally to the interaction force; the deflection was measured by a laser 
interferometer coupled to the instrument (Chavan et al., 2012). A grid of measurements was 
performed at room temperature for less than 2 h. For each experimental condition, about 
50-70 curves were acquired over at least three different repeats. Single curves were acquired 
at the speed of 1 μm/s and the indentation of the cell evaluated up to a defined threshold of 
400 nm. Before every experiment, the optical sensitivity and the geometrical factor were 
calibrated. The collected curves were analysed using a custom software programmed with 
Python 3 (Python Software Foundation, www.python.org) and the Numpy/Scipy Scientific 
Computing Stack (Jarrod et al., 2011). Every dataset was pre- filtered to eliminate irrelevant 
curves using a semi-automatic procedure. 
To convert the curve in a reliable elasticity information, a further fitting step against a 
theoretical model is required. Among the many approaches proposed in literature (Chen et 
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al., 2014), the simplest and more accepted is based on the Hertzian dynamics (Johnson, 
1985). The hypothesis behind the theoretical derivation of the Hertz formula (isotropy, 
homogeneity and pure elasticity of the sample) are fairly satisfied by a cellular system, and 
the corresponding Young’s modulus does not provide a robust absolute indicator of the 
elasticity unless an extreme care is posed in the experimental procedure (probe selection, 
calibration, measurement protocol, data analysis) (Nataliia et al., 2014; Hermann et al., 
2017). Given that cells show a largely viscous behavior (Trepat et al., 2007), special attention 
should be posed to the selection of the dynamical protocol (Fabry et al., 2001). In particular, 
if the indentation speed is maintained the same for all the experiments and it is kept under 
few μm/s, it is possible to obtain a robust effective elasticity indicator without explicitly 
accounting for viscosity (Guz et al., 2014). 
Nevertheless, the use of the Hertz model provided to be effective in experimental designs in 
which the elasticity of single cells is used as a biomarker. Here a method is proposed to obtain 
relative elasticity that exploits the Hertz model but avoiding the main tricky steps of the 
standard implementations (see results). 
Quantitative Phase Microscopy (QPM) 
QPM aims at reconstructing the three dimensional (3D) shape of semi-transparent objects 
through recording the phase of the light. Cells grown on coverslips were fixed in 4% 
paraformaldehyde for 20 min and washed in PBS; then slides were mounted and observed. 
A home-made acquisition system equipped with a Nikon 40X infinity-corrected objective (NA 
0.75; WD 0.66 mm), mounted on a motorized Z-axis with a 0.01 μm resolution step, allowed 
to integrate standard modular components (Optem FUSION, Qioptiq Photonics GmbH & Co 
KG). The sample was scanned using a motorized X-Y stage with a 0.5 μm resolution step. A 
modular stepper motor controller (phyMOTION™, Phytron, Gröbenzell, Germany) drives 
three motorized axes. A LED lamp is integrated for the illumination; a Gig-E DMK 23G274 
camera (The Imaging Source, Bremen, Germany) equipped with a 1600×1200 pixels 
monochrome CCD is used. The control software was developed in LabVIEW [National 
Instruments, Austin, Texas] to automate all the microscope functions. An area of about 1cm2 
was imaged, resulting in 80-100 stack per sample, each comprising 15 Z planes acquired with 
a 1μm step around the estimated best focal plane. Each Z-stack was transformed in a 3D 
phase map and, after calibration, in a thickness map where each pixel encodes for the optical 
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thickness of the sample (the product of the thickness times the refractive index) by 
implementing a method based on the Transport of Intensity Equation (TIE) (Petecchia et al., 
2017). The reconstruction was performed inverting the TIE (Teague, 1983) using a strategy 
(Zuo et al., 2013) based on the Savitzky-Golay filters (Savitzky and Golay, 1964). The 
procedure was implemented in a custom software coded in Python 3 (Python Software 
Foundation, www.python.org) and based on the original Matlab source code provided by the 
authors. All the reconstructed maps were further processed in order to isolate (mask) single 
cells using a semi-automatic procedure implemented in the free software Gwyddion (Necas 
et al., 2011). A set of morphometric indicators was calculated for each cell, and a relevant 
subset was selected for comparison, as reported in Table 1 and sketched for visual reference 
in Fig. 4. 
Statistical analysis 
Data are expressed as means ± SD of at least three independent biological experiments 
performed as technical triplicates. Statistical analysis was performed using ANOVA with 
Tukey’s post-test (GraphPad Software, Inc., San Diego, CA, USA). Multivariate linear 
regression analysis was used after testing of normal Gaussian distribution and logarithmic 
transformation. Statistical significance was assumed for p-values ≤ 0.05. In order to visually 
evaluate possible (direct or inverse) correlations among all parameters obtained from the 
experiments (biochemical, morphometric or mechanical) a full correlation matrix was 
calculated using the pandas Python package (https://pandas.pydata.org). Each cell of the 




Lipid accumulation pathways 
The spectrophotometric quantification of TG content in hepatocytes showed that, compared 
to controls, lipid accumulation increased significantly (p≤0.05) with Fru (+57%), FA (+87%) 
and the increase was larger in cells exposed to Fru/FA combination (+277%); the effect of 
combined FA/TNFα was similar to FA alone (+90% vs control) (Fig. 1A). The microscopic 
analysis of cytosolic LDs in ORO-stained FaO cells showed a marked accumulation of LDs in 
all steatotic conditions as compared to controls (Fig. 1B). In control cells, the quantitative 
analysis showed only small (about 0.9±0.3 µm) and few (about 2 LDs/cell) droplets dispersed 
in the cytosol. LD size increased selectively in all steatotic conditions: about +39% with Fru, 
+214% with FA, +334% with Fru/FA, and +50% in FA/TNFα cells (Fig. 1C). LD number, by 
contrast, invariably increased to 10 (Fru), 13 (FA), 14 (Fru/FA), and 18 (FA/TNFα) LDs/cell (Fig. 
1D). Interestingly, with respect to FA alone the exposure of cells to FA/TNFα combination 
decreased the LD size of about -52%, but increased the LD number from 13 to 18 LDs/cell. 
 
 
Figure 23. Lipid accumulation in different steatosis models 
For FaO cells incubated in the absence (Ctrl) or in the presence of fructose (Fru), oleate/palmitate (FA), Fru/FA, FA/TNFα we 
show: (A) TG content expressed as percent TG content relative to controls, normalized for proteins determined with 
Bradford assay. (B) Microphotographes of cells stained with DAPI and Oil Red-O (ORO) (magnification 40x; Bar: 10 μm). (C-
D) Average size of LDs. and number of LDs/cell. Values are mean±S.D. from at least three independent experiments. 
Statistical significance between groups was assessed by ANOVA followed by Tukey’s test. Symbols: Ctrl vs all treatments 
*p≤0.05; FA vs all treatments #p≤0.05; Fru vs all treatments $ p≤0.05. 
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On the other hand, LD accumulation slightly affected cell viability: compared to control, a 
significant (p≤0.05) decrease was noted with Fru (-15%), Fru/FA (-27%) and FA/TNFα (-24%) 
but not with FA alone (Fig. 2A). 
Hepatic lipid accumulation depends on the balance between lipolytic and lipogenic pathways 
which are under the master control of PPARα and PPAR γ (Varga et al., 2011), whose mRNA 
expression was assessed by qPCR (Fig. 2B). Fru alone increased PPARα mRNA expression 
(1.53-fold induction vs control; p≤0.05), without affecting PPARγ. On the other hand, FA, 
Fru/FA, and FA/TNFα up-regulated PPARγ expression (2.2-, 1.5- and 2.8-fold induction vs 
control, respectively; p≤0.05), but only FA/TNFα up-regulated also PPARα expression (1.8- 
fold induction vs control controls; p≤0.05).  
Also ADRP mRNA expression, a marker for LD accumulation, changed differently in the 
different conditions. It was unchanged with Fru, significantly upregulated with FA and Fru/FA 
(1.85- and 2.08-fold induction vs control, respectively; p≤0.05), and again comparable to 
control with FA/TNFα (Fig. 2C). By contrast, IkBip mRNA expression, a marker for hepatic 
cell damage, was unaffected with Fru and FA,but became up-regulated with Fru/FA and 





Figure 24. Modulation of cell function in different steatosis models 
(A) The cell viability based on metabolic activity was assessed by resazurin assay; data are expressed as percentage values 
with respect to controls. The mRNA expression of PPARα and PPARγ (B), of ADRP and of IkBip (C) were evaluated by qPCR 
using GAPDH as the internal control. Data are expressed as fold induction with respect to controls. Bars represent SD. ANOVA 
followed by Tukey’s test was used to assess the statistical significance between groups. Symbols: Ctrl vs all treatments 
*p≤0.05; FA vs all treatments #p≤0.05; Fru vs all treatments $ p≤0.05. 
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Lipid accumulation and single cell biomechanics 
The elasticity of living cells in different steatotic conditions was assessed by SCFS through 
recording the force vs displacement curves (Fig. 3A-B). The curves require to be processed 
using a reliable a model. The simplest and more accepted approach is based on the Hertzian 
dynamics (Johnson, 1985). When an elastic sample is pushed using a rigid indenter of known 
geometry, the Hertz model predicts the behavior of the experienced force F as a function of 
the indentation depth δ (Puricelli et al., 2015; Abdelaziz et al., 2008) which, for a spherical 










where E is the Young’s modulus and ν is the Poisson ratio of the sample. Fitting this formula 
to the collected curves supplies an estimate of the Young’s modulus for single cell. This 
procedure is called direct fit (DFIT). When we are interested in a relative value of the elasticity 
to monitor its changes in different conditions, a more robust procedure can be introduced 
based on the so called Force Integration to Equal Limits (FIEL) method (A-Hassan et al., 1998). 
The FIEL approach evaluated the interaction work w (represented by the grey area in Fig. 3), 
rather than the interaction force. It makes possible to relate the change in the elasticity 













thus, eliminating most of the tricky steps involved in the standard DFIT procedure. The 
relative elasticity Er,n of a sample n was calculated with respect to the average of the control 








The FIEL analysis, which has been specifically tuned for this study, guarantees an 
unprecedented sensitivity and robustness in the quantification of the mechanical properties, 
thus allowing to resolve small changes with statistical relevance. 
Table 2 compares the main results obtained with the FIEL and the standard DFIT methods. 
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As depicted in Fig. 3C, the relative elasticity Er values obtained with the DFIT approach are 
more broadly distributed (SD 2 to 4 folds larger than the one obtained with the FIEL method). 
Moreover, the FIEL distributions more closely resemble a Gaussian (Shapiro coefficient closer 
to 1) (Shapiro and Wilk, 1965). 
The FIEL approach (Fig. 3D) showed that Er significantly (p≤0.05) increased in cells exposed to 
either Fru or FAs as single agents (1.11 and 1.15 fold increase vs control, respectively), and a 
larger (1.17 fold increase vs control), but not statistically significant increase with respect to 
FAs and Fru occurred in cells exposed to Fru/FA combination. Conversely, the FA/TNFα 




Figure 25. Effects of fatty acids, fructose and TNFα on single cell biomechanical properties 
(A)Example of a force-displacement curve showing the two main steps: a no contact condition (1), indentation of the cell (2). 
The force value (the grey area under the curve) is computed in the FIEL procedure to derive elasticity. (B) Picture from a nano-
indentation experiment: the spherical tip indenting a cell. (C) Probability density functions of both FIEL and DFIT methods. (D) 
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Relative Elasticity (Er) of single cell respect to the control, obtained through the FIEL method. Symbols: Ctrl vs all treatments 
*p≤0.05; FA vs all treatments #p≤0.05; Fru vs all treatments $ p≤0.05. 
Lipid accumulation and single cell morphometry 
The 3D shape of cells was reconstructed using QPM. In QPM images, each pixel encodes the 
physical thickness of the sample, providing a quantitative information related to several 
geometrical parameters. Fig. 4 provides an example of a reconstructed image of control cells 
represented with a 2D (Fig. 4A) or 3D (Fig. 4C) perspective, and summarizes the main 2D and 
3D geometrical parameters of cells in different conditions (Fig.4B-D): cell roughness (RC), cell 
height (HC), surface extension (SE), cell contact area (AC) and radius of curvature (CR). 
 
Figure 26. Single cell morphometry analysis in different steatosis models 
Representative views of the reconstructed QPM images of control FaO cells represented with a 2D (A) or 3D (B) perspective. 
In the 2D perspective, the colour encodes the thickness of the cells; (C) and (D) graphic explanation of the morphometric 
parameters: radius of the curvature (CR), cell height (HC), cell roughness (RC), surface extension (SE), cell contact area (AC). 
 
While fructose alone did not significantly modify any of the morphometric parameters, FAs 
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alone led to significant (p≤0.05) alteration of almost all parameters (Fig. 5). In details, FAs 
make the cells thinner and larger than control cells as indicated by the marked reduction in 
HC (-60% vs control) and the increase in AC (+50% vs control) (Fig. 5B and D), and with a 
smoother surface and larger protrusions as indicated by the increase in CR (+400% vs control) 
and the decrease in SE (-60% vs control) (Fig. 5A and E). A similar trend was observed in Fru/FA 
cells, with a cell morphometry being intermediate between Fru and FA, nevertheless the 
highest grade of steatosis. By contrast, with FA/TNFα cells appeared peculiarly smaller 
compared to FA, and displayed a significant decrease in SE (-20% vs control) (Fig. 5C). 
 
 
Figure 27. Single cell morphometric parameters in different steatosis models 
The morphometric indicators computed for all the treatments are presented relative to the controls: (A) cell roughness (RC); 
(A) cell height (HC); (C) surface extension (SE); (D) cell contact area (AC); (E) radius of the curvature (CR). Statistical significance 
respect to the control is marked when at least #p≤0.05. 
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Correlation among parameters 
The possible correlations between the biochemical, functional and biomechanical 
parameters above discusses were assessed through the estimated correlation matrix (Fig. 6). 
Single cell elasticity Er correlated positively (p ≤0.05) with extent of TG accumulation, LD size, 
level of ADRP expression, and cell area (Ac) and negatively with cell viability (Fig. 2D). On the 
other hand, the level of IkBip expression, a marker for liver damage, correlated positively 
with number of LDs/cell and PPARα and PPARγ expression and correlated negatively with cell 
area (Ac). Intracellular TG content correlated positively with both LD size and ADRP 
expression, a marker for hepatic steatosis. Cell viability correlates negatively with TG content, 
LD number and size, and PPARα expression. 
 
Figure 28 Correlation matrix of biochemical and mechanical parameters 
Correlation matrix was computed among all the biochemical, mechanical and morphometric parameters. Statistical 
significance was assumed for correlation coefficients higher than 0.6 or lower than -0.6. Therefore, correlation coefficients 
within the interval -0.6≤ 𝑝 ≤ 0.6 are not presented in the matrix. ### Values higher than 0.6 are represented in green, 




Although NAFLD is raising dramatically worldwide, to date there are no sustainable 
treatments for this disease. The ongoing research focus on molecular steps that may mediate 
NAFLD onset and progression as potential therapeutic targets. This study provides new 
insights, at the single cell level, on the biomechanical and morphological changes of steatotic 
hepatocytes in response to distinct and relevant hits using in vitro models of NFALD. We 
found that lipid storage in LDs dramatically alters both the elasticity and the morphometry 
of the hepatic cells with variable effects depending on the structural features of LDs. 
From a physical point of view, LDs protruding from the ER membrane are different from other 
vesicular organelles of the cell in that their core is highly hydrophobic and their shape is 
invariably spherical. In fact, while vesicular organelles have an aqueous lumen and flexible 
shape, LDs are always round to minimize the interface between hydrophobic core and 
cytosol. In NAFLD patients, we can find macrovesicular steatosis with large LDs and good 
long-term prognosis, or microvesicular steatosis with small LDs and more severe prognosis. 
Here, we adopted four different protocols to induce different kinds of hepatosteatosis 
consisting of excess fructose, excess fatty acids, a combination of both, and a combination 
of fatty acids and the pro-inflammatory cytokine TNFα. All conditions mimic valuable steps 
of a dysmetabolically-active context such as that occurring in in vivo when steatogenic factors 
are active. 
The different grade and features of steatosis in the proposed in vitro models were firstly 
analyzed in terms of TG accumulation and LD number and size. TG accumulation increased in 
all steatotic conditions, but more markedly in cells treated with Fru/FA combination. LD size 
and number increased slightly in cells exposed to Fru, and more in cells exposed to FAs. 
Interestingly, Fru/FA combination markedly enlarged the LDs without changing their number, 
whereas FA/TNFα led to an increase in LD number with a reduction of their size with respect 
to FAs alone. The changes of LDs were paralleled with those of ADRP expression with increased 
passing from Fru to FAs and was maximal in Fru/FA cells, but decreased in FA/TNF  cells. 
These findings indicate that Fru/FA combination mimics a condition of macrovesicular 
steatosis in vitro, while FA/TNFα combination induced a condition more similar to 
microvesicular steatosis. The correlation between in vitro macro- and microvesicular steatosis 
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with the ongoing cell dysfunction was confirmed by the changes in expression of IkBip, a 
marker for ER stress, and of PPARs. Both IkBip and PPARα expression was almost unaffected 
by Fru or FAs as single agents, while a marked up-regulation was caused by Fru/FA 
combination and an even larger up-regulation by FA/TNFα. Moreover, the up- regulation of 
PPAR in cells exposed to FA/TNFα indicates that microvesicular steatosis is a more damaging 
condition as PPARα activation is known to be associated with progression of steatosis, 
inflammation and fibrosis in pre-clinical models of non-alcoholic fatty liver disease (Silva and 
Peixoto, 2018). 
Taken together these results indicate that: (i) level of ADRP expression was mainly dependent 
on LD size rather than on the grade of steatosis being quantified as intracellular TGs; (ii) up- 
regulation of IkBip expression, a marker of ER stress and cell damage, was dependent on the 
number of LDs/cell rather than on the steatosis grade. Therefore, the condition induced by 
FA/TNFα combination seems to be a reliable model of a microvesicular-like steatosis 
(Santhekadur et al., 2017). 
To date, there is an increasing interest in studying the cell stiffness as a main driver of 
physiological regulation. Hepatocyte mechanical properties—at the single cell level—were 
not still investigated, and a limited number of studies were performed exclusively on 
adipocytes using AFM (Young-Nam et al., 2011). Here, we implemented an innovative 
approach to quantify the single cell stiffness in term of the relative elasticity Er measured by 
SCFS. We found that single cell stiffness was increased in cells exposed to either Fru or FAs 
as single agents, but the largest increase was induced by Fru/FA combination. Interestingly, 
the microvesicular-like steatosis induced by FA/TNFα combination showed a cell stiffness 
similar to that observed for FAs alone. This observation has practical and translational 
applications, in that it demonstrates that single cell stiffness depends on the steatosis grade 
rather than on LDs organization and distribution inside the cell. 
In parallel, also the single cell morphometry assessed by QPM changed as a function of the 
steatosis grade and features. While a rather low grade of steatosis, such as that induced by 
fructose alone, did not alter the geometric parameters, the more marked steatosis induced 
by FAs made the cells thinner and larger than control cells and with a smoother surface and 
larger protrusions. On the other hand, Fru/FA cells showed a morphometry intermediate 
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between those of Fru and FA cells although the highest grade of steatosis. By contrast, cells 
with microvesicular-like steatosis induced by FA/TNFα appeared smaller compared to FA cells 
although they had a similar TG content. Therefore, we can conclude that geometric 
parameters do not depend exclusively on the total TGs accumulated in steatotic cells, but 
mainly on the number of LDs in cytosol. 
We verified the possible correlations between the main biochemical, functional and 
biomechanical parameters recorded at the level of single cell. The TG content correlated 
positively with LD size and ADRP expression and negatively with cell viability and PPARα 
expression, thus indicating that, although TG synthesis is a protective response, an excess of 
intracellular fat leads to hepatic cell damages less or more severe depending on the extent of 
steatosis. We also found a positive correlation between Er and the level of TG accumulation, 
ADRP expression, the LD size and the cell area; instead Er correlated negatively with the cell 
viability. These results indicate that the single cell elasticity of hepatocytes increases along 
with the steatosis grade. On the other hand, the IkBip expression correlated positively with 
the number of LDs in the cytosol and the PPAR expression and correlated negatively with the 
cell area, thus suggesting that a higher number of small LDs damages the hepatocyte more 
than a small number of larger LDs, accordingly to what reported in vivo for microvesicular 
steatosis. 
Taken together the present results suggest that at the single hepatocyte level: (i) the cell 
stiffness is directly influenced by the extent of TG accumulation and by the size of LDs and 
reflects negatively on cell viability; (ii) a condition of microvesicular steatosis (high 
number of LDs/cell) is associated to a more severe cell damage as indicated by the largest 
over expression of IkBip and PPARs, and the shrinking of the cell. 
Therefore, our findings showing that in vitro hepatocytes stiffen with LD accumulation, point 
the attention to the potential role of mechanobiology in metabolic diseases, particularly 
those linked to overweight and obesity. Indeed, alterations of cell biomechanics might 
sustain the grade and speed of evolution of steatosis reflecting on liver stiffness in relation 
to the steatogenic inducer (e.g., dietary loads). The fine mechanisms relating the 
onset/progression of NAFLD to the morphological and mechanical phenotype of the 
hepatocyte are not yet completely understood, but our results show the existence of a link 
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between these aspects whose causality is worth investigating in future activity. 
Moreover, this study paves the way to further experimental and translational applications. 
In fact, the link between physiopathological conditions and single cell elasticity might be 
exploited as a label-free biomarker of the disease progression, eventually opening for high 
throughput mechanical phenotyping approaches (Otto et al., 2015). In this view, it is 
envisaged that the effect of physical and chemical agents in counteracting/reducing liver 
steatosis might be monitored looking at the differential effect on the biomechanics of 
hepatocytes. 
Table 1 
Symbols and definitions of the main morphometric parameters used in the text; for additional details see the on-line 
documentation of the Gwyddion software [37, http://gwyddion.net/documentation/user-guide-en/statistical-
analysis.html] 
Parameter Symbol Description 
Cell Roughness RC RMS of the height after subtracting a smoothed shape obtained by 
low pass filtering the surface with a cut-off set to the 2% of the 
Nyquist frequency 
Cell Height HC Max height inside the region belonging to the selected region 
(cells) 
Surface Extension SE Surface area calculated upon triangulation of the height map 
Cell Contact Area AC Area in the plane occupied by the selected region (cells)  
Radius of Curvature  CR Curvature radius at the max height (cell body) of the filtered 
surface (see Cell roughness) 
 
Table 2 
Mean and standard deviation of the gaussian probability density function, fitted on the relative Young’s modulus 
distribution, are presented for both the DFIT and the FIEL methods. The result of the Shapiro normality test on the 
distributions are shown in the third column for each method. 
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 FIEL DFIT 
 Mean SD Shapiro Mean SD Shapiro 
Ctrl 1,026 0,181 0,971 1,367 0,459 0,903 
Fru 1,214 0,277 0,919 1,731 0,725 0,890 
Fru/FA 1,318 0,331 0,949 1,608 0,668 0,903 
FA 1,223 0,330 0,885 1,975 1,186 0,747 




10.New Perspectives of S-
Adenosylmethionine (SAMe) applications 
to attenuate fatty acid-induced steatosis 
and oxidative stress in hepatic and 
endothelial cells 
 
Paper in preparation 
ABSTRACT 
S-Adenosyl-L-methionine (SAMe) is an endogenous pleiotropic molecule playing many 
functions, in the liver especially, including acting as a precursor for cysteine, one of amino 
acids of glutathione--the major physiologic defence mechanism against oxidative stress. 
SAMe is particularly important in opposing the toxicity of free oxygen radicals generated by 
various pathogens. SAMe also acts as the main methylating agent in the liver. Administration 
of SAMe as supernutrient results in many beneficial effects in various tissues, mainly in the 
liver, and especially in the mitochondria. 




S-adenosylmethionine (SAMe) is an endogenous, pleiotropic amino acid metabolite involved 
in many crucial biochemical pathways, including biosynthesis of hormones and 
neurotransmitters (Cantoni, 1985; Bottiglieri, 2001). SAMe is synthesized mainly in the liver, 
and then distributed throughout the body (Friedel et al., 1989). SAMe acts as the main methyl 
donor in mammalian cells, where transfer of a methyl group to an acceptor molecule, such 
as DNA, proteins and phospholipids, modifies their structure and function (Mato, 2013). 
Indeed, DNA methylation switch on/off the gene transcription, protein methylation regulates 
the enzyme activity, phospholipid methylation modulates membrane fluidity. Moreover, 
SAMe is precursor for cysteine, one of the amino acids of glutathione, the major physiological 
defence against reactive oxygen species (ROS), thus it acts also as protection against 
oxidative stress. 
SAMe has been involved in many liver diseases (Lu and Mato, 2012; Mato, 2013). Reduced 
hepatic SAMe levels were described in patients with alcoholic hepatitis resulting in decreased 
hepatic GSH levels (Lee et al., 2004), and SAMe administration has been shown to normalize 
the GSH levels (Vendemiale et al., 1989). Many studies done mostly in alcoholic liver disease, 
cholestasis of pregnancy, and primary biliary cirrhosis have shown significant improvement 
in liver test abnormalities during therapy with SAMe (Anstee and Day, 2012). 
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease associated to 
obesity (Loomba and Sanyal, 2013; Huang et al., 2013), and is correlated with type 2 diabetes 
and cardiovascular risk (Anstee et al., 2013). Hepatic steatosis is the hallmark of NAFLD 
(Cohen et al., 2011) and free fatty acids (FAs) are the major mediators of steatosis; in fact, 
patients with NAFLD have elevated levels of circulating FAs. In the liver, FAs are esterified to 
TGs and stored in cytosolic lipid droplets (LDs) as protection against their toxicity, or 
alternatively, FAs are metabolized through β-oxidation in mitochondria and peroxisomes, 
and through β-oxidation in the endoplasmic reticulum (ER) with consequent ROS production. 
LDs (Cohen et al., 2011; Sahini, 2014) consist of a hydrophobic lipid core surrounded by a 
phospholipid monolayer and LD-associated proteins which regulate lipid metabolism and 
traffic (Xu et al., 2017). Among them, the adipose differentiation-related protein (ADRP) is 
crucial for formation and structural maintenance of LDs and is a marker for the extent of lipid 
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accumulation, as its overexpression stimulates lipogenesis and inhibits lipolysis (Grasselli et 
al., 2010). 
NAFLD may encompass simple steatosis (NAFL), non-alcoholic steatohepatitis (NASH), 
cirrhosis, and even hepatocellular carcinoma (Cohen et al., 2011). Progression of NAFL to 
NASH is sustained by oxidative stress resulting from reactive oxygen species (ROS) deriving 
from fat catabolism (Day and James., 1998; Rolo et al., 2011). Oxidative stress, in fact, 
activates inflammatory signaling pathways such as that sustained by the nuclear factor 
kappa-B (NF-κB), a transcription factor of the inflammatory response also involved in liver 
diseases (Hoesel and Schmid, 2013). 
Both hepatocytes and endothelial cells participate in progression of fatty liver disease, and 
obesity-related metabolic disorders cause endothelial dysfunction. Endothelium is a crucial 
blood–tissue interface controlling energy supply according to organ needs, as it is the first 
rate-limiting step in the utilization of long-chain FAs as fuels. Endothelial cells play regulatory 
functions through releasing various factors including nitric oxide (NO) and ROS (Shah et al., 
1997). In the liver, the endothelial cells of sinusoids act in fibrosis development by sustaining 
wound healing response and inflammation (Braet and Wisse, 2002; Connolly et al., 2010). 
Wound healing process depends on endothelial cell migration which is mediated by the 
intercellular adhesion molecule-1 (ICAM-1) on the plasma membrane (Gay et al., 2011). 
Here, we used rat hepatoma FaO cells exposed to a mixture of oleate/palmitate that 
represent a reliable in vitro model for hepatic steatosis widely employed in previous studies 
of our group (Grasselli et al., 2011; Grasselli et al., 2014). As FAs seem to play also direct 
effects on oxidative stress of vascular endothelium (Zhou et al., 2009), we used also human 
endothelial HECV cells exposed to FAs that could be compared to in vivo atherosclerosis, as 
endothelial damage is typically observed in metabolic syndrome (Szmitko et al., 2003). 
The results showed that SAMe ameliorated lipid accumulation in hepatic cells and reduced 
lipid-dependent oxidative imbalance in both hepatic and endothelial cells thus showing 
potential applications as therapeutic agents. 
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MATERIALS AND METHODS 
Chemicals 
All chemicals, unless otherwise indicated, were supplied by Sigma-Aldrich Corp. (Milan, Italy). 
Cell culture and treatments 
FaO cells (European Collection of Authenticated Cell Cultures -ECACC- Salisbury, Wiltshire, 
UK) are a rat hepatoma cell line maintaining hepatocyte-specific markers (Lauris et al., 1986). 
Cells were grown in a humidified atmosphere with 5% CO2 at 37°C in Coon's modified Ham's 
F12 medium supplemented with L-Glutamine and 10% foetal calf serum (FCS). HECV cells 
(Cell Bank and Culture - GMP-IST- Genoa, Italy) are a human endothelial cell line isolated from 
umbilical vein; they were grown at 37°C in Dulbecco’s modified Eagle’s medium High Glucose 
(D-MEM) supplemented with L-Glutamine and 10% FCS. For treatments, cells were grown 
until 80% confluence, then incubated overnight in serum-free medium with 0.25% bovine 
serum albumin (BSA). To mimic in vitro the effect of a high fat diet, cells were treated for 3 h 
with a mixture of oleate/palmitate at a final concentration of 0.75 mM (2:1 molar ratio). 
Thereafter, ‘steatotic’ cells (OP) were incubated for 24h in the absence or in the 
presence of SAMe (25, 50 and 100 M). Stock solution of SAMe 100 mM in HCl 0.1 M was 
diluted with the culture medium to the working concentration. 
Protein quantification 
The protein content was determined by the bicinchoninic acid (BCA) method using BSA as a 
standard (Wiechelman et al., 1988). All measurements were performed using a Varian Cary50 
spectrophotometer. 
Quantification of triglycerides 
At the end of the treatments, FaO and HECV cells were scraped and centrifuged at 14,000xg 
for 3 min. After cell lysis, lipids were extracted in chloroform/methanol (2:1) then chloroform 
was evaporated (Grasselli et al., 2011). In each extract, TG content was determined by 
spectrophotometric analysis using the ‘Triglycerides liquid’ kit (Sentinel diagnostics, Milan, 
Italy). Values were normalized for the protein content determined by the bicinchoninic acid 
(BCA). Data are expressed as percent TG content relative to controls. 
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ROS production and lipid peroxidation measurement 
The oxidation of the cell-permeant 2’-7’ dichlorofluorescin diacetate (DCF-DA, Fluka, 
Germany) to 2’-7’dichlorofluorescein (DCF) is used for quantifying in situ the production of 
H2O2 and other ROS (Halliwell and Whiteman., 2004). Stock solution of DCF-DA (10mM in 
DMSO) was prepared and stored at -20°C in the dark. At the end of treatment, cells were 
scraped and gently spun down (600xg for 10 min at 4°C). After washing, cells were loaded 
with 10 µM DCF-DA in PBS for 30 min at 37°C in the dark. Then, cells were centrifuged, 
suspended in PBS and the fluorescence was measured fluorometrically (λex=495 nm; 
λem=525 nm). All measurements were performed in a LS50B fluorimeter (Perkin Elmer, USA) 
at 25°C using a water-thermostated cuvette holder. 
Lipid peroxidation was determined spectrophotometrically through the thiobarbituric acid 
reactive substances (TBARS) assay which is based on the reaction of malondialdehyde (MDA; 
1,1,3,3-tetramethoxypropane) with thiobarbituric acid (TBA) (Iguchi et al., 1993). Briefly, 1 
vol. of cell suspension was incubated for 45 min at 95°C with 2 vol. of TBA solution (0.375% 
TBA, 15% trichloroacetic acid, 0.25 N HCl). Then, 1 vol. of N-butanol was added, and the 
organic phase was read at 532 nm in a Varian Cary 50 Bio UV-VIS spectrophotometer (Agilent, 
Milan, Italy) at 25°C using Peltier-thermostated cuvette holder. The MDA level was expressed 
as pmol MDA/mL/mg protein. 
Oil-Red O staining 
Neutral lipids were visualized using the selective Oil-RedO (ORO) dye (Grasselli et al., 2010). 
Briefly, after fixing in 4% paraformaldehyde, cells were washed with PBS, stained for 20 min 
with 0.3% ORO solution prepared from a stock 0.5% in isopropanol and diluted in water. After 
washing with distilled water, slides were examined by Leica DMRB light microscope equipped 
with a Leica CCD camera DFC420C (Leica, Wetzlar, Germany). 
Measurement of Nitrite/Nitrate (NOx) Levels 
NO production was measured by spectrophotometric measurement of the end products, 
nitrites and nitrates, using the Griess reaction (Green et al., 1982). After treatments, nitrite 
accumulation (μmol NaNO2/mg sample protein) was calculated against a standard curve of 
sodium nitrite (NaNO2). All spectrophotometric analyses were carried out at 25°C recording 
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absorbance at 540nm with a Varian Cary 50 spectrophotometer. Data are means ± S.D. of at 
least four independent experiments. 
RNA extraction and real-time qPCR 
RNA was isolated using Trizol reagent, cDNA was synthesized and quantitative real-time PCR 
(qPCR) was performed in quadruplicate using 1x IQTMSybrGreen SuperMix and Chromo4TM 
System apparatus (Biorad, Milan, Italy) (Grasselli et al., 2011). The relative quantity of target 
mRNA was calculated by the comparative Cq method using glyceraldehyde 3-phosphate 
dehydrogenase (Gapdh) as housekeeping gene and expressed as fold induction with respect 
to controls (Pfaffl, 2001). Primer pair sequences and efficiencies are reported in Tables S1 
and S2. 
Wound Healing assay 
The migration of HECV was examined using the wound healing assay (Gay et al., 2011). The 
cells were seeded on 35×10mm tissue culture dishes and incubated for 24 h or until 
confluence was reached. After 3h of incubation with oleate/palmitate mixture, the cell 
monolayer was scraped with a p100 pipet tip making two crossing straight lines to create a 
‘‘scratch’’ (Eppendorf AG, Hamburg, Germany). Then, two views on the cross were 
photographed on each well attached to the microscope at 4x magnification. The medium was 
replaced with fresh medium in the absence or presence of SAMe at different concentrations 
(25, 50 and 100 µM). Set of images were acquired at 3, 6 and 24 h. To determine the 
migration of HECV, the images were analysed using ImageJ free software 
(http://imagej.nih.gov/ij/). Percentage of the closed area was measured and compared with 
the value obtained before treatment. An increase of the percentage of closed area indicated 
the migration of cells. Data are means±S.D. of at least three independent experiments. 
Statistical analysis 
RNA and protein data are expressed as means ± S.D. of at least four independent experiments 
in triplicate. Statistical analysis was performed using ANOVA with Tukey’s post- test 




Effects of SAMe on lipid accumulation in hepatic cells 
Cells exposed to high concentrations of FAs mimic in vitro what is occurring in vivo in different 
tissues during high fat feeding and/or obesity. FaO cells were overloaded of lipids by 
exposure to oleate/palmitate mixture (0.75 mM) for 3h. Then, cells were treated for 24h with 
increasing concentrations of SAMe (25, 50 and 100 µM). No cytotoxic effects of the 
treatments were detected by MTT assay (data not shown). 
The intracellular TG content was quantified in control (C) and steatotic cells incubated in the 
absence (OP) or in the presence of SAMe. In lipid-loaded FaO cells (Fig.1A), we observed a 
significant increase in TG content with respect to control (+113%; p≤0.001), and a significant 
decrease upon treatment with SAMe 25, 50 and 100 µM (-49%, -89% and -75%, respectively, 
compared to steatotic cells; p≤0.001). When the cytosolic LDs were visualized by ORO 
staining (Fig.1B), we observed that the number and size of LDs increased markedly in lipid- 
loaded cells (OP) compared to control and decreased upon incubation with SAMe. ADRP is 
the main LD-associated protein in the liver cells, and it regulates the TG traffic from/to LDs. 
ADRP mRNA level (Fig.1C) was significantly up-regulated in steatotic FaO cells (2.06-fold 
induction vs control; p≤0.05), and it was further up-regulated after exposure to SAMe (about 
3-fold induction vs control; p≤0.05 for all SAMe concentrations). 
The extent of lipid accumulation in liver cells depends on the balance between lipolytic and 
lipogenic pathways. Therefore, the lipid-lowering action of SAMe might be sustained by 
stimulation of oxidative and/or secretory pathways. Lipolytic pathways lead to the final FA 
oxidation, mainly in mitochondria. CPT1 is a mitochondrial protein acting as shuttle for FAs, 
so acting upstream to the mitochondrial FA oxidation. CPT1 mRNA expression was up- 
regulated in steatoic FaO cells (1.83-fold induction vs control; p≤0.001) and it was further up- 
regulated exposure to SAMe (about 2.9-fold induction vs control; p≤0.001 for all SAMe 
concentrations) (Fig.1C). UCP2 is a mitochondrial uncoupling protein that separates oxidative 
phosphorylation from ATP synthesis resulting in energy dissipation as heat. Also, UCP2 
expression was significantly up-regulated upon lipid-loading (1.82-fold induction vs control; 
p≤0.05) (Fig.1C), but SAMe at all concentrations did not alter significantly UCP2 expression. 
As an attempt to reduce the TG accumulation, steatotic FaO cells stimulated the release of 
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TGs into the medium with respect to control (+29%; p≤0.05). Exposure to SAMe led to a 
significant reduction in TG release compared to steatotic cells (-35%, -58% and -52%, for 





Figure 29. Effects of SAMe on lipid accumulation 
For Fao cells incubated in the absence (C) or in the presence of oleate/palmitate (OP) alone or with different concentrations 
of SAMe 25, 50 and 100 µM (OP+SAMe 25, OP+SAMe 50, OP+SAMe 100) we show: (A) TG content expressed as percentage 
of TG content relative to control; normalized for proteins determinated with Bradford assay. (B) Microphotographes of cells 
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stained with Oil Red-O (ORO) (magnification 20x; Bar: 10 μm). (C) The mRNA expression of adipose differentiation-related 
protein (ADRP), carnitine palmitoyltransferase 1 (CPT-1) and uncoupling protein 2 (UCP-2) evaluated by quantitative PCR 
(qPCR); glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as the internal control and data expressed as fold 
induction with respect to controls. (D) Extracellular TG content quantified in the medium by spectrophotometric assay. 
Statistical significance between groups was assessed by ANOVA followed by Tukey’s test. Symbols: C vs all treatments 
*p≤0.05; **p≤0.01; ***p≤0.001; OP vs all treatments &p≤0.05, &&p≤0.01, &&&p≤0.001 
Effects of SAMe on oxidative stress in hepatic cells 
As a first indicator of the oxidative imbalance being potentially associated to lipid 
dysmetabolism we assessed lipid peroxidation by TBARS assay. As expected, the MDA level 
(Fig. 2A) increased in steatotic FaO cells (+63% compared to control; p≤0.001), and a dose- 
dependent decrease occurred upon exposure to SAMe compared to steatotic cells (-50%, - 
70% and -79%, for doses of 25, 50 and 100 µM, respectively; p≤0.05). 
The lipid peroxidation is typically caused by higher levels of intracellular ROS, mainly 
hydrogen peroxide (H2O2), that we quantified by fluorimetric analysis (Fig. 2B). Steatotic FaO 
cells (OP) treated with SAMe showed a dose-dependent decrease in DCF florescence with 
respect to steatotic cells used as control (-9%, -24% and -34%, for doses of 25, 50 and 100 
μM, respectively; p≤0.05 and p≤0.01, respectively). 
The changes in H2O2 levels were paralleled by changes in the enzymatic activity of catalase, 
the main enzyme catalyzing the H2O2 decomposition (Fig. 2C). Catalase activity was 
stimulated in steatotic FaO cells (+61% compared to control; p≤0.001) and it was reduced 
upon exposure of steatotic cells to SAMe (-77%, -65% and -97%, for doses of 25, 50 and 100 
μM, respectively; p≤0.05 and p≤0.01, respectively). 
In control FaO cells, neither the MDA level, DCF signal and catalase activity were affected by 
SAMe (data not shown). 
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Figure 30. Effects of SAMe on oxidative stress 
For Fao cells incubated in the absence (C) or in the presence of oleate/palmitate (OP) alone or with different concentrations 
of SAMe 25, 50 and 100 µM (OP+SAMe 25, OP+SAMe 50, OP+SAMe 100) we show: (A) The intracellular level of MDA (pmol 
MDA/mL x mg of sample protein) quantified by TBARS assay data are expressed as percentage values with respect to 
controls and normalized for total proteins; (B) The ROS level were also quantified by spectrofluorimeter assay of DCF-stained 
cells and data are expressed as percent mean fluorescence intensity (MFI) relative to steatotic cells and normalized for total 
proteins. (C) Catalase specific activity (micromoles of decomposed H2O2 per min/mg of sample protein) evaluated by 
spectrophotometric assay, data are expressed as percentage values with respect to controls and normalized for total 
proteins. Statistical significance between groups was assessed by ANOVA followed by Tukey’s test. Symbols: C vs all 
treatments *p≤0.05; **p≤0.01; ***p≤0.001; OP vs all treatments &p≤0.05, &&p≤0.01, &&&p≤0.001 
 
Effects of SAMe on lipid accumulation and function in endothelial cells 
HECV cells were overloaded of lipids by exposure to oleate/palmitate mixture (0.75 mM) for 
3h. Then, cells were treated for 24h with different doses of SAMe (25, 50 and 100 μM). MTT 
assay was performed to exclude toxic effects of the treatments (data not shown). 
In lipid-loaded HECV cells (Fig.3A), we observed a significant increase in TG content with 
respect to control (+241%; p≤0.001), and a significant decrease upon treatment with SAMe 
25 μM (-33%; p≤0.01) and 50 μM (-73%, p≤0.001) compared to steatotic cells. 
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NO is a major modulator of endothelial cell activity. In lipid-loaded HECV cells, we observed 
an increase in NO release with respect to control (+61%; p≤0.001), that was counteracted by 
SAMe at all concentrations of 25, 50 and 100 μM (-58%, -55% and -41% respectively, with 
respect to steatotic cells; p≤0.001) (Fig.3B). 
Lipid-loading also resulted in oxidative stress in HECV cells. The MDA level (Fig.3C) increased 
in lipid-loaded HECV cells (+48% compared to control; p≤0.01), and decreased occurred upon 
exposure to SAMe compared to steatotic cells (-32%, -42% and -41%, for doses of 25, 50 and 
100 μM, respectively; p≤0.001). 
SAMe effects on migrating ability of HECV cells was evaluated using the Wound Healing assay 
(Fig.3D). No significant differences in cell migration rate were observed at all times after the 






Figure31. Effects of SAMe on lipid accumulation 
For HECV cells incubated in the absence (C) or in the presence of oleate/palmitate (OP) alone or with different 
concentrations of SAMe 25, 50 and 100 µM (OP+SAMe 25, OP+SAMe 50, OP+SAMe 100) we show: (A) TG content expressed 
as percentage of TG content relative to control; normalized for proteins determinated with Bradford assay.; (B) NO release 
expressed as percentage of NO release relative to control; normalized for proteins (C) The intracellular level of MDA (pmol 
MDA/mL x mg of sample protein) quantified by TBARS assay data are expressed as percentage values with respect to 
controls and normalized for total proteins; (D) The migration of HECV was examined using the wound healing assay. Set of 
images were acquired at 3, 6 and 24 h. To determine the migration of HECV, the images were analysed using ImageJ free 
software (http://imagej.nih.gov/ij/). Percentage of the closed area was measured and compared with the value obtained 
before treatment. An increase of the percentage of closed area indicated the migration of cells. Data are means±S.D. of at 
least three independent experiments. Statistical significance between groups was assessed by ANOVA followed by Tukey’s 
test. Symbols: C vs all treatments *p≤0.05; **p≤0.01; ***p≤0.001; OP vs all treatments &p≤0.05, &&p≤0.01, &&&p≤0.001 
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DISCUSSION 
Hepatocytes and endothelial cells participate in progression of fatty liver disease, and 
obesity-related metabolic disorders cause endothelial dysfunction. Due to the increasing 
prevalence of obesity and obesity-related disorders worldwide, in the last decades there has 
been a growing interest in the discovery of promising molecule to treat these disorders. 
SAMe represents the major physiological defence against ROS and previous study done in 
many liver diseases, such as alcoholic liver disease, cholestasis of pregnancy, and primary 
biliary cirrhosis, shown significant improvement in liver test abnormalities during therapy 
with SAMe. The present study provided insights into the effects and the molecular 
mechanisms through which SAMe, an endogenous molecule playing many functions, may 
ameliorate fatty acids-induced steatosis and oxidative stress in hepatic and endothelial cells. 
In the cell models of the current study, the exposure of hepatocytes and endotheliocytes to 
fatty acids mimics, respectively, an in vitro model of NAFLD and atherosclerosis. Excess fatty 
acids on hepatocytes stimulates triglyceride intracellular accumulation and up-regulation of 
ADRP, CPT1 and UCP2 expression levels. Lipid peroxidation, ROS production and catalase 
activity were also enhanced in steatotic hepatocytes. Exposure of steatotic hepatocytes to 
different concentrations of SAMe led to a decrease in triglyceride content and lipid droplets 
size and number. CPT1, a mitochondrial protein acting as shuttle for FAs involved in 
mitochondrial FA oxidation, was up regulated in steatotic cells and furthermore after the 
exposure to SAMe, at all concentrations. In the light of that, the lipid-lowering action of SAMe 
might be sustained by stimulation of oxidative and/or secretory pathways. UCP2, a 
mitochondrial uncoupling protein, was significantly up-regulated upon lipid-loading but 
SAMe at all concentration did not change significantly its expression. Lipid peroxidation, ROS 
production and catalase activity were all significantly decreased upon treatment with SAMe. 
On the other side, exposure of endothelial cells to oleate and palmitate, led to an increase in 
triglyceride content and lipid peroxidation. As a response to lipid-loading, endothelial cells 
released NO and produced ROS thus triggering proinflammatory events. The subsequent 
treatment with SAMe at different concentrations led to a decrease of triglyceride content 
and NO and ROS production. 
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We can conclude that SAMe is an efficacious lipid-lowering and antioxidant agent for 
steatotic hepatocytes and endotheliocytes. The anti-steatotic effect of the molecule seems 
to be sustained by an increase in catabolic pathways at mitochondrial level. 
In conclusion, the beneficial effect of SAMe on the in vitro models of NAFLD and 
atherosclerosis suggests that the molecule possess a potential therapeutic benefit on these 
pathological conditions. 
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11.Cell model for adipogenic 
differentiation to investigate molecular 
events associated to adipocytes 
hypertrophy 
 
Paper in preparation 
 
ABSTRACT 
Over the past several decades, there has been a significant change in lifestyle: the increase 
of a sedentary lifestyle and of the consume of calorie-dense and fat food leaded to an 
increase trend of obesity. The increase of obesity worldwide is accompanied by the 
increasing prevalence of many obesity-related disorders as cardiovascular diseases, diabetes, 
cancers. The epidemic of overweight and obesity worldwide represents one of the major 
challenges in chronic disease prevention; therefore, over the last years, the study of adipose 
tissue biology and the mechanisms involved in adipocyte hypertrophy has gained attention. 
Lipid droplets (LDs) hypertrophy in adipocytes is the main cause of energy metabolic system 
dysfunction and obesity: enlarged adipocytes are associated with insulin resistance and are 
an independent predictor of type 2 diabetes. Adipose tissue, apart from its classical role as 
an energy storage depot, is also a major endocrine organ secreting many factors, whose local 
and circulating levels are affected by the degree of adiposity. 
To understand the molecular link between adipocyte hypertrophy and metabolic diseases 
we developed a procedure for inducing hypertrophy. To do this we used an in vitro model in 
which mature 3T3-L1 adipocytes were loaded with oleate/palmitate mixture, resulting in 
artificially hypertrophied mature adipocytes. Real-time RT-PCR analysis of PPARg and 
adiponectin expression in different adipocytes revealed higher expression in the 
hypertrophic adipocytes, respect to undifferentiated 3T3 cells. 
In order to clarify the role of hypertrophic adipocytes in obesity, isolated from other factor, 






Obesity is an important public health burden in both developed and developing countries, as 
it is associated with an increased risk of metabolic and cardiovascular diseases. The 
accumulation of excess fat in white adipose tissue (WAT) can occur through an increase in 
adipocyte volume (hypertrophy) and/or number (hyperplasia). Hypertrophic adipocytes are 
enlarged depending on the enlarging of cytosolic lipid droplets (LDs) storing the triglycerides 
(TGs). 
During adipogenesis, fibroblast-like pre-adipocytes differentiate into mature adipocytes 
through a rearrangement of the molecular machinery and the peroxisome proliferator 
activated receptor gamma (PPAR γ is the major determinant of this process (Moset et al., 
2016). PPARγ promotes primarily the lipogenic processes and contributes to FA uptake and 
TG accumulation during adipogenesis but also in mature adipocytes (Tamori et al., 2002; 
Brun et al., 1996). Mature adipocytes strictly regulate the balance between lipogenesis and 
lipolysis, and produce a panel of adipokines such as leptin, resistin, adiponectin, tumor 
necrosis factor-a (TNF-α), interleukin-1b (IL-1b) that modulate metabolism of the other 
tissues (Rajala and Scherer, 2003). 
The 3T3-L1 cells are well-established murine preadipocytes displaying a fibroblast-like 
morphology that, under appropriate conditions, progress towards an adipocyte-like 
phenotype (Green and Meuth, 1974). A large body of articles have employed 3T3-L1 cells to 
investigate adipogenesis and obesity-related characteristics. One of the main advantages of 
this cell line is that provides a homogenous and reproducible system (Poulos et al., 2010). 
In obesity conditions, hypertrophic adipocytes increase reactive oxygen species (ROS) 
production and inflammation and modulate the panel of released adipokines such as 
adiponectin and TNFα (Furukawa et al., 2004). Discrepant results about adiponectin 
production in hypertrophic adipocytes have been reported. While in human serum, high 
levels of adiponectin exerted anti-inflammatory, anti-atherogenic and anti-diabetic effects 
(Ouchi et al., 1999; Yamauchi et al., 2003), in mouse 3T3-L1 adiponectin over-expression led 
to increased cell size and TG content (Maeda et al., 2001). Adipose tissue of obese mice 
releases also TNFα, a proinflammatory cytokine which acts on peripheric tissues where it 
modulates degree of adiposity, impairs glucose and FA uptake and stimulates lipolysis leading 
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to hyperlipidaemic conditions. 
Metallothioneins (MTs) are low-molecular-weight, cysteine-rich proteins acting in the 
metabolism of essential metals and protection against toxic heavy metals (Haq et al., 2003; 
Sato and Bremner, 1993, but they seem to be involved also in the regulation of WAT 
formation at earlier stages, are induced during the development of obesity (Sato et al., 2013). 
On the other hand, MTs have a potential to prevent obesity-related diseases, at least in part, 
through suppression of free radical generation and endoplasmic reticulum stress, in female 
mice (Sato et al., 2013). Moreover, MT-gene silencing led to enhanced lipid accumulation in 
3T3-L1 cells (Kadota et al., 2017). 
In the present study, we developed an adipocyte hypertrophy model to investigate 
differences between mature and hypertrophic adipocytes. 3T3-L1 pre-adipocytes were 
differentiated and then cultured for another 2 days with a mixture of long-chain fatty acids 
(oleate/palmitate 1 mM). Our findings suggest that adipocyte hypertrophy is enough to 
provoke changes at different cell levels: alterations of mitochondrial morphology and 
consequently activity, increase of oxidative stress. 
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MATERIALS & METHODS 
Chemicals 
All chemicals, unless otherwise indicated, were supplied by Sigma-Aldrich Corp. (Milan, Italy). 
Cell culture and treatments 
3T3-L1 mouse fibroblasts were purchased from the American Type Culture Collection 
(Manassas, VA, USA) and kindly provided by Prof. Bruzzone (University of Genoa). Cells were 
maintained in Dulbecco’s modified Eagle medium (D-MEM) containing 25 mmol/l glucose 
and 10% Foetal Bovine Serum (FBS, Euroclone, Milan, Italy) under 5% CO2 at 37°C. For 
adipocyte differentiation, cells were seeded at 2x105 cells/mL in petri dishes. At 2-day post 
confluence, adipogenesis was induced by adding the differentiation mixture containing 1μM 
insulin, 1μM dexamethasone (DEX), and 500μM 3-isobuthyl-1-methylxanthine (IBMX) to the 
culture medium for 2 days. Then, cells were incubated with 100nM insulin for 7 days, 
changing the medium every 2–3 days. In all experiments, more than 90% of the cells were 
mature adipocytes after 10 days of incubation. Adipogenic differentiation was monitored at 
different days by lipid staining. To induce cellular hypertrophy, mature adipocytes were 
exposed to oleate/palmitate mixture (1 mM) for 2 days. 
Protein quantification 
The protein content was determined by the Bradford assay using bovine serum albumin 
(BSA) as a standard (Bradford, 1976). 
Quantification of triglycerides 
The TG content of 3T3-L1 cells in the different conditions was measured as previously 
described (Grasselli et al., 2011). Briefly, cells were scraped, centrifuged at 800xg for 10 min 
and lysed in phosphate buffered saline (PBS). Lipids were extracted in chloroform/methanol 
(2:1), and after chloroform evaporation TG were quantified using the ‘Triglycerides liquid’ kit 
(Sentinel diagnostic, Milan, Italy). The absorbance at 546 nm was recorded using a Varian 
Cary UV-VIS spectrophotometer 50 Bio (Agilent Technologies, Milan, Italy). Values were 
normalized for the protein content. Data are expressed as percent TG content relative to 
controls. 
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Lipid droplet staining and analysis 
3T3-L1 cells were grown on collagen-coated glass slides. At the end of treatments cells were 
washed twice with PBS, fixed in 4% formaldehyde/PBS for 20 min, then washed in PBS. 
Neutral lipids of LDs were visualized using the selective Oil-RedO (ORO) dye as previously 
described (Baldini et al., 2019). Briefly, cells were stained for 30 min with 0.3% ORO solution 
which was freshly prepared from a stock solution of 0.5% in isopropanol, washed and 
mounted. LDs were also visualized using the fluorescent probe BODIPY 493/503 (Molecular 
Probes, Life Technologies, Monza, Italy) (Vecchione et al., 2017). After fixation and washing 
cells were incubated with 1 μg/mL BODIPY 493/503 in PBS for 30 min, washed and mounted 
with 4′,6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, Milan, Italy). Images were 
obtained using a Leica DMRB light microscope equipped with a Leica CCD camera DFC420C 
(Leica, Wetzlar, Germany). In each population, more than 500 cells were analyzed. 
ROS production and lipid peroxidation measurement 
The production of H2O2 and other ROS in situ was assessed through the oxidation of the cell- 
permeant 2′-7′ dichlorofluorescin diacetate (DCF-DA, Fluka, Germany) to 2′-7′ 
dichlorofluorescein (DCF) (Halliwell and Whiteman, 2004). Briefly, cells were scraped and 
gently spun down (600×g for 10 min at 4°C). After washing, cells were loaded with 10μM DCF-
DA freshly prepared from a stock solution (10mM in DMSO) in PBS for 30 min at 37°C in the 
dark. Then, cells were centrifuged, suspended in PBS and the fluorescence signal (ex=495 nm; 
em=525 nm) was recorded using a Cary Eclipse Fluorescence Spectrophotometer (Agilent, 
Santa Clara, CA, United States) at 25 °C in water-thermostated cuvette holder. The 
fluorescence signal was expressed as MFI (mean fluorescence intensity)/mg of protein. 
Lipid peroxidation was determined spectrophotometrically through the thiobarbituric acid 
reactive substances (TBARS) assay which is based on the reaction of malondialdehyde (MDA; 
1,1,3,3-tetramethoxypropane) with thiobarbituric acid (TBA) (Iguchi et al., 1993). Briefly, 1 
vol. of cell suspension was incubated for 45 min at 95°C with 2 vol. of TBA solution (0.375% 
TBA, 15% trichloroacetic acid, 0.25 N HCl). Then, 1 vol. of N-butanol was added and the 
organic phase was read at 532 nm in a UV-VIS spectrophotometer at 25°C using Peltier- 
thermostated cuvette holder. The MDA level was expressed as pmol MDA/mL/mg protein. 
RNA extraction and Quantitative real-time polymerase chain reaction 
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Total RNA was isolated using Trizol reagent, according to the manufacturer's instructions. 
RNA concentration was quantified spectrophotometrically at 260 nm and purity was 
evaluated by measuring the ratio A260/A280. Total RNA (1.5 μg) was reverse transcribed 
using the RevertAid H Minus Reverse Trancriptase MULV (Thermo Fisher Scientific, 
Massachussets, USA), according to the manufacturer's suggestions, in a Master Cycler 
Personal (Eppendorf, Milan, Italy). Quantitative real-time PCR (qPCR) was performed in 
triplicate using iQTM SYBR Green Supermix (Biorad, Monza, Italy) and CFX96TM Real-Time 
System (Biorad, Monza, Italy). All primer pairs were designed ad hoc starting from the coding 
sequences (http://www.ncbi.nlm.nih.gov/Genbank/GenbankSearch.html) and were 
synthesized by TibMolBiol custom oligosynthesis service (Genova, Italy). The relative quantity 
of target mRNA was calculated by using the comparative Cq method and was normalized 
for the expression of GAPDH gene, used as reference gene. The normalized expression of the 
target genes was thus expressed as relative quantity of mRNA (fold induction) with respect 
to controls (C). The data were analyzed using a Bio-Rad CFX manager software. Primer pairs 
designed ad hoc starting from the coding sequences of Mus musculus and synthesized by 
TibMolBiol (Genova, Italy) are listed in Table1. 
 
Adiponectin Fwd GCTCTCCTGTTCCTCTTAATCC 60 E9PWU4 
Adiponectin Rev GCAATCTCTGCCATCACG   
PPARγ Fwd GGAATTAGATGACAGTGACTTGGC 60 P37238 
PPARγ Rev GGAGCACCTTGGCGAACAG   
TNFα Fwd CATCTTCTCAAAATTCGAGTGACAA 60 P06804 
TNFα Rev TGGGAGTAGACAAGGTACAACCC   
UCP1 Fwd GATGGTGAACCCGACAACTT 56 P12242 
UCP1 Rev CTGAAACTCCGGCTGAGAAG   
VLCAD Fwd TGAATGACCCTGCCAAG 60 P50544 
VLCAD Rev CCACAATCTCTGCCAAGC   
GAPDH Fwd GACCCCTTCATTGACCTCAAC 60 P16858 
GAPDH Rev CGCTCCTGGAAGATGGTGATGGG   
 
Mitochondrial Oxygen Consumption 
Mitochondrial function was investigated by assessing respiration parameters using an 
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Oxygraph 2 k (O2K) high-resolution respirometer and processed with DatLab 6.2 software 
(Oroboros Instruments GmbH, Innsbruck, Austria). Aliquots of 2x106 cells for each condition 
(pre-adipocytes, mature and hypertrophic adipocytes) were analysed by All the parameters 
were corrected for non-mitochondrial background oxygen consumption. Breifly, cells were 
collected and suspended in 2 mL of Mir05 buffer (0.5 mM EGTA, 3 mM MgCl2, 60 mM K- 
lactobionate, 20 mM taurine, 10 mM H2PO4, 20 mM HEPES, 110 mM sucrose, 1 g/L BSA, 
pH=7.1) (Einer et al., 2019). For the measurement, cell suspension was injected in the in the 
oxygraph chamber and the oxygen consumption related to mitochondrial respiration was 
measured under continuous stirring, at 37°C. First, 10 μg/mL digitonin was added to 
permeabilize cells. Non-phosphorylating respiration was induced by adding the complex I- 
linked substrates glutamate (10 mM) and malate (2 mM). Subsequently, the OXPHOS-
capacity of complex I-linked activity was measured after addition of a saturating 
concentration of ADP (2.5 mM). Then, succinate (10 mM) was added to evaluate OXPHOS- 
capacity of complex I&II-linked activity. The maximum oxygen consumption, which defines 
the electron transfer system capacity, was determined by adding the uncoupling compound 
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) at 1 μM steps. At the end, 1 
μM rotenone (complex I inhibitor) and 2.5 μM antimycin A (complex III inhibitor) were added. 
Data were corrected for non-mitochondrial background by subtraction of oxygen 
consumption level measured after addition of rotenone and antimycin A. 
All the parameters were corrected for non-mitochondrial background by subtraction of 
oxygen consumption level measured after addition of rotenone and antimycin A (residual 
oxygen consumption non related to mitochondrial respiration). 
Mitochondria content evaluation 
The fluorescent probe MitoTracker Deep Red (Invitrogen, Thermo Fisher Scientific, Milan, 
Italy) was employed to label the membrane of intact mitochondria in living cells (Claus et al., 
2011). At the end of treatment, cells were scraped and gently spun down (600×g for 10 min 
at 4 °C). After washing, cells were loaded with 0.1 µM MitoTracker in PBS freshly prepared 
from a stock solution (1.5 mM in DMSO) for 20 min at 37°C in the dark. Then, cells were 
centrifuged, suspended in PBS and the fluorescence (ex=644 ex=644 nm; em=665 nm) was 
measured in a Cary Eclipse Fluorescence Spectrophotometer at 25 °C using a water-
thermostated cuvette holder. The fluorescence signal was expressed as MFI (mean 
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fluorescence intensity)/mg of protein. 
Western Blot 
Cells were collected by centrifugation and lysed in RIPA buffer (1% NP-40, 0.1% SDS, 50 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 0.5% Sodium Deoxycholate, 1 mM EDTA). Lysates were 
centrifuged at 16,000 g/10 min at 4 °C. Equal amounts of protein (about 40 μg) were 
separated by SDS-PAGE and transferred to PVDF membranes (Bio-Rad, Munich, Germany). 
Membranes were blocked with 5% skim milk in Tris Buffered Saline with 0.1% Tween 20 (TBST 
and incubated overnight at 4°C using mouse anti-Hsp60 antibody (611562, BD Transduction 
LaboratoriesTM, USA) or rabbit anti-citrate synthase (CS) antibody (16131-1-AP, Proteintech, 
United Kingdom) or rodent anti-OxPhos Complex Monoclonal Antibody (cocktail of multiple 
OxPhos antibodies: C-I-20, bovine complex I; C-II-30, bovine heart complex II; C- III-Core 2, 
bovine heart complex II, III; C-IV-I, human complex IV subunit I; C-V-alpha, bovine complex V; 
45-8099, Thermo Fisher Scientific, Massachussets, United States). Appropriate secondary 
antibodies conjugated to horseradish peroxidase (HRP) and ECL solution were used to 
visualize proteins; the chemiluminescence signal was detected with the ChemiDoc™ Touch 
Imaging System (Bio-Rad, Munich, Germany). 
Statistical analysis 
Data are expressed as means ± S.D. of at least three independent experiments. GraphPad 
Prism 7.0 software was used for statistical evaluation. Statistical analysis was performed 




In vitro model of adipocyte hypertrophy 
Differentiation of 3T3-L1 pre-adipocytes into mature adipocytes and then the progression 
towards hypertrophic adipocytes was assessed by cell morphology analysis and LD labelling. 
The spectrophotometric quantification of cellular TG content showed that lipid accumulation 
increased significantly in mature adipocytes (+110%; p≤0.001), and a larger increase was 
observed in hypetrophic cells (+225%; p≤0.001) compared to pre-adipocytes (Fig.1A). 
Changes in cell volume and LD enlargement typically occur in vivo during adipogenesis 
differentiation and hypertrophy. The morphometric analysis of ORO- and BODIPY-stained 
cells revealed that in vitro mature adipocytes were occupied by medium-sized LDs, while 
hypertrophic adipocytes contained very large or single LD (Fig.1B). The mean size and the 
size distribution of LDs were determined by computerized image analysis (Fig.1C). The 
average LD diameter in mature adipocytes was about 9.3±0.4 μm that increased to 16.2±2.6 
μm in hypertrophic adipocytes. 
 
Figure 32. In vitro adipocyte hypertrophy 
For 3T3L1 cells undifferentiated (pre-adipocytes), differentiated (mature) and hypertrophic we show: (A) TG content 
expressed as percent TG content relative to control, normalized for proteins determined with Bradford assay. (B) 
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Microphotographs of cells stained with ORO (magnification 40x). (C and insert) Microphotographs of cells stained with DAPI 
and BODIPY 493/503 (magnification 40x) and OilRedO; images were captured sequentially and then merged. For microscopy 
analysis a Leica DMRB light microscope equipped with a Leica CCD camera DFC420C was employed. Statistical significance 
between groups was assessed by ANOVA followed by Tukey's test. Symbols: Pre-adipocytes vs all treatments ***p ≤ 0.001; 
Mature vs all treatments ###p≤0.001. 
As a response to increased intracellular TG, mature adipocytes released increased level of 
TGs into the culture medium (+237%; p≤0.05) with respect to control pre-adipocytes and the 
TG release was almost doubled in hypertrophic adipocytes (+491%; p≤0.001) (Fig.2C). As a 
marker for adipogenesis, PPARγ mRNA expression was assessed by qPCR (Fig.2A). In mature 
3T3-L1 adipocytes, PPARγ overexpression accompanied the increase in the intracellular TG 
content (10.1-fold induction vs control; p≤0.001) and an even larger PPARγ overexpression 
was observed in hypertrophic cells (12.5-fold induction vs control controls; p≤0.001). On the 
other hand, although mature adipocytes showed a significant overexpression of adiponectin 
mRNA (2341-fold induction vs control; p≤0.001) compared to pre-adipocytes, no further 
increase in adiponectin mRNA was observed in hypertrophic adipocytes (2542-fold induction 
vs control; p≤0.001) (Fig.2B). 
 
 
Figure 33. Markers for lipogenesis and adipocyte hypertrophy 
For 3T3L1 cells undifferentiated (pre-adipocytes), differentiated (mature) and hypertrophic we show: The mRNA expression 
of PPARγ (A) and adiponectin (B) evaluated by qPCR using GAPDH as the internal control. Data are expressed as fold 
induction with respect to controls. (C) The extracellular TG content quantified in the medium by spectrophotometric assay; 
data are expressed as percent TG content relative to controls and normalized for total proteins. Anova followed by Turkey’s 
test was used to assess the statistical significance between groups. Symbols: Pre-adipocytes vs all treatments, *p ≤ 0.05, 
***p ≤ 0.001; Mature vs all treatments, #p ≤ 0.05, ##p≤0.01. 
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Adipocyte Hypertrophy and Oxidative Stress 
Lipid accumulation typically results in increased fat oxidation producing excess of ROS which 
may damage important cellular components such as membranes (Seifert et al., 2010). When 
intracellular ROS production was quantified in situ by fluorimetric analysis of DCF-stained 
cells (Fig. 3A), we observed an increase in DCF signal in hypertrophic adipocytes with respect 
to mature adipocytes (+38% vs control, p≤0.01). 
Excess ROS may result in oxidative stress condition which trigger lipid peroxidation of 
membranes that we assessed by TBARS assay. We found increased MDA levels in mature 
adipocytes (+98% vs control; p≤0.01) and a larger increase in hypertrophic adipocytes (+161% 
vs control; p≤0.01) (Fig.3B) which are sign of fat-dependent oxidative stress. 
In the attempt to counteract oxidative stress mature adipocytes overexpressed the 
antioxidant peptides MT-1 and MT-2 (4.69- and 1,97-fold induction, vs control respectively; 
p≤0.01). However, no further increase in MT expression was observed in hypertrophic 
adipocytes (4,82- and 2.31-fold induction, vs control respectively; p≤0.001) (Fig.3C). 
 
Figure 34. Adipocyte hypertrophy increased ROS production and oxidative stress 
In 3T3L1 cells undifferentiated (pre-adipocytes), differentiated (mature) and hypertrophic we assessed: (A) The ROS level 
were quantified by spectrofluorimeter assay of DCF-stained cells and data are expressed as percent mean fluorescence 
intensity (MFI) relative to mature adipocytes and normalized for total proteins; (B) The intracellular level of MDA (pmol 
MDA/mL x mg of sample protein) quantified by TBARS assay. Data are expressed as percentage values with respect to 
controls and normalized for total proteins. (C) The mRNA expression of MT1 and MT2 evaluated by qPCR using GAPDH as  
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the internal control. Data are expressed as fold induction with respect to controls. Anova followed by Turkey’s test was used 
to assess the statistical significance between groups. Symbols: Pre-adipocytes vs all treatments, *p ≤ 0.05, ***p ≤ 0.001; 
Mature vs all treatments, ##p≤0.01. 
Adipocyte Hypertrophy and mitochondrial activity 
Assessing mitochondrial function typically relies on respiration investigation, and here we 
employed an intact cell approach using the Oxygraph 2 k (O2K) high-resolution respirometer 
(Fig.4A). Both the routine respiration and the non-phosphorylating respiration linked to 
complex I activity [N(GM)L] were rather constant in all conditions (about 50 pmol/s and 25 
pmol/s, respectively). By contrast, both the OXPHOS-capacity of complex I-linked activity 
[N(GM)P] and of complex I&II-linked activity [NS(GMS)P], as well as the maximum oxygen 
consumption [NS(GMS)ET] were significantly reduced in hypertrophic condition. In details, 
[N(GM)P] in pre- and mature adipocytes was about 70 pmol/s and decreased to 45.91 pmol/s 
in hypertrophic adipocytes (-27%; p≤0.05 vs mature). [NS(GMS)P] decreased from about 100 
pmol/s in pre- and mature adipocytes to 66.23 pmol/s in hypertrophic adipocytes (-33%, 
p≤0.05 vs mature adipocytes), and [NS(GMS)ET] from about 162 pmol/s in both pre- and 
mature adipocytes to 92.39 pmol/s in the hypertrophic cells (-43%, p≤0.01 vs mature 
adipocytes). 
The levels of OXPHOS proteins in all the above conditions were assessed by western blotting. 
The protein level of all the complexes was similar in pre-adipocytes and mature adipocytes; 
only the complex IV showed a slight reduction in mature adipocytes (-18%, p≤0.05, with 
respect to control). By contrast, a significant reduction in the protein level of all the 
complexes was observed in hypertrophic adipocytes with respect to mature adipocytes: - 
30%, for complex I (p≤0.001), -16% for complex II (p≤0.01), -24% for complex III (p≤0.001), - 
40% for complex IV (p≤0.001) and -33% for complex V (p≤0.001) (Fig.4B). 
In order to verify if the differences in mitochondrial respiration could depend on a loss of 
mitochondria in hypertrophic adipocytes we assessed the expression of citrate synthase (CS) 
and heat shock protein 60 (HSP60), which are frequently used as biomarkers for 
mitochondrial content (Larsen et al., 2012). Although, both the CS and HSP60 levels 
decreased during adipogenesis process passing from pre- to mature adipocytes, no 
differences were observed between mature and hypertrophic adipocytes (Fig.4C). Also the 
mitotracker fluorescence, a probe selective for intact mitochondria, did no show changes in 
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hypertrophic adipocytes respect to mature adipocytes (data not shown). 
 
 
Figure 35. Adipocyte hypertrophy impaired mitochondrial respiration 
In 3T3-L1 cells mimicking pre-adipocyte, mature and hypertrophic adipocyte condition the mitochondria function and 
integrity were assessed. (A) Oxygen consumption related to mitochondrial respiration was assessed by using the Oxygraph   
2 k (O2K) high-resolution respirometer. The following parameters were measured: routine respiration, non-phosphorylating 
respiration linked to complex I activity [N(GM)L], OXPHOS-capacity of complex I-linked activity [N(GM)P], OXPHOS-capacity 
of complex I&II-linked activity [NS(GMS)P], maximum oxygen consumption [NS(GMS)ET]. Data are expressed as pmol/s. (B) 
Protein level of the individual OXPHOS complexes was assessed by Western blotting and densitometric analysis. (C-I-20, 
bovine complex I; C-II-30, bovine heart complex II; C-III-Core 2, bovine heart complex II, III; C-IV-I, human complex IV subunit 
I; C-V-alpha, bovine complex V). (C) Protein expression of HSP60 and Citrate Synthase (CS) were evaluated by Western 
blotting and densitometric analysis. GAPDH was the protein loading control used as housekeeping gene. Data are expressed 
as percentage values with respect to controls. Anova followed by Turkey’s test was used to assess the statistical significance 
between groups. Symbols: Pre-adipocytes vs all treatments, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001; Mature vs all treatments, 




Obesity is a pandemic condition that leads to health impairment by increasing the risk of 
developing several diseases such as T2DM, MetS, CVDs and several types of cancer. The 
molecular mechanisms connecting obesity to onset and progression of these diseases need 
to be clarified, but it is well recognized that fat accumulation in adipose tissue results in an 
altered expression of several hormones, growth factors, and adipokines. 
Obesity depends on adipocyte hypertrophy which is an adaptive response to nutrient excess 
and correlates directly with metabolic disease (Rydén et al., 2014). When the hypertrophic 
threshold is reached the adipocyte buffering capacity is exceeded leading to ectopic lipid 
deposition in peripheral tissues. Previous studies showed that adipocyte and LD size 
influence several metabolic functions (Margareta et al., 2006). 
To promote hypertrophy, after differentiation 3T3-L1 adipocytes were challenged for 2 days 
with a mixture of oleate (C18:1), and palmitate (C16:0), the fatty acids most abundant in the 
diet and in the body. As a first result we could observe, as expected, an increase in triglyceride 
content in mature adipocytes and a further increase in the hypertrophic condition. Lipid 
droplets average size was increased in differentiated adipocytes exposed to oleate and 
palmitate, thus confirming the induction of the hypertrophic condition. As a response to 
increased intracellular fat content, mature adipocytes released increased level of 
triglycerides into the culture medium and this released was almost doubled in hypertrophic 
condition. 
As a marker for adipogenesis, we assessed PPARγ expression: in mature cells, PPARγ 
overexpression accompanied the increase in the intracellular triglyceride content and an 
even larger overexpression was observed in hypertrophic cells. 
Once preadipocytes have committed to the adipogenesis program, a transcriptional cascade 
is activated and induces the expression of metabolic genes and adipokines associated with 
the adipocyte phenotypes, such as leptin, adiponectin, TNF-α, and IL-6. Indeed, we observed 
an increased adiponectin expression in mature adipocytes and hypertrophic ones. 
Lipid accumulation typically results in increased fat oxidation and consequent ROS 
production which may damage important cellular components. We observed an increase in 
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ROS production upon differentiation and an even larger increase in the hypertrophic model. 
Excess ROS may damage cellular membranes, leading to lipid peroxidation: MDA levels in 
mature adipocytes were increased and a larger increase in hypertrophic adipocytes, which 
are sign of fat-dependent oxidative stress. The levels of the antioxidant proteins MT1 and 
MT2 are known to be increased during the development of obesity in the attempt to 
counteract oxidative stress in mature adipocytes. MT-1 and MT-2 were overexpressed in 
both mature and hypertrophic adipocytes; however, no further increase in MT expression 
was observed in hypertrophic adipocytes. 
Furthermore, we investigated the effects at mitochondrial level of the exposure of mature 
adipocytes to fatty acids. Employing an O2K high-resolution respirometer, we evaluated 
different parameters of mitochondrial respiration. Taken together, the results clearly 
indicate that the hypertrophic condition in vitro led to a general reduction in the 
mitochondrial oxygen consumption, although the routine respiration, which is controlled by 
basal energy demand of the cells, was unchanged. The reduction in activity of both complex 
I and II in hypertrophic adipocytes was paralleled by a marked decrease in the capacity of the 
electron transfer system (ETS) measured from the noncoupled state of maximum respiration. 
In order to investigate the reason of the mitochondrial respiration decrease in hypertrophic 
adipocytes, we measured ss the levels of OXPHOS proteins of all the five respiratory 
complexes. The results obtained suggested that the lower mitochondrial oxygen 
consumption that we observed in hypertrophic adipocytes seems to be depend on the 
reduction in the amount of the mitochondrial complexes. 
With the intention to clarify whether the decrease in mitochondrial oxygen consumption and 
OXPHOS proteins level in hypertrophic cells is due to a decrease in mitochondria content or 
mitochondria morphology, we assessed the expression of citrate synthase (CS) and heat 
shock protein 60 (HSP60), which are frequently used as biomarkers for mitochondrial 
content. Although, both the CS and HSP60 levels decreased during adipogenesis process 
passing from pre- to mature adipocytes, no differences were observed between mature and 
hypertrophic adipocytes. As a confirm, the mitotracker fluorescence, a probe selective for 
intact mitochondria, did no show changes in hypertrophic adipocytes respect to mature 
adipocytes. Therefore, we can conclude that the decrease in mitochondrial oxygen 
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consumption and OXPHOS proteins level which in hypertrophic adipocytes does not depend 




The prevalence of obesity has increased worldwide in the past 50 years, reaching pandemic 
levels. Obesity represents a major health challenge because it substantially increases the risk 
of diseases such as type 2 diabetes mellitus, fatty liver disease, hypertension, myocardial 
infarction, stroke, and several cancers, thereby contributing to a decline in both quality of 
life and life expectancy. Obesity prevention and treatments frequently fail in the long term 
(for example, behavioral interventions aiming at reducing energy intake and increasing 
energy expenditure) or are not available or suitable (bariatric surgery) for the majority of 
people affected. For all these reasons, in the last decades, many studies have been 
performed to elucidate the molecular mechanisms involved in obesity progression and 
therapy, and often cellular models have been developed for the experimental investigations. 
In the light of that, the aim of my thesis project was (i) to investigate the cellular and 
molecular changes determined by overnutrition and overweight at different organ levels 
using in vitro models of metabolic disorders and (ii) to assess the possible effects of natural 
and synthetic compounds to counteract these conditions. Below we summarized the main 
results of my research activities. 
12.1 Effects of steatogenic compounds on hepatocytes as a 
model of hepatic steatosis 
Overconsumption of fats and sugars is a major cause of development of non-alcoholic fatty 
liver disease (NAFLD). My studies explored the pathways sustaining the interfering metabolic 
effects of different steatogenic agents in hepatocytes and provided new insights, at the single 
cell level, on the biomechanical and morphological changes of steatotic cells using an in vitro 
model of NAFLD. 
Cells were exposed alone or in combination to excess of oleate and palmitate (0.75 mM), of 
fructose (5.5 mM) or of TNFα (10 ng/ml). The different grade and features of steatosis were 
firstly analyzed in terms of triglycerides (TG) accumulation and lipid droplets (LD). Our results 
showed that the intracellular TG content increased more markedly in cells treated with 
fructose and fatty acids in combination. Interestingly, the combination of fructose and fatty 
acids, markedly enlarged the LD without changing their number, whereas fatty acids and 
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TNFα in combination led to an increase in LD number with a reduction of their size with 
respect to fatty acids alone. ADRP expression level mirrored the changes in lipid droplets. All 
these finding together suggests that the combination of sugar and fat mimics a condition of 
macrovesicular steatosis in vitro, while fatty acids in combination with TNFα induced a 
condition more similar to microvesicular steatosis. The correlation between in vitro macro- 
and microvesicular steatosis with the ongoing cell dysfunction was confirmed by the changes 
in expression of IkBip, a marker for ER stress, and of PPARs. 
In parallel, in the same cellular steatotic models, we quantified the single cell stiffness in term 
of relative elasticity measured by single cell force spectroscopy (SCFS) by using an innovative 
approach. Single cell stiffness was increased in cell exposed to either fructose or fatty acids 
as single agents, but the largest increase was induced by the combination of the two 
steatogenic agents, which mimics a macrovesicular steatosis in vitro. Interestingly, the 
microvesicular-like steatosis showed a cell stiffness similar to the one observed for fatty acids 
alone. This observation demonstrated that single cell stiffness depends on the steatosis 
grade rather than on lipid droplets organization and distribution inside the cell. 
Moreover, we reconstructed the three-dimensional shape of steatotic cells by quantitative 
phase microscopy (QPM) in order to obtain information about the single cell morphometry, 
which changed as a function of the steatosis grade and features. While a rather low grade of 
steatosis, such as that induced by fructose alone, did not alter the geometric parameters, the 
more marked steatosis induced by fatty acids made the cells thinner and larger than control 
cells and with a smoother surface and larger protrusions. On the other hand, cells mimicking 
the macrovesicular condition showed a morphometry intermediate between those treated 
with fructose and fatty acids as single agents, although the highest grade of steatosis. By 
contrast, cells with microvesicular-like steatosis appeared smaller compared to cells exposed 
to fatty acids alone, although they had a similar triglyceride content. Therefore, we can 
conclude that geometric parameters do not depend exclusively on the total triglycerides 
content in steatotic cells, but mainly on the number of lipid droplets in cytosol. Therefore, 
our findings point the attention to the potential role of mechanobiology in metabolic 
diseases, particularly those linked to overweight and obesity. 
12.2 Molecular events associated to adipocyte hypertrophy 
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Obesity depends on adipocyte hypertrophy which is an adaptive response to nutrient excess 
and correlates directly with metabolic disease. The aim of the present study was to compare 
mature and hypertrophic adipocytes at molecular and cellular level. 
To promote hypertrophy, after differentiation 3T3-L1 mouse adipocytes were challenged for 
2 days with a mixture of oleate and palmitate. As a first result we could observe, as expected, 
an increase in triglyceride content in mature adipocytes and a further increase in the 
hypertrophic condition. Lipid droplets average size was increased in differentiated 
adipocytes exposed to oleate and palmitate, thus confirming the induction of the 
hypertrophic condition. As a response to increased intracellular fat content, mature 
adipocytes released increased level of triglycerides into the culture medium and this released 
was almost doubled in hypertrophic condition. 
As a marker for adipogenesis, we assessed PPARγ and adiponectin expression. In adipocytes, 
increased PPARγ expression accompanied the increase in fat content and the largest 
overexpression was observed in hypertrophic cells. By contrast, we observed an increased 
adiponectin expression during adipogenesis but without differences between mature and 
hypertrophic adipocytes. 
Lipid accumulation typically results in increased fat oxidation and consequent ROS 
production which may damage important cellular components. We observed an increase in 
ROS production during adipogenesis and the largest increase occurred in the hypertrophic 
adipocytes. Excess ROS may lead to lipid peroxidation, and in fact MDA levels were increased 
in mature adipocytes and a larger increase in hypertrophic adipocytes, which are sign of fat- 
dependent oxidative stress. 
Furthermore, we investigated the effects at mitochondrial level of adipocyte differentiation 
and hypertrophy. Employing an O2K high-resolution respirometer, we evaluated different 
parameters of mitochondrial respiration. Taken together, the results clearly indicated that 
the hypertrophic condition in vitro led to a general reduction in the mitochondrial oxygen 
consumption, although the routine respiration, which is controlled by basal energy demand 
of the cells, was unchanged. The reduction in activity of both complex I and II in hypertrophic 
adipocytes was paralleled by a marked decrease in the capacity of the electron transfer 
system (ETS) measured from the noncoupled state of maximum respiration. For a better 
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understanding we assessed also the levels of OXPHOS proteins of all the five respiratory 
complexes. The results obtained suggested that the lower mitochondrial oxygen 
consumption that we observed in hypertrophic adipocytes might depend on the reduction in 
the amount of the mitochondrial complexes. 
In order to verify the mitochondria content, we assessed the expression of citrate synthase 
(CS) and heat shock protein 60 (HSP60), which are frequently used as biomarkers for 
mitochondrial content. Although, both the CS and HSP60 levels decreased during 
adipogenesis process passing from pre- to mature adipocytes, no differences were observed 
between mature and hypertrophic adipocytes. As a confirm, the mitotracker fluorescence, a 
probe selective for intact mitochondria, did no show changes in hypertrophic adipocytes 
respect to mature adipocytes. Therefore, we can conclude that the decrease in mitochondrial 
oxygen consumption and OXPHOS proteins level which in hypertrophic adipocytes does not 
depend on a reduced mitochondrial content, but on alteration of mitochondria morphology 
and integrity. 
12.3 Effects of natural and synthetic compounds on lipid 
accumulation and inflammation 
12.3.1 Silybin 
Silybin is the major active constituent of silymarin, an extract of the milk thistle seeds 
(Silybum marianum L. Gaertner, Compositae). It exhibits pharmacological effects, particularly 
in the liver by exerting antioxidant, anti-inflammatory and antifibrotic properties. The 
present study provides a deeper characterization of some patho-physiologically relevant 
mechanisms of action of silybin administered at dose of 50 μmol/L directly to fatty 
hepatocytes.  
As a first result we observed a significant reduction in TG accumulation, and this lipid 
lowering activity seems to be promoted by activation of lipid catabolism pathways, as 
suggested by up-regulation of PPARα and PPARδ, and by inhibition of lipogenic pathways, as 
suggested by the downregulation of PPARγ. The stimulation of catabolism of fatty acids by 
silybin was confirmed by the up-regulation of CPT-1, the first component and rate-limiting 
step of mitochondrial β-oxidation, of CYP2E1, involved in microsomal oxidation, and of AOX, 
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involved in peroxisomal α-oxidation. 
Another sign that silybin ameliorate hepatic steatosis was the increase in miR-122 level in 
steatotic cells upon treatment with silybin. Moreover, our results suggested that the anti- 
steatotic action of silybin implies upregulation of AQP9 and increase of glycerol permeability 
in hepatocytes. As well as a reduction of the fat-stimulated autophagy as demonstrated by 
the downregulation of the LC3-II and Atg7 expression in steatotic cells. 
Uptake of fatty acids by hepatocytes is regulated by PCSK9, and this effect is independent of 
its action on LDL receptor. Indeed, PCSK9 promotes degradation of CD36, which is involved 
in fatty acids uptake and triglyceride storage/secretion. Our data showed that PCSK9 mRNA 
was downregulated in steatotic cells, and silybin significantly reversed PCSK9 downregulation 
in steatotic cells, and apparently restored cellular function while reducing fatty acids influx 
in the hepatocyte. 
Silybin was also able to modify the lipid droplets composition, with a reduction in content of 
the saturated fatty acids and an increase in content of the unsaturated ones, as well as with 
an increase in the amount of short-medium chain fatty acids.  
Silybin shown also effects at the mitochondrial level leading to a significant increase in 
mitochondria size, improvement of the organization of mitochondrial cristae, and reduction 
in both basal and maximal. 
The reduction in fat accumulation exerted by silybin in the steatotic hepatocytes is associated 
with the improvement of the oxidative unbalance as demonstrated by the reduction in lipid 
peroxidation (MDA levels, namely), catalase activity, NF-κB activation and the oxidative DNA 
damage measured as extracellular levels of 8-OHdG. Looking at all these results together, the 
present study suggests that the antioxidant capacity of silybin effectively counteracts the 
possible damaging effects of a high rate of fat catabolism which is stimulated in the attempt 
to reduce excess FA accumulation. 
All these results suggest together a complex and pleiotropic role for silybin in the hepatic 
cells, involving several key molecular intracellular pathways active during liver steatosis and 




Figure 36 Effects of silybin on liver: scheme of the effects of the nutraceutic silybin on liver  
 
11.3.2SAMe 
SAMe, an endogenous molecule playing many functions, is an important physiological 
defence against excess of ROS and previous studies described a potential role for treatment 
of liver abnormalities. The present study provided insights into the effects and the molecular 
mechanisms through which SAMe, may ameliorate fatty acids-induced steatosis and 
oxidative stress in hepatic and endothelial cells. 
In the cell models of the current study, the exposure of hepatocytes and endotheliocytes to 
fatty acids mimics, respectively, an in vitro model of NAFLD and atherosclerosis. Exposure of 
steatotic hepatocytes to different concentrations of SAMe led to a decrease in triglyceride 
content and lipid droplets size and number. CPT1, a mitochondrial protein acting as shuttle 
for FAs involved in mitochondrial FA oxidation, was up regulated in steatotic cells and 
furthermore after the exposure to SAMe, at all concentrations. In the light of that, the lipid- 
lowering action of SAMe might be sustained by stimulation of oxidative and/or secretory 
pathways. UCP2, a mitochondrial uncoupling protein, was significantly up-regulated upon 
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lipid-loading but SAMe at all concentration did not change significantly its expression. Lipid 
peroxidation, ROS production and catalase activity were all significantly decreased upon 
treatment with SAMe. 
On the other side, exposure of endothelial cells to oleate and palmitate, led to an increase in 
triglyceride content and lipid peroxidation. As a response to lipid-loading, endothelial cells 
released NO and produced ROS thus triggering proinflammatory events. The subsequent 
treatment with SAMe led to a decrease of triglyceride content and NO and ROS production. 
We can conclude that SAMe is an efficacious lipid-lowering and antioxidant agent for 
steatotic hepatocytes and endotheliocytes. The anti-steatotic effect of the molecule seems 
to be sustained by an increase in catabolic pathways at mitochondrial level. In conclusion, 
the beneficial effect of SAMe on the in vitro models of NAFLD and atherosclerosis suggests 
that the molecule possess a potential therapeutic benefit on these pathological conditions. 
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13. Summary of major findings and future 
perspectives 
 
The presents PhD thesis has been focused on two different aims:  
1. To study the molecular mechanisms associated with excess fat accumulation in different 
tissues involved in a condition of obesity: liver, vascular endothelium and adipose tissue. 
To this aim, three cellular models of NAFLD, atherosclerosis and adipocyte hypertrophy were 
developed and employed. 
Our studies demonstrated, first of all, that the in vitro model of NAFLD, that we developed, well 
mimics in vitro the onset and progression of NAFLD from simple steatosis to steatohepatitis. My 
studies explored, in particular, the pathways sustaining the interfering effects of different 
steatogenic agents such as fatty acids, fructose and TNF on hepatocytes. The main findings of 
these studies demonstrated the metabolic interference among these compounds at the level of 
the hepatic cells leading to a more severe steatosis with respect to the single agents (Chapter 5; 
Chapter 6). Treatment with different steatotic agents alone or in combination, led to different 
grade and features of steatosis. Analysis of triglyceride content, lipid droplet morphology and 
different molecular markers, suggests that the combination of sugar and fat mimics a condition 
of macrovesicular steatosis, while fatty acids in combination with TNFα induced a condition more 
similar to microvesicular steatosis. Interestingly, our studies provided also new insights, at the 
single cell level, on the biomechanical and morphological changes associated with more or less 
sever steatosis depending mainly on the size of the lipid droplets (Baldini et al., 2019). Single cell 
stiffness analysis demonstrated that all the steatotic conditions shown an increase in cell 
stiffness with respect to control cells and that the macrovesicular steatosis was associated with 
the largest increase in single cell stiffness. The results obtained demonstrated that the stiffness 
at single cell level depends on the grade of steatosis rather than on lipid droplets organization 
and distribution inside the cell (Chapter 9). 
In parallel, my research investigated endothelium dysfunction being associated with NAFLD and 
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obesity. My results obtained using an in vitro model of endothelial dysfunction showed that 
treatment with long chain fatty acids induced fat accumulation and oxidative stress also in 
human endothelial cells thus well mimicking a condition of atherosclerosis in vitro (Chapter 10).  
FInaly, the most recent part of my activity was focused on an in vitro model of adipocyte 
hypertrophy, represented by mouse pre-adipocytes treated with an adipogenic mixture allowed 
to clarify the molecular and cellular changes involved in adipocyte maturation and hypertrophy 
(Chapter 11). After a preliminary characterization of the model in term of triglyceride content, 
lipid droplet morphology and molecular markers, I proceeded evaluating the oxidative stress and 
the mitochondria function and integrity. The hypertrophic condition shown a larger increase in 
fat accumulation and a consequent increase in free radical production and oxidative stress. The 
most important finding of this study was that the hypertrophic condition in vitro led to a general 
reduction in the mitochondrial oxygen consumption and in the amount of the mitochondrial 
OXPHOS proteins, although mitochondrial content was unchanged compared to mature 
adipocyte. 
 
2. To identify and investigate some natural compounds that may be employed as 
nutraceuticals:  
• Silybin. Silybin was used to treat FaO cells with different grade of steatosis (Chapter 5; 
Chapter 6; Chapter 7; Chapter 8). We found that the beneficial effects of silybin on 
hepatic steatosis involved: (i) increase in lipid catabolism pathways, (ii) inhibition of 
lipogenic pathways, (iii) reduction of lipid peroxidation, catalase activity and NF-κB 
activation, (iv) amelioration of the profile of fatty acids (FA) stored in lipid droplets with 
an increase in the short/medium chain FA ratio, and a decrease in the 
saturated/monounsaturated FA ratio, (v) stimulation of mitochondrial FA oxidation, 
(vi) increase in the level of  miR-122, the master regulator of hepatic lipid metabolism; 
(vii) increase in AQP9 expression and glycerol permeability, (viii) diminution of fat-
stimulated autophagy. At mitochondrial level, silybin led to a significant increase in 
mitochondria size, improved the organization of mitochondrial cristae, increased the 
polarization of the inner membrane of mitochondria and the ATP production. 
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In conclusion, my studies provided new insights about the protective effects of silybin 
administered directly to hepatocytes mimicking in vitro the NAFLD progression. 
Further studies are on the way to translate such promising results into long-term 
beneficial effects, in the hope that onset, progression and worsening of NAFLD/NASH 
will be prevented/delayed in human being by using more natural nutraceutic 
approaches led to a decrease in triglyceride content being associated with an average 
reduction in lipid droplet size and number, and an increase in mitochondria fatty acid 
oxidation 
• S-Adenosylmethionine (SAMe). Our studies (Chapter 10) provided insights into the 
effects and the molecular mechanisms through which SAMe, an endogenous 
molecule playing many functions as methyl donor, may ameliorate fatty acid-induced 
steatosis and oxidative stress in hepatic and endothelial cells, respectively. We 
demonstrated that SAMe in steatotic hepatocytes played significant anti-steatotic 
and protective effects. Indeed, on steatotic hepatocytes SAMe led to a decrease in 
triglyceride content. The anti-steatotic effect of the molecule seems to be sustained 
by an increase in catabolic pathways at mitochondrial level. Moreover, SAMe was 
also efficacious on stressed endothelial cells. Treatment of dysfunctional endothelial 
cells with SAMe at different concentrations led to a decrease of nitric oxide and ROS 
production. 
In conclusion, the beneficial effect of SAMe on the in vitro models of NAFLD and 
atherosclerosis suggests that the molecule possess a potential therapeutic benefit 
on these pathological conditions that should be investigated even more in the 
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